
<html lang="en"     class="pb-page"  data-request-id="cd55495b-bbee-494f-b47c-b68cbf4b5aca"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.7b01075;requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-20;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery" /></meta><meta name="dc.Creator" content="Yanli  Wang" /></meta><meta name="dc.Creator" content="Yuze  Sun" /></meta><meta name="dc.Creator" content="Ran  Cao" /></meta><meta name="dc.Creator" content="Dan  Liu" /></meta><meta name="dc.Creator" content="Yuting  Xie" /></meta><meta name="dc.Creator" content="Li  Li" /></meta><meta name="dc.Creator" content="Xiangbing  Qi" /></meta><meta name="dc.Creator" content="Niu  Huang" /></meta><meta name="dc.Description" content="To explore novel kinase hinge-binding scaffolds, we carried out structure-based virtual screening against p38α MAPK as a model system. With the assistance of developed kinase-specific structural fi..." /></meta><meta name="Description" content="To explore novel kinase hinge-binding scaffolds, we carried out structure-based virtual screening against p38α MAPK as a model system. With the assistance of developed kinase-specific structural fi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 16, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01075" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01075" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01075" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01075" /></link>
        
    
    

<title>In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01075" /></meta><meta property="og:title" content="In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0010.jpeg" /></meta><meta property="og:description" content="To explore novel kinase hinge-binding scaffolds, we carried out structure-based virtual screening against p38α MAPK as a model system. With the assistance of developed kinase-specific structural filters, we identify a novel lead compound that selectively inhibits a panel of kinases with threonine as the gatekeeper residue, including BTK and LCK. These kinases play important roles in lymphocyte activation, which encouraged us to design novel kinase inhibitors as drug candidates for ameliorating inflammatory diseases and cancers. Therefore, we chemically modified our substituted triazole-class lead compound to improve the binding affinity and selectivity via a “minimal decoration” strategy, which resulted in potent and selective kinase inhibitors against LCK (18 nM) and BTK (8 nM). Subsequent crystallographic experiments validated our design. These rationally designed compounds exhibit potent on-target inhibition against BTK in B cells or LCK in T cells, respectively. Our work demonstrates that structure-based virtual screening can be applied to facilitate the development of novel chemical entities in crowded chemical space in the field of kinase inhibitor discovery." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01075"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01075">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01075&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01075&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01075&amp;href=/doi/10.1021/acs.jmedchem.7b01075" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8552-8564</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01050" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01114" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanli++Wang">Yanli Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuze++Sun">Yuze Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ran++Cao">Ran Cao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Liu">Dan Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuting++Xie">Yuting Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Li">Li Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiangbing++Qi">Xiangbing Qi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7139-5164" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Niu++Huang">Niu Huang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6912-033X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">National Institute of Biological Sciences, Beijing, No. 7 Science Park Road, Zhongguancun Life Science Park, Beijing 102206, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Peking University-Tsinghua University-National Institute of Biological Sciences Joint Graduate Program, School of Life Sciences, Tsinghua University, Beijing 100084, China</span></div><div class="corresp-info"><strong>*</strong>X.Q.: phone, 86-10-80726688-8655; fax, 86-10-80708048; e-mail, <a href="/cdn-cgi/l/email-protection#6b1a0213020a050c0902050c2b05020918450a08450805"><span class="__cf_email__" data-cfemail="62130b1a0b030c05000b0c05220c0b00114c03014c010c">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>N.H.: phone, 86-10-80720645; fax, 86-10-80720813; e-mail, <a href="/cdn-cgi/l/email-protection#a9c1dcc8c7cec7c0dce9c7c0cbda87c8ca87cac7"><span class="__cf_email__" data-cfemail="8fe7faeee1e8e1e6facfe1e6edfca1eeeca1ece1">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01075&amp;href=/doi/10.1021%2Facs.jmedchem.7b01075" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8552–8564</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 25, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 July 2017</li><li><span class="item_label"><b>Published</b> online</span>16 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 October 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01075" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01075</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8552%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYanli%2BWang%252C%2BYuze%2BSun%252C%2BRan%2BCao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D20%26contentID%3Dacs.jmedchem.7b01075%26title%3DIn%2BSilico%2BIdentification%2Bof%2Ba%2BNovel%2BHinge-Binding%2BScaffold%2Bfor%2BKinase%2BInhibitor%2BDiscovery%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8564%26publicationDate%3DOctober%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01075"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3226</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01075" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yanli&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Yuze&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Ran&quot;,&quot;last_name&quot;:&quot;Cao&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yuting&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Xiangbing&quot;,&quot;last_name&quot;:&quot;Qi&quot;},{&quot;first_name&quot;:&quot;Niu&quot;,&quot;last_name&quot;:&quot;Huang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8552-8564&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01075&quot;},&quot;abstract&quot;:&quot;To explore novel kinase hinge-binding scaffolds, we carried out structure-based virtual screening against p38α MAPK as a model system. With the assistance of developed kinase-specific structural filters, we identify a novel lead compound that selectively inhibits a panel of kinases with threonine as the gatekeeper residue, including BTK and LCK. These kinases play important roles in lymphocyte activation, which encouraged us to design novel kinase inhibitors as drug candidates for ameliorating inflammatory diseases and cancers. Therefore, we chemically modified our substituted triazole-class lead compound to improve the binding affinity and selectivity via a “minimal decoration” strategy, which resulted in potent and selective kinase inhibitors against LCK (18 nM) and BTK (8 nM). Subsequent crystallographic experiments validated our design. These rationally designed compounds exhibit potent on-target inhibition against BTK in B cells or LCK in T cells, respectively. Our work demonstrates that structure-based &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01075&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01075" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01075&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01075" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01075&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01075" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01075&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01075&amp;href=/doi/10.1021/acs.jmedchem.7b01075" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01075" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01075" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01075%26sid%3Dliteratum%253Aachs%26pmid%3D28945083%26genre%3Darticle%26aulast%3DWang%26date%3D2017%26atitle%3DIn%2BSilico%2BIdentification%2Bof%2Ba%2BNovel%2BHinge-Binding%2BScaffold%2Bfor%2BKinase%2BInhibitor%2BDiscovery%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D20%26spage%3D8552%26epage%3D8564%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/jmcmar.2017.60.issue-20/20171026/jmcmar.2017.60.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To explore novel kinase hinge-binding scaffolds, we carried out structure-based virtual screening against p38α MAPK as a model system. With the assistance of developed kinase-specific structural filters, we identify a novel lead compound that selectively inhibits a panel of kinases with threonine as the gatekeeper residue, including BTK and LCK. These kinases play important roles in lymphocyte activation, which encouraged us to design novel kinase inhibitors as drug candidates for ameliorating inflammatory diseases and cancers. Therefore, we chemically modified our substituted triazole-class lead compound to improve the binding affinity and selectivity via a “minimal decoration” strategy, which resulted in potent and selective kinase inhibitors against LCK (18 nM) and BTK (8 nM). Subsequent crystallographic experiments validated our design. These rationally designed compounds exhibit potent on-target inhibition against BTK in B cells or LCK in T cells, respectively. Our work demonstrates that structure-based virtual screening can be applied to facilitate the development of novel chemical entities in crowded chemical space in the field of kinase inhibitor discovery.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As of June 2017, 30 drugs targeting kinase ATP-binding sites have been approved for clinical use.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> However, the discovery of novel and selective kinase inhibitors using high throughput screening (HTS) approaches has become increasingly challenging in an already crowded chemical landscape, since most commercially available chemical libraries have been screened exhaustively against various kinase targets.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Moreover, almost all of the inhibitors that target kinase ATP-binding site contain structural scaffolds forming hydrogen bond (HB) interactions with the kinase hinge backbone, including adenosine-mimic purine analogues, pyrimidine, quinoline, thiazole/imidazole, and indolinone (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), which has further limited the available chemical space for novel drug discovery.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Given the highly conserved structure of the ATP-binding site across the entire kinase superfamily, especially the hinge region, the lack of target heterogeneity makes it challenging to develop selective kinase inhibitors.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Lack of selectivity clearly leads to side effects for many kinase inhibitors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Collectively, these factors constitute a severe bottleneck for kinase drug discovery.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative hinge-binding scaffolds collected from literature.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Hydrogen bonds forming between kinase hinge region and ligand are highlighted in red. The residues of the hinge region are annotated based on its position to the gatekeeper residue (gk).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is well established that the kinase gatekeeper residue plays a centrally important role in determining the selectivity of kinase inhibitors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> About 20% of human protein kinases have a small gatekeeper residue (e.g., glycine, alanine, cysteine, serine, or threonine) that directly affects the ability of drugs to access the hydrophobic back pocket. Increased accessibility typically improves inhibitor binding affinity and specificity. A subset of kinases have threonine as their gatekeeper residue which provides additional opportunity for designing kinase inhibitor to form a specific HB interaction. Among these, BTK and LCK are known to be important for the activation of lymphocytes.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> BTK is a member of the TEC subfamily that functions as a critical component in the B-cell antigen receptor (BCR) signaling pathway.<a onclick="showRef(event, 'ref10 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref12 ref13">(10, 12, 13)</a> LCK is a SRC subfamily protein with an essential function in proximal T cell antigen receptor (TCR) signal transduction.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The p38α MAPK plays a vital role in inflammation by regulating the biosynthesis of tumor necrosis factor (TNF) α, interferon (IFN) γ, and other cytokines via transcriptional and post-transcriptional mechanisms in response to extracellular stimuli.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> It has long been anticipated that interventions targeting the activity of BTK, LCK, or p38α MAPK can have strong therapeutic effects.<a onclick="showRef(event, 'ref11 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref11 ref18 ref19">(11, 18, 19)</a> The pharmaceutical industry has undertaken great efforts to develop selective inhibitors against these kinases, and some inhibitors are currently showing promise in both preclinical models and clinical trials.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19-22)</a> The BTK inhibitor ibrutinib, 1-[(3<i>R</i>)-3-[4-amino-3-(4-phenoxyphenyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one (PCI-32765),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> was approved by the U.S. FDA for the treatment of chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenstrom’s macroglobulinemia (WM).<a onclick="showRef(event, 'ref12 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref12 ref24 ref25">(12, 24, 25)</a> Ibrutinib also shows significant activities across a variety of inflammatory diseases.<a onclick="showRef(event, 'ref23 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref26">(23, 26)</a> A second-generation BTK inhibitor, acalabrutinib, was shown to be more potent and selective than ibrutinib, and a few other BTK inhibitors have also entered clinical trials (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Figure S1</a>).<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> The oral administration of selective LCK inhibitors, e.g., <i>N</i>-(4-(1-((1<i>s</i>,4<i>s</i>)-4-(4-acetylpiperidin-1-yl)cyclohexyl)-4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-3-yl)-2-methoxyphenyl)-1-methyl-1<i>H</i>-indole-2-carboxamide (A-770041),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> can inhibit IL-2 production and exhibit anti-inflammatory activity in mouse models.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a></div><div class="NLM_p last">Here, we performed structure-based hierarchical virtual screening to identify novel hinge-binding scaffolds from a chemical library containing more than 100 000 diverse drug-like compounds. We selected p38α MAPK as our starting model system as in our previous computational study<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and discovered a novel lead compound with high ligand efficiency (LE).<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> Starting with this lead, we then carried out structure-based optimization with a “minimal decoration” strategy against both BTK and LCK, which is to optimize the lead compound by loading the target-specific functional groups onto the privileged structural scaffold based on key molecular interactions. This finally led to the discovery of novel and highly potent inhibitors of BTK and LCK with impressive selectivity. These candidates were further assessed by measuring their on-target activities in cells. The identified compounds could bring practical benefits in developing novel kinase inhibitors for the treatment of inflammatory disease as well as cancers.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Hierarchical Virtual Screening</h3><div class="NLM_p">Many approaches have been proposed to identify novel inhibitors for protein kinase.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34-36)</a> Herein, we used our established pipeline to perform structure-based hierarchical virtual screening against the ATP-binding site of p38α MAPK (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A).<a onclick="showRef(event, 'ref31 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref31 ref37 ref38 ref39 ref40">(31, 37-40)</a> We developed two kinase-specific structural filters to exclude hits that lacked the kinase-binding properties: (1) hydrogen bonding with hinge region backbone atoms, including those of the carbonyl group of His107 and the amide group of Met109; (2) favorable contacts with residues surrounding the hydrophobic back pocket, including Val38, Leu75, Ile84, and Leu104. In total, we docked 107 238 compounds, which generated 380 382 unique binding poses. After exclusion of undesired binding poses with structural filters, 201 285 docking poses were subjected to further minimization-based MM-GB/SA refining and rescoring. This led to defined 21 893 molecules as qualified hits having favorable binding energies. After a second round of automatic filtering, the top 500 ranked molecules with the lowest energy scores among the 10 381 compounds surviving the structural filters were selected and re-evaluated with MD-based MM/PBSA binding energy calculations. Ultimately, eight hits with favorable binding energies and reasonable binding poses were chosen for experimental test (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Figure S2A</a>). Four of these were active at the concentration of 50 μM in p38α MAPK activity inhibition assays (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Figure S2B</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Workflow of hierarchical virtual screening campaign against p38α MAPK. (B) Predicted binding pose of lead compound in p38α MAPK ATP-site. Potential hydrogen bonds are represented with orange lines. (C) Dose-dependent inhibition of p38α MAPK kinase activity by the lead compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Among the four active hits, <i>N</i>-(2-chloro-6-fluorobenzyl)-3-(furan-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>1</b>) caught our attention, owing to both the unique binding mode of 1<i>H</i>-1,2,4-triazol-5-amino moiety and the high number of hydrogen bonds that it forms with the hinge region of p38α MAPK (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). The IC<sub>50</sub> value of <b>1</b> against p38α MAPK is 14.4 ± 1.2 μM (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). <b>1</b> was predicted to form four hydrogen bonds with the hinge region: (1) the hydroxyl group of the gatekeeper (gk for short) residue Thr106; (2) the backbone carbonyl of His107 (gk + 1); (3) the backbone amide of Met109 (gk + 3); (4) the backbone amide of Gly110 (gk + 4). Most currently available kinase inhibitors form one or two hydrogen bonds with the hinge region, and a few form three, but we are unaware of any compound that forms four hydrogen bonds.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Interestingly, molecular dynamics simulations showed that the side chain of Thr106 changed its conformation in the starting crystal structural model (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OUY">1OUY</a>) and formed a stable HB interaction with <b>1</b> using its hydroxyl group (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Figure S3</a>). <b>1</b> has a considerably structural novelty as compared with the currently available small-molecule kinase drugs (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Figure S4, Table S1</a>). In addition, none of the structurally similar compounds are reported to have kinase activities based on similarity search in existing patents and literatures in SciFinder database (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Table S2</a>), which further demonstrated the novelty of our identified scaffold. <b>1</b> was passed through one of the publicly available pan assay interference compounds (PAINS) filters (<a href="http://zinc15.docking.org/patterns/home/" class="extLink">http://zinc15.docking.org/patterns/home/</a>),<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and the promiscuous aggregate-based inhibition was ruled out by the addition of detergent in biochemical assay condition. Therefore, <b>1</b> was chosen as our lead compound for further structural optimization.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Crystal Structure Determination of p38α MAPK Bound with <b>1</b></h3><div class="NLM_p">To validate our binding pose predictions and to facilitate further structural modifications, we determined the crystal structure of p38α MAPK bound with <b>1</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYX">5XYX</a>). The data collection and refinement statistics are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Table S3</a>. The binding pose of <b>1</b> in the crystal structure is very similar to our computational prediction (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Specifically, three HB interactions are formed between the ligand 1<i>H</i>-1,2,4-triazol-5-amine group and the kinase hinge region, including the hydroxyl group of Thr106, the backbone carbonyl of His107, and the backbone amide of Met109 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). Notably, the predicted conformational change of side chain of Thr106 in p38α MAPK that resulted from the <b>1</b> binding was apparent in our crystal complex structure. Our structural study also reveals the unique binding pose of 1<i>H</i>-1,2,4-triazol-5-amine scaffold that is different from that of any of the currently available kinase inhibitors (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D). This not only accounts for the high number of hydrogen bonds that <b>1</b> forms but also explains its gatekeeper targeting property. Surprisingly, the predicted HB interaction between furan oxygen atom of <b>1</b> and the amide group of Gly110 was not present in the crystal complex structure (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Given the previously reported “hinge glycine flip” phenomenon,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> we carefully checked the backbone conformation of Gly110 in our solved crystal complex structure and noted that the carbonyl group of Met109 rather than amide group of Gly110 orients toward the ligand. Thus, the crystal structure strongly suggests that <b>1</b> forms a weak hydrogen bond (C–H···O) with the backbone carbonyl group of Met109, with a distance of 2.88 Å between the carbonyl oxygen atom and the furan carbon atom.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Crystal complex structure of p38α MAPK bound with the lead compound. Protein and the lead compound structures are colored in white and pink, respectively. Hydrogen bonds are represented with orange and cyan lines. The 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density map (contoured at 1σ) around the inhibitor is shown as purple mesh. (B) Schematic representation of the unique binding mode of the lead compound with a focus on the hinge-binding motif 1,2,4-triazol-5-amine and (C) active-conformation and (D) inactive-conformation binding modes of representative kinase inhibitors containing a 5-amine-pyrazole fragment. Hydrogen bonds between kinase hinge and ligand are highlighted with red circles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the flipped conformation of hinge glycine complicated the structural comparison between computational models and experimentally determined crystal structure, we found that the predicted ligand binding poses were progressively improved by the increased computational complexity, as exemplified by the gradually reduced root-mean-square deviation (RMSD) in comparison with crystal complex structure, from molecular docking (2.134 Å) to MM-GB/SA (1.002 Å) and to MD-PB/SA (0.351 Å) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Figure S5</a>). This finding suggests that using increasingly sophisticated and physically realistic methods progressively improves the accuracy of ligand binding mode prediction, which is consistent with our previous studies.<a onclick="showRef(event, 'ref37 ref38 ref43'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref43">(37, 38, 43)</a></div><div class="NLM_p last">We superimposed the crystal structures of kinases with threonine as gatekeeper residue (including BTK, LCK, FYN, LYN, and BMX) onto our determined crystal complex structure of the p38a MAPK; <b>1</b> could form key hinge-binding HB interactions without obvious steric clashes with the binding site residues. Therefore, we tested the selectivity of <b>1</b> against in-house kinases with gatekeeper residue of threonine. As expected, <b>1</b> showed comparable inhibition activities, including BTK (1.1 ± 0.1 μM), LCK (0.5 ± 0.1 μM), FYN (0.6 ± 0.2 μM), LYN (0.5 ± 0.2 μM), and BMX (18.3 ± 0.2 μM). We also assessed the inhibition activity against in-house kinases with gatekeeper residues larger than threonine (FGFR1, GSK3β, MET, IKKε, AKT1/2, IGF1R, JAK3, ROCK1, SYK, DYRK1A, ITK, and FLT3). <b>1</b> showed no significant inhibition against these kinases with larger-sized gatekeeper residues (data not shown). These results support that both the access to back pocket and the HB interaction with threonine gatekeeper are critical for the determination of the selectivity of <b>1</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structure-Based Lead Optimization against LCK and BTK</h3><div class="NLM_p">Given its small molecular size and unique hinge-binding characteristics, <b>1</b> holds promise as a starting point for the development of more potent and selective kinase inhibitors. Here, we focused on two important targets, BTK and LCK, both of which have threonine as their gatekeeper residues.</div><div class="NLM_p">Unlike p38α MAPK, both LCK and BTK have an additional residue inserted in their hinge regions that adds to the total space at the opening of ATP-binding site and increases the tolerance of these proteins for inhibitors with relatively bulkier substituents (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). Additionally, the gk + 6 residue (Asp112) in p38α MAPK differs from the counterpart residues (gk + 7) in LCK and BTK, which are Ser323 and Cys481, respectively (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). Notably, Cys481<sup>BTK</sup> has been exploited for the development of covalent inhibitors against BTK, as exemplified by the clinical drug ibrutinib.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Superposition of crystal complex structures of p38α MAPK bound with <b>1</b> and LCK complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BYM">3BYM</a>). (B) Superposition of crystal structures of p38α MAPK bound with <b>1</b> and BTK complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T9T">3T9T</a>). (C) Strategies of structural modification for potent selective kinase inhibitors against LCK and BTK on the structural basis of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By superimposing our crystal complex structure with the previously reported PDB structures of LCK (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BYM">3BYM</a>) and BTK (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T9T">3T9T</a>) in complex with other inhibitors, we found that (1) the benzimidazoletriazine based LCK inhibitor, <i>N</i>-phenyl-1-(4-((3,4,5-trimethoxyphenyl)amino)-1,3,5-triazin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-amine (AM0) extends outside the hinge region with its bulky 3,4,5-trimethoxyl substituent (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A), which has been thought to contribute to its potency (IC<sub>50</sub> = 6 nM);<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> (2) the BTK inhibitor (<i>Z</i>)-4-(dimethylamino)-<i>N</i>-(7-fluoro-4-(<i>o</i>-tolylamino)imidazo[1,5-<i>a</i>]quinoxalin-8-yl)-<i>N</i>-methylbut-2-enamide (IAQ) forms a covalent bond with Cys442 (gk + 7) using the acrylamide “warhead”, which is known to be critical for its low nanomolar inhibition potency (IC<sub>50</sub> = 1.93 nM) and its selectivity.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In these complex structures, the aforementioned functional groups (methoxyl, acrylamide) of both the LCK and BTK inhibitors are located at the opening of ATP-binding site, which is the same position that is occupied by the furan moiety of <b>1</b> in our crystal complex structure of p38α MAPK. On this basis, we proposed a structurally modifying strategy that includes two stages (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C): (1) replacing the furan group of <b>1</b> with a more easily decorated phenyl group; (2) loading functional groups of interest (e.g., hydroxyl and amine and later methoxyl and acrylamide) on the specific different sites of the phenyl ring.</div><div class="NLM_p">Specifically, we designed <b>2</b> by replacing the furan with a phenyl group, which substantially reduced p38 MAPK inhibition activity (27.1 ± 7.4 μM) but left BTK and LCK inhibition activity largely unchanged. In silico modeling indicated that the meta site of phenyl ring orients toward Asp112<sup>p38α</sup>. We thus introduced HB-donor containing groups (hydroxyl or amine) at this position to promote the formation of additional HB interaction and to facilitate subsequent chemical decoration. As expected, both modifications improve the potency against p38α MAPK (<b>3</b>, 9.2 ± 0.4 μM; <b>4</b>, 8.8 ± 1.5 μM) compared with the parent compound <b>2</b>. These modifications also significantly improved compound solubility. Importantly, the inhibition potency of both <b>3</b> and <b>4</b> against both BTK and LCK was comparable to that observed originally with <b>1</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). We determined the cocrystal structure of p38α MAPK in complex with <b>3</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYY">5XYY</a>). Data collection and refinement statistics are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Table S4</a>. Consistently, <b>3</b> adopts the same binding pose as <b>1</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A), and the introduced phenol substituent forms an additional HB interaction with the side chain carboxyl group of Asp112.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Crystal structure of p38α MAPK in complex with <b>3</b>. (B) Crystal structure of BTK in complex with <b>8</b>. Protein and ligand structures are colored in white and hot pink, respectively. Hydrogen bonds are represented with cyan dash lines. The 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density map (contoured at 1σ) around the inhibitor is shown as purple mesh.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Results for the Chemical Modifications on <b>1</b> against p38α MAPK, BTK, and LCK<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0009.gif" alt="" id="GRAPHIC-d161e773-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">The IC<sub>50</sub> values were determined for each compound (mean ± SEM) from three independent tests.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Designing Potent LCK and BTK Inhibitors</h3><div class="NLM_p">We also attempted O- and N-methylation on the 3,4,5-sites of phenyl group which generates <b>5</b>, <b>6</b>, and <b>7</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Encouragingly, <b>7</b> exhibited a significantly improved potency against LCK (IC<sub>50</sub> = 0.018 ± 0.007 μM) and inferior inhibition activity against p38α MAPK (IC<sub>50</sub> > 100 μM). The fact that these modifications substantially reduced the affinity toward p38α MAPK can be attributed to the following: (1) O-/N-methylation eliminates the HB-donor potential and prevents the favorable interaction with Asp112<sup>p38α</sup>; (2) O-/N-methylation increases the size of the substituent to an extent that exceeds the tolerance of the p38α MAPK hinge region, which lacks the one-residue insertion compared with LCK. Unfortunately, the poor water solubility of <b>7</b> might lead to the failed attempts in obtaining the crystals of LCK bound with <b>7</b>.</div><div class="NLM_p">Covalent kinase inhibitors developed to target BTK have shown great promise in treating cancers and inflammatory diseases.<a onclick="showRef(event, 'ref23 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref23 ref46 ref47 ref48">(23, 46-48)</a> However, the first-generation BTK inhibitor (ibrutinib) was shown to irreversibly inhibit other off-target kinases at clinically relevant concentration (e.g., TEC, ITK, and ErbB2/HER2).<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> This could be responsible for certain side effects of ibrutinib including bleeding, rash, atrial fibrillation, and diarrhea.<a onclick="showRef(event, 'ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50">(48-50)</a> Although it is not fully elucidated, the mechanism of bleeding may be related with the inhibition of TEC. Starting from <b>5</b>, we introduced the acrylamide moiety as the “warhead” to the meta-substitution position of the phenyl ring, generating <b>8</b>, which exhibits significantly improved BTK inhibition (IC<sub>50</sub> = 5 nM). We further assessed the selectivity of <b>8</b> against several off-targets of ibrutinib (<sup>33</sup>P filtration binding assay, Reaction Biology Corp.). Encouragingly, <b>8</b> has a BTK/TEC selectivity ratio of 160 (BTK, 1.91 ± 0.02 nM; TEC, 306.45 ± 75.02 nM) compared with ibrutinib’s selectivity ratio of 17 (BTK, 0.11 ± 0.01 nM; TEC, 1.86 ± 0.01 nM). Note that the reported BTK/TEC selectivity ratio of ibrutinib was 4.7 (BTK, 1.5 ± 0.2 nM; TEC, 7.0 ± 2.5 nM).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Besides, <b>8</b> also shows considerable selectivity against ITK and ErbB2 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Table S5</a>).</div><div class="NLM_p last">We determined the cocrystal structure of BTK bound with <b>8</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYZ">5XYZ</a>). Data collection and refinement statistics are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Table S6</a>. As expected, <b>8</b> forms three hydrogen bonding interactions with the BTK hinge region, including one hydrogen bond with the side chain of the gatekeeper residue Thr474 and two hydrogen bonds with backbones of the Glu475 and Met477 residues. It also forms a covalent bond with the thiol group of Cys481 using the acrylamide warhead (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). We also used LC–MS/MS to confirm the presence of the covalent bond between BTK and <b>8</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Table S7</a>).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Assessing the On-Target Cellular Effects of the Candidate Compounds</h3><div class="NLM_p">Compared to currently available LCK and BTK inhibitors, <b>7</b> and <b>8</b> exhibit low Tanimoto coefficients (<i>T</i><sub>c</sub> < 0.3) and high ligand efficiency<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">Supporting Information Table S8</a>), highlighting the structural novelty and druggability of our compounds. We assessed the on-target inhibition of BTK and LCK by <b>1</b>, <b>7</b>, and <b>8</b>. First, we examined the effects of BTK inhibition on the phosphorylation level of BTK and its physiological substrate PLCγ2 in Ramos cells. All three compounds inhibited the autophosphorylation of BTK and the phosphorylation of PLCγ2, with varying potencies (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Second, we examined the effects of LCK inhibition on the phosphorylation level of ZAP70 and its physiological substrate LAT in Jurkat cells. <b>7</b> significantly inhibited the phosphorylation of both ZAP70 and LAT, while <b>1</b> and <b>8</b> showed only moderate inhibition, even at high concentrations (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). These cellular assay results suggest the reasonability of regarding <b>7</b> primarily as an LCK inhibitor and regarding <b>8</b> primarily as a BTK inhibitor. In addition, the inhibition activity of all three inhibitors are dose-dependent, and the cellular inhibition activities of all three compounds are consistent with their in vitro determined molecular potencies.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. On-target inhibition of BTK and LCK by <b>1</b>, <b>7</b>, and <b>8</b> in B and T cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Here, we employed in silico screening techniques to search for novel kinase inhibitors using p38α MAPK as a model system. The identified lead compound <b>1</b> is structurally dissimilar to any known kinase hinge binders and is characterized by a unique gatekeeper residue of threonine targeting mode of action. As expected, <b>1</b> has inhibition activity against multiple kinases that share the same common gatekeeper residue of threonine, including p38α MAPK (14.4 μM), BTK (1.1 μM), and LCK (0.5 μM), among several others. Impressed with the attractive properties of <b>1</b> (low MW, high LE, and amenability to modification), we used it as a starting scaffold and attempted to make minimal decorations to improve the binding affinity against selected kinases like LCK and BTK that have threonine as their gatekeeper residues. Encouragingly, <b>7</b> and <b>8</b> were more potent and more highly selective than the lead compound against LCK (18 nM) and BTK (8 nM). The potent on-target inhibition effects of these compounds (<b>1</b>, <b>7</b>, and <b>8</b>) observed in cellular assays highlight the promise of these novel compounds as candidate drugs for the treatment of cancers and inflammatory diseases. Moreover, our work underscores both the power and flexibility of in silico approaches for drug discovery and represents a successful example of how a “minimal decoration” strategy can be used to turn an initial lead compound into attractive candidate drugs.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Computational Details</h3><div class="NLM_p last">The crystal structure of p38α MAPK (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OUY">1OUY</a>) was selected as the starting model. Hierarchical virtual screening was conducted using our previously reported computational pipeline.<a onclick="showRef(event, 'ref31 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref31 ref39 ref40">(31, 39, 40)</a> First, we docked our in-house compound library against the ATP-binding site of p38α MAPK using DOCK 3.5.54.<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51-53)</a> This generated multiple poses for each compound. Second, we carried out MM-GB/SA refinement and rescoring using the protein local optimization program (PLOP).<a onclick="showRef(event, 'ref37 ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref37 ref54 ref55 ref56">(37, 54-56)</a> During this process, the protein was kept rigid and the binding energy was calculated according to the equation <i>E</i><sub>bind</sub> = <i>E</i><sup>R*L</sup> – <i>E</i><sup>L</sup> – <i>E</i><sup>R</sup>. The top ranking compounds with the lowest binding energies were further evaluated with a MD-based MM-PB/SA method implemented in the AMBER10.0 suite.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> AMBER99SB<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and general Amber force field (GAFF)<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> were applied to the receptor and the ligands, respectively.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Protein Expression and Purification</h3><div class="NLM_p">Human p38α MAPK was cloned into the pET28a vector using the <i>Nco</i>I/<i>Not</i>I restriction sites. Human BTK kinase domain (residues 382–659) was inserted into modified pFastBac-HTB (a PreScission-cleavable 6*His tag was introduced into the vector). The inserted genes were sequenced to ensure the sequence was correct.</div><div class="NLM_p last">The expression and purification of wild type and mutant p38α MAPK were carried out as previously reported.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The protein (purity >98%) was concentrated to 17 mg/mL in storage buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5% glycerol, 10 mM MgCl<sub>2</sub>, 5 mM DTT). The expression and purification of BTK kinase domain were performed as previously described.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The protein was then concentrated to 6 mg/mL in stock buffer (20 mM Tris, pH 8.0, 50 mM NaCl, 3 mM DTT). The samples were immediately fresh frozen in liquid nitrogen and stored at −80 °C.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Kinase Assays</h3><div class="NLM_p">The enzymatic activities of LCK, BTK, FYN, LYN, and BMX were measured in a 384-well format with an HTRF KinEASE-TK assay kit (Cisbio Inc.) according to product instructions. Briefly, analyte enzymes were initially incubated with different concentrations of compounds or vehicle control. The enzymatic reactions were started by adding a mixture of ATP and TK substrate–biotin. After incubation at room temperature for 40 min, the reaction was stopped and antibody detection mixture was added. Next, following a 30 min incubation at room temperature, the fluorescence at 620 and 665 nm was measured on an Envision plate reader (PerkinElmer). Specifically, for BTK inhibitor evaluation, 1 μg/mL enzyme, 18 μM ATP, and 0.3 μM TK substrate–biotin were used. For the LCK assay, 0.1 μg/mL LCK (Thermo Fisher Scientific), 2 μM ATP, and 0.1 μM TK substrate–biotin were used. For the FYN assay, 0.5 μg/mL FYN (Thermo Fisher Scientific), 10 μM ATP, and 0.6 μM TK substrate–biotin were used. In the LYN assay, 0.2 μg/mL LYN (Thermo Fisher Scientific), 1 μM ATP, and 0.1 μM TK substrate–biotin were used. In the BMX assay, 1 μg/mL BMX (Thermo Fisher Scientific), 14 μM ATP, and 0.3 μM TK substrate–biotin were used. The enzymatic activity of p38α MAPK was measured in a 384-well format with a Z′-LYTE kinase assay kit-Ser/Thr 15 peptide (Thermo Fisher Scientific) as specified in a previous report.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> 0.1% (v/v) Triton X-100 was added in p38α kinase activity assay to prevent the nonspecific inhibition due to aggregation.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a></div><div class="NLM_p last">The inhibition selectivity of <b>8</b> and ibrutinib against BTK and TEC was evaluated commercially (Reaction Biology Corporation) using a miniaturized radioisotope (<sup>33</sup>P) based assay platform.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Briefly, after compounds were incubated with specific kinase/substrate pairs for 20 min, the reaction was started by addition of <sup>33</sup>P ATP. Reactions are spotted onto P81 ion exchange paper 2 h later. Then kinase activity was then detected using a filter-binding method.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Crystallography</h3><div class="NLM_p">We used the hanging drop vapor diffusion method for protein crystallization. For apo p38α MAPK protein crystallization, the reservoirs contained an aqueous solution of 0.2 M MgCl<sub>2</sub>, 0.1 M Bis-Tris, pH 6.5, and 25% PEG3350. The complex crystals were obtained by soaking apo crystals in reservoir solution containing 1–2.5 mM compound for 12 h at 20 °C. For crystallization of the BTK complex, the protein (6 mg/mL) was incubated with 0.9 mM <b>8</b> for 30 min on ice. Crystallization was performed using a hanging drop procedure where the reservoir solution contained 100 mM Tris (pH 8.5), 25% (w/v) polyethylene glycol 3350, and 0.2 mM sodium chloride. The resultant crystals were cryoprotected using reservoir solution supplemented with 15–20% v/v glycerol and were then flash cooled in liquid nitrogen.</div><div class="NLM_p last">Diffraction data were collected at the Shanghai Synchrotron Research Facility beamline BL17U.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The data were processed using HKL-2000.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The structures of the p38α MAPK complex (both <b>1</b> and <b>3</b>) and the BTK complex (<b>8</b>) were determined by molecular replacement using the p38α and BTK structures (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OUY">1OUY</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T9T">3T9T</a>) as the searching models. After initial refinement, candidate inhibitor compounds were modeled into the electron density using COOT.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The complex structures of the p38α MAPK mfc1 p38α MAPK mfc2, and BTK were finally refined 2.61 Å, 1.70 Å, and 2.64 Å, resolution, using REFMAC.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> B and T Cell Activation and Phospho-Blots</h3><div class="NLM_p last">The activation of human Ramos B and Jurkat T cells was performed using previously reported methods.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Briefly, Ramos B cells or Jurkat T cells (2 × 10<sup>6</sup>) were incubated with or without varying concentrations of candidate inhibitor compounds for 1.5 h at 37 °C in a 5% CO<sub>2</sub> incubator. Goat anti-human IgM F(ab′)2 (40 μg/mL, Thermo Fisher Scientific) or Dynabeads human T-activator CD3/CD28 (Thermo Fisher Scientific) was then added to stimulate respectively Ramos B cells or Jurkat T cells for 5 min at 37 °C. The cells were then centrifuged at 300<i>g</i>, washed once with cold DPBS, and lysed on ice for 20 min in RIPA buffer (Sigma-Aldrich) containing phosphatase inhibitor cocktail 2 and a protease inhibitor cocktail (both from Sigma-Aldrich). Samples were then centrifuged at 20 000<i>g</i> for 20 min at 4 °C. The supernatants were collected and analyzed by immunoblotting with phospho-specific antibodies against the BTK pY223, PLCγ2 pY1217, ZAP70 pY319, or LAT pY191 epitopes, respectively. These same blots were then stripped of the phospho-specific antibodies and reanalyzed using antibodies against the BTK, PLCγ2, ZAP70, or LAT proteins to measure total protein levels. All of the antibodies were obtained from Cell Signaling Technology.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p">General synthetic routes to compounds <b>1</b>–<b>8</b> were provided in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Route for the Synthesis<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) when X = Cl, aminoguanidine nitrate, acyl chloride, NaOH, MeCN, 0 °C, then H<sub>2</sub>O reflux; (2) when X = OH, carboxylic acid, CDI, aminoguanidine nitrate, base, solvent, 0–100 °C; (b) (1) 2-chloro-6-fluorobenzaldehyde, solvent, reflux; (2) NaBH<sub>3</sub>CN, acetic acid, room temperature; (c) trifluoroacetic acid, THF, 0 °C; (d) hydrazine hydrate, Raney Ni, ethanol, 60 °C; (e) acryloyl chloride, trimethylamine, THF, 0 °C.</p></p></figure><div class="NLM_p"><b>General Chemistry Information.</b> All solvents and reagents were purchased from commercial sources and used as received. Yields were not optimized. All reactions were monitored by thin layer chromatography (TLC) analysis. LC–MS analysis was performed on a Waters UPLC system operating in APCI (+ or – ) or ESI (+ or – ) ionization mode. Analytes were eluted using a linear gradient with a mobile phase of water/acetonitrile and detected at 220 nm. HRMS analysis was performed on Agilent 1290 UHPLC-Agilent 6540 QTOF. Analytes were eluted using a linear gradient with a mobile phase of water/acetonitrile containing 0.1% formic acid. Column chromatography was carried out on silica gel (200–300 mesh). Analytical HPLC was performed using a corona charged aerosol detector or photodiode array detector with a BEH C18 (1.7 μm, 2.1 mm × 150 mm, Waters, America) at a temperature of 50 °C and a flow rate of 0.3 mL/min. Mobile phases A and B under neutral conditions were water and acetonitrile, respectively. The ratio of mobile phase B was increased linearly from 20% to 100% over 3.5 min and then maintained at 100% over the next 1.5 min. All final test compounds were purified to >95% chemical purity as measured by analytical HPLC. Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were recorded on a Varian Mercury plus 400 (400 MHz). All <sup>1</sup>H NMR spectra were consistent with the proposed structures. All proton shifts are given in parts per million (ppm) downfield from TMS (δ) as the internal standard in deuterated solvent, and coupling constants (<i>J</i>) are in hertz (Hz). NMR data were reported as follows: chemical shift, integration, multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublets; td, triplet of doublets; ddd, doublet of doublet of doublets; and brs, broad singlet), and coupling constants.</div><div class="NLM_p"><b><i>N</i>-(2-Chloro-6-fluorobenzyl)-3-(furan-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (1).</b><i>Step 1.</i> A suspension of aminoguanidinium nitrate (22.0 g, 160.5 mmol) in acetonitrile (200 mL) was cooled to 0 °C. NaOH (20.0 g, 500.0 mmol) was added in portions, and the mixture was stirred at room temperature for 3 h. Then, furan-2-carbonyl chloride (20.0 g, 153.2 mmol) was added dropwise at 0 °C. After the addition, the mixture was stirred at room temperature for 6 h. The solvent was then removed by rotatory evaporation. The residue was dissolved in water (200 mL) and heated to reflux for 5 h. The solvent was removed under reduced pressure to give a crude product, which was purified by column chromatography (silica gel, dichloromethane/methanol = 50:1 to 10:1) to give 3-(furan-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine as a white solid (8.5 g, yield 37%). Mass spectrum (ESI) <i>m</i>/<i>z</i> calcd for C<sub>6</sub>H<sub>6</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 151.05, found 151.10. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 12.07 (s, 1H), 7.68 (s, 1H), 6.71–6.61 (m, 1H), 6.54 (s, 1H), 6.08 (s, 2H).</div><div class="NLM_p"><i>Step 2.</i> A stirred mixture of 3-(furan-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (8.5 g, 56.6 mmol) and 2-chloro-6-fluorobenzaldehyde (17 g, 107.2 mmol) in anhydrous toluene (100 mL) was heated to reflux for 8 h. After cooling to room temperature, NaBH<sub>3</sub>CN (5.0 g, 79.6 mmol) and acetic acid (20 mL) were added. Then, the mixture was stirred at room temperature for 3 h. The reaction mixture was quenched with water (10 mL), and the solvent was removed under reduced pressure. The residue was purified by reverse phase flash column chromatography (C<sub>18</sub>) to give <i>N</i>-(2-chloro-6-fluorobenzyl)-3-(furan-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>1</b>) as a white solid (3.2 g, yield 19.3%). HPLC purity: 98.58%. HRMS <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>10</sub>ClFN<sub>4</sub>O [M + H]<sup>+</sup> 293.0527, 295.0527, found 293.2722, 295.2885. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.22 (s, 1H), 7.70 (s, 1H), 7.37 (dd, <i>J</i> = 20.6, 7.3 Hz, 2H), 7.24 (t, <i>J</i> = 8.7 Hz, 1H), 6.94 (s, 1H), 6.73 (s, 1H), 6.55 (s, 1H), 4.50 (s, 2H).</div><div class="NLM_p"><b><i>N</i>-(2-Chloro-6-fluorobenzyl)-3-phenyl-1<i>H</i>-1,2,4-triazol-5-amine (2).</b><i>Step 1.</i> To a solution of aminoguanidinium nitrate (531 mg, 3.88 mmol) in H<sub>2</sub>O (3 mL) was added NaOH (155.2 mg, 3.88 mmol) at 0 °C before benzoyl chloride (545 mg, 3.88 mmol) was added. The mixture was heated to reflux for 5 h before the solvent was removed under reduced pressure. The crude product was purified by column chromatography (silica gel, dichloromethane/methanol = 50:1 to 10:1) to give 3-phenyl-1<i>H</i>-1,2,4-triazol-5-amine as a white solid (40 mg, yield 6.5%). Mass spectrum (ESI) <i>m</i>/<i>z</i> calcd for C<sub>8</sub>H<sub>8</sub>N<sub>4</sub> [M + H]<sup>+</sup> 161.05, found 161.10.</div><div class="NLM_p"><i>Step 2.</i> A stirred mixture of 3-phenyl-1<i>H</i>-1,2,4-triazol-5-amine (40 mg, 0.25 mmol) and 2-chloro-6-fluorobenzaldehyde (79 mg, 0.5 mmol) in ethanol (15 mL) was heated to reflux for 8 h. After cooling to room temperature, NaBH<sub>3</sub>CN (75 mg, 1.2 mmol) and acetic acid (0.5 mL) were added. Then, the mixture was stirred at room temperature for 3 h before it was quenched with water (10 mL) and the solvent was removed under reduced pressure. The residue was purified by reverse phase flash column chromatography (C<sub>18</sub>) to give <i>N</i>-(2-chloro-6-fluorobenzyl)-3-phenyl-1<i>H</i>-1,2,4-triazol-5-amine (2) as a white solid 11 mg, yield 14.6%). HPLC purity: 96.63%. HRMS <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>12</sub>ClFN<sub>4</sub> [M – H]<sup>−</sup> 301.0735, 303.0735, found 301.2102, 303.1912. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.18 (s, 1H), 7.91 (m, 2H), 7.49 (m, 1H), 7.45–7.31 (m, 4H), 7.23 (m, 1H), 4.52 (s, 2H).</div><div class="NLM_p"><b>3-(5-((2-Chloro-6-fluorobenzyl)amino)-1<i>H</i>-1,2,4-triazol-3-yl)phenol (3).</b><i>Step 1.</i> A suspension of aminoguanidinium nitrate (5.46 g, 39.82 mmol) and K<sub>2</sub>CO<sub>3</sub> (5.5 g, 39.82 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (50 mL) was stirred at room temperature for 1 h. A solution of 3-hydroxybenzoic acid (5.0 g, 36.2 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (30 mL) was treated with <i>N</i>,<i>N</i>′-carbonyldiimidazole (CDI) (6.46 g, 39.82 mmol) at 0 °C. Then, the solution was stirred at room temperature for 1 h. Then, the solution was added dropwise to the suspension. After the addition, the reaction mixture was stirred at room temperature for 3 h. The mixture was then heated to 100 °C for 5 h. After cooling to room temperature, the mixture was filtered and the solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, dichloromethane/methanol = 100:1 to 10:1) to give 3-(5-amino-1<i>H</i>-1,2,4-triazol-3-yl)phenol as a white solid (2.67g, yield 41.9%). Mass spectrum (ESI) <i>m</i>/<i>z</i> calcd for C<sub>8</sub>H<sub>8</sub>N<sub>4</sub>O [M – H]<sup>−</sup> 175.07, found 175.10. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.06 (s, 1H), 9.47 (s, 1H), 7.36–7.29 (m, 2H), 7.17 (t, <i>J</i> = 8.0 Hz, 1H), 6.77–6.67 (m, 1H), 6.00 (s, 2H).</div><div class="NLM_p"><i>Step 2.</i> The mixture of 3-(5-amino-1<i>H</i>-1,2,4-triazol-3-yl)phenol (5.0 g, 28.38 mmol), 2-chloro-6-fluorobenzaldehyde (5.0 g, 31.53 mmol), and <i>p</i>-toluenesulfonicacid (500 mg, 2.90 mmol) in isopropanol (50 mL) was heated to reflux overnight. The solution was allowed to cool to room temperature before NaBH<sub>3</sub>CN (4.0 g, 63.65 mmol) and acetic acid (2 mL) were added. Then, the resulting mixture was stirred at room temperature for 10 h before being quenched with water. The solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, dichloromethane/methanol = 100:1 to 10:1) to give 3-(5-((2-chloro-6-fluorobenzyl)amino)-1<i>H</i>-1,2,4-triazol-3-yl)phenol (<b>3</b>) as a white solid (1.2 g, yield 13.3%). HPLC purity: 95.04%. HRMS <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>12</sub>ClFN<sub>4</sub>O [M – H]<sup>−</sup> 317.0684, 319.0684, found 317.1660, 319.2549. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (s, 1H), 9.43 (s, 1H), 7.35 (s, 4H), 7.13–7.27 (m, 2H), 6.90 (s, 1H), 6.75 (s, 1H), 4.51 (s, 2H).</div><div class="NLM_p"><b>3-(3-Aminophenyl)-<i>N</i>-(2-chloro-6-fluorobenzyl)-1<i>H</i>-1,2,4-triazol-5-amine (4).</b><i>Step 1.</i> A suspension of aminoguanidinium nitrate (2.58 g, 18.82 mmol) and NaOH (789.79 mg, 19.75 mmol) in methanol (30 mL) was stirred at room temperature for 3 h, the solvent was evaporated off, and the residue was resolved by <i>N</i>,<i>N</i>-dimethylformamide (DMF) (30 mL). A solution of 3-nitrobenzoic acid (3.0 g, 17.95 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) (2.55 g, 19.73 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (30 mL) was treated with <i>N</i>,<i>N</i>′-carbonyldiimidazole (CDI) (3.2 g, 19.73 mmol) at 0 °C. The solution was stirred at room temperature for 3 h. Then, it was added dropwise to the suspension. After the addition, the reaction mixture was stirred at room temperature for 3 h. The solvent was removed by rotatory evaporation, and the residue was dissolved in water (100 mL) and heated to reflux for 18 h. After cooling to room temperature, it was filtered, and the solid was recrystallized from methanol to give 3-(3-nitrophenyl)-1<i>H</i>-1,2,4-triazol-5-amine as a yellow solid (3.0 g, yield 81.5%). Mass spectrum (ESI) <i>m</i>/<i>z</i> calcd for C<sub>8</sub>H<sub>7</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 206.06, found 206.20. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.38 (s, 1H), 8.65–8.60 (m, 1H), 8.28 (d, <i>J</i> = 7.8 Hz, 1H), 8.22–8.16 (m, 1H), 7.71 (t, <i>J</i> = 8.0 Hz, 1H), 6.22 (s, 2H).</div><div class="NLM_p"><i>Step 2.</i> The mixture of 3-(3-nitrophenyl)-1<i>H</i>-1,2,4-triazol-5-amine (300 mg, 1.46 mmol) and 2-chloro-6-fluorobenzaldehyde (300 mg, 1.89 mmol) in anhydrous toluene (10 mL)/DMSO (0.1 mL) was heated to reflux for 15 h. The solution was allowed to cool to room temperature before NaBH<sub>3</sub>CN (200 mg, 3.18 mmol) and acetic acid (1 mL) were added. Then, the resulting mixture was stirred at room temperature for 3 h before being quenched with water. The solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, dichloromethane/methanol = 50:1 to 10:1) to give <i>N</i>-(2-chloro-6-fluorobenzyl)-3-(3-nitrophenyl)-1<i>H</i>-1,2,4-triazol-5-amine as a light-yellow solid (150 mg, yield 29.5%). Mass spectrum (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>11</sub>ClFN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 348.06,350.06, found 348.10, 350.10. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.82 (s, 1H), 8.34 (d, <i>J</i> = 7.8 Hz, 1H), 8.29–8.22 (m, 1H), 7.69 (t, <i>J</i> = 8.0 Hz, 1H), 7.40–7.27 (m, 2H), 7.14 (t, <i>J</i> = 8.8 Hz, 1H), 4.70 (s, 2H).</div><div class="NLM_p"><i>Step 3.</i> The mixture of <i>N</i>-(2-chloro-6-fluorobenzyl)-3-(3-nitrophenyl)-1<i>H</i>-1,2,4-triazol-5-amine (50 mg, 0.14 mmol) and hydrazine hydrate (0.5 mL, 80% in water) in ethanol (10 mL) was heated to 60 °C. Then, Raney Ni (10 mg) was added. The resulting mixture was stirred at this temperature for 3 h. After cooling to room temperature, it was filtered and the solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, dichloromethane/methanol = 50:1 to 10:1) to give 3-(3-aminophenyl)-<i>N</i>-(2-chloro-6-fluorobenzyl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>4</b>) as a white solid (36 mg, yield 78.8%). HPLC purity: 100%. HRMS <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>13</sub>ClFN<sub>5</sub> [M + H]<sup>+</sup> 318.0844, 320.0844, found 318.1504, 320.0482. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.33 (ddd, <i>J</i> = 19.0, 9.5, 6.9 Hz, 2H), 7.27–7.19 (m, 2H), 7.19–7.08 (m, 2H), 6.78 (d, <i>J</i> = 7.8 Hz, 1H), 4.64 (s, 2H).</div><div class="NLM_p"><b><i>N</i>-(2-Chloro-6-fluorobenzyl)-3-(3-(methylamino)phenyl)-1<i>H</i>-1,2,4-triazol-5-amine (5).</b><i>Step 1.</i> The mixture of 3-aminobenzoic acid (500 mg, 3.65 mmol) and triethylamine (1.11 g, 10.97 mmol) in methanol (6 mL) was allowed to cool to 0 °C before di-<i>tert</i>-butyl dicarbonate (880 mg, 4.03 mmol) was added. Then, the resulting mixture was stirred at room temperature for 10 h before being quenched with water. The solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, dichloromethane/methanol = 100:1 to 10:1) to give 3-((<i>tert</i>-butoxycarbonyl)amino)benzoic acid as a white solid (800 mg, yield 92.5%). Mass spectrum (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>15</sub>NO<sub>4</sub> [M – H]<sup>−</sup> 236.10, found 236.10.</div><div class="NLM_p"><i>Step 2.</i> The mixture of 3-((<i>tert</i>-butoxycarbonyl)amino)benzoic acid (1.0 g, 4.21 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (10 mL) was allowed to cool to 0 °C before sodium hydride (505.7 mg, 12.64 mmol, 60% dispersion in mineral oil) was added. The mixture was stirred at this temperature for 1 h before iodomethane (1.26 g, 8.80 mmol) was added. The resulting mixture was stirred at room temperature for 5 h before being quenched with water. The solvent was removed under reduced pressure, and the residue was dissolved in methanol (10 mL)/water (1 mL) before sodium hydroxide (337.2 mg, 8.43 mmol) was added. After the starting material was consumed by TLC analysis, the mixture was adjusted to pH 3–4 by 3 M HCl and extracted with ethyl acetate (50 mL). The ethyl acetate solution was dried and concentrated to give 3-((<i>tert</i>-butoxycarbonyl)(methyl)amino)benzoic acid as a white solid (950 mg, yield 89.7%). Mass spectrum (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>17</sub>NO<sub>4</sub> [M – H]<sup>−</sup> 250.12, found 250.10. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.06 (s, 1H), 7.83 (t, <i>J</i> = 1.8 Hz, 1H), 7.75–7.72 (m, 1H), 7.53 (ddd, <i>J</i> = 8.0, 2.3, 1.2 Hz, 1H), 7.49–7.43 (m, 1H), 3.20 (s, 3H), 1.40 (s, 9H).</div><div class="NLM_p"><i>Step 3.</i> A suspension of aminoguanidinium nitrate (360 mg, 2.63 mmol) and K<sub>2</sub>CO<sub>3</sub> (660 mg, 4.78 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (3 mL) was stirred at room temperature for 1 h. A solution of 3-((<i>tert</i>-butoxycarbonyl)(methyl)amino)benzoic acid (600 mg, 2.39 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (30 mL) was treated with <i>N</i>,<i>N</i>′-carbonyldiimidazole (CDI) (426 mg, 2.63 mmol) at 0 °C. The solution was stirred at room temperature for 1 h. Then it was added to the suspension. The resulting mixture was stirred at room temperature for 3 h, then it was heated to 100 °C for 3 h. The mixture was cooled to room temperature, filtered, and concentrated. The residue was purified by column chromatography (silica gel, dichloromethane/methanol = 100:1 to 10:1) to give <i>tert</i>-butyl (3-(5-amino-1<i>H</i>-1,2,4-triazol-3-yl)phenyl)(methyl)carbamate as a yellow oil (220 mg, yield 31.8%). Mass spectrum (ESI) m/z calcd for C<sub>14</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 290.15, found 290.20. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.85–7.80 (m, 1H), 7.73–7.67 (m, 1H), 7.61 (s, 1H), 7.29 (t, <i>J</i> = 7.9 Hz, 1H), 7.23–7.18 (m, 1H), 7.04 (s, 2H), 3.23 (s, 3H), 1.46 (s, 9H).</div><div class="NLM_p"><i>Step 4.</i> The mixture of <i>tert</i>-butyl (3-(5-amino-1<i>H</i>-1,2,4-triazol-3-yl)phenyl)(methyl)carbamate (200 mg, 0.69 mmol), 2-chloro-6-fluorobenzaldehyde (200 mg, 1.26 mmol), and <i>p</i>-toluenesulfonic acid (11.9 mg, 0.069 mmol) in isopropanol (5 mL) was heated to reflux overnight. The solution was allowed to cool to room temperature before NaBH<sub>3</sub>CN (120 mg, 1.91 mmol) and acetic acid (0.5 mL) were added. Then, the resulting mixture was stirred at room temperature for 5 h before being quenched with water. The solvent was removed under reduced pressure. The crude <i>tert</i>-butyl (3-(5-((2-chloro-6-fluorobenzyl)amino)-1<i>H</i>-1,2,4-triazol-3-yl)phenyl)(methyl)carbamate was used directly without further purification.</div><div class="NLM_p"><i>Step 5.</i> The mixture of crude <i>tert</i>-butyl (3-(5-((2-chloro-6-fluorobenzyl)amino)-1<i>H</i>-1,2,4-triazol-3-yl)phenyl)(methyl)carbamate (100 mg) in tetrahydrofuran (THF) (5 mL) was cooled to 0 °C before trifluoroacetic acid (10 mL) was added. Then, the resulting mixture was stirred at room temperature for 5 h. The solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, dichloromethane/methanol = 100:1 to 10:1) to give <i>N</i>-(2-chloro-6-fluorobenzyl)-3-(3-(methylamino)phenyl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>5</b>) as a white solid (45 mg, yield 19.6%,two steps). HPLC purity: 99.84%. HRMS <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>15</sub>ClFN<sub>5</sub> [M + H]<sup>+</sup> 332.1000, 334.1000, found 332.4052, 334.4059. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, mixture of rotamers, 2:1) δ13.17 (s, 0.5H), 12.07 (s, 1H), 7.35 (s, 3H), 7.23 (s, 1.5H), 7.12 (s, 4.5H), 6.85 (s, 1H), 6.48–6.52 (m, 1.5H), 6.13 (s, 0.6H), 5.71–5.75 (m, 1.5H), 4.51 (s, 3H), 2.69 (s, 4.5H).</div><div class="NLM_p"><b>3-(3-Amino-4-methoxyphenyl)-<i>N</i>-(2-chloro-6-fluorobenzyl)-1<i>H</i>-1,2,4-triazol-5-amine (6).</b><i>Step 1.</i> A suspension of aminoguanidinium nitrate (139 mg, 1.01 mmol) and KOH (57 mg, 1.02 mmol) in methanol (2 mL) was stirred at room temperature for 1.5 h and concentrated. The residue was diluted with <i>N</i>,<i>N</i>-dimethylformamide (DMF) (2 mL). A solution of 4-methoxy-3-nitrobenzoic acid (197 mg, 1.0 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (5 mL) was treated with <i>N</i>,<i>N</i>′-carbonyldiimidazole (CDI) (190 mg, 1.17 mmol) at 0 °C. The solution was stirred at room temperature for 1.5 h. Then it was added dropwise to the suspension. After the addition, the reaction mixture was stirred at room temperature for 2 h. The solvent was removed by rotatory evaporation, the residue was dissolved in water (50 mL) and heated to reflux for 5 h. After cooling to room temperature, it was filtered, and the solid was recrystallized from methanol to give 3-(4-methoxy-3-nitrophenyl)-1<i>H</i>-1,2,4-triazol-5-amine as a light-yellow solid (110 mg, yield 46.8%). Mass spectrum (ESI) <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>9</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 236.07, found 236.20. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (s, 1H), 8.26 (d, <i>J</i> = 1.4 Hz, 1H), 8.11 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 7.42 (d, <i>J</i> = 8.9 Hz, 1H), 6.14 (s, 2H), 3.95 (s, 3H).</div><div class="NLM_p"><i>Step 2.</i> The mixture of 3-(4-methoxy-3-nitrophenyl)-1<i>H</i>-1,2,4-triazol-5-amine (100 mg, 0.43 mmol) and 2-chloro-6-fluorobenzaldehyde (150 mg, 0.95 mmol) in anhydrous toluene (10 mL) was heated to reflux for 15 h. The solution was allowed to cool to room temperature before NaBH<sub>3</sub>CN (45 mg, 0.72 mmol) and acetic acid (1 mL) were added. Then, the resulting mixture was stirred at room temperature for 3 h before being quenched with water. The solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, dichloromethane/methanol = 50:1 to 10:1) to give <i>N</i>-(2-chloro-6-fluorobenzyl)-3-(4-methoxy-3-nitrophenyl)-1<i>H</i>-1,2,4-triazol-5-amine as a light-yellow solid (70 mg, yield 43.6%) that was used directly in the next step. Mass spectrum (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>13</sub>ClFN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 378.07, 380.07, found 378.30, 380.30.</div><div class="NLM_p"><i>Step 3.</i> The mixture of <i>N</i>-(2-chloro-6-fluorobenzyl)-3-(4-methoxy-3-nitrophenyl)-1<i>H</i>-1,2,4-triazol-5-amine (70 mg, 0.19 mmol) and hydrazine hydrate (1.0 mL, 80% in water) in ethanol (10 mL) was heated to 60 °C. Then, Raney Ni (10 mg) was added. The resulting mixture was stirred at room temperature for 3 h. After cooling to room temperature, it was filtered and the solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, dichloromethane/methanol = 50:1 to 10:1) to give 3-(3-amino-4-methoxyphenyl)-<i>N</i>-(2-chloro-6-fluorobenzyl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>6</b>) as a white solid (50 mg, yield 77.6%). HPLC purity: 96.1%. HRMS <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>15</sub>ClFN<sub>5</sub>O [M + H]<sup>+</sup> 348.0949, 350.0949, found 348.4669, 350.4831. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.36–7.23 (m, 4H), 7.11 (t, <i>J</i> = 8.3 Hz, 1H), 6.89 (d, <i>J</i> = 8.2 Hz, 1H), 4.63 (s, 2H), 3.88 (s, 3H).</div><div class="NLM_p"><b><i>N</i>-(2-Chloro-6-fluorobenzyl)-3-(3,4-dimethoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-amine (7).</b><i>Step 1.</i> A suspension of aminoguanidinium nitrate (13.55 g, 98.83 mmol) and NaOH (240.6 mg, 6.02 mmol) in methanol (100 mL) was stirred at room temperature for 3 h. The solvent was evaporated off, and the residue was dissolved in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (100 mL). A solution of 3,4-dimethoxybenzoic acid (15.0 g, 82.34 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (150 mL) was treated with <i>N</i>,<i>N</i>′-carbonyldiimidazole (CDI) (14.69 g, 90.59 mmol) at 0 °C. Then, the solution was stirred at room temperature for 3 h, and the solution was added dropwise to the suspension. After the addition, the reaction mixture was stirred at room temperature for 3 h. The solvent was then removed by rotatory evaporation, the residue was dissolved in water (150 mL) and heated to reflux for 18 h. After cooling to room temperature, it was filtered, and the solid was recrystallized from methanol to give 3-(3,4-dimethoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-amine as an off-white solid (9.38 g, yield 51.7%). Mass spectrum (ESI) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 221.10, found 221.40. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.95 (s, 1H), 7.46–7.39 (m, 2H), 6.98 (d, <i>J</i> = 8.8 Hz, 1H), 5.93 (s, 2H), 3.77 (d, <i>J</i> = 3.4 Hz, 6H).</div><div class="NLM_p"><i>Step 2.</i> The mixture of 3-(3,4-dimethoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-amine (8 g, 36.33 mmol), 2-chloro-6-fluorobenzaldehyde (8 g, 50.46 mmol), and <i>p</i>-toluenesulfonic acid (625.5 mg, 3.63 mmol) in isopropanol (40 mL) was heated to reflux overnight. The solution was allowed to cool to room temperature before NaBH<sub>3</sub>CN (5.0 g, 79.56 mmol) and acetic acid (1 mL) were added. Then, the resulting mixture was stirred at room temperature for 5 h before it was quenched with water. The solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, dichloromethane/methanol = 50:1 to 10:1) to give <i>N</i>-(2-chloro-6-fluorobenzyl)-3-(3,4-dimethoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>7</b>) as a white solid (4.5 g, yield 34.1%). HPLC purity: 100%. HRMS <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>16</sub>ClFN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 363.0946, 365.0946, found 363.1035, 365.1004. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, mixture of rotamers 2:1) δ 13.13 (s, 0.5H), 12.06 (s, 1H), 7.50–7.41 (m, 3H), 7.40–7.29 (m, 3H), 7.28–7.15 (m, 2H), 7.05 (d, <i>J</i> = 8.2 Hz, 0.5H), 6.98 (d, <i>J</i> = 8.8 Hz, 1H), 6.87 (t, <i>J</i> = 5.4 Hz, 1H), 6.12 (t, <i>J</i> = 6 Hz, 0.5H), 4.53 (d, <i>J</i> = 4.9 Hz, 2H), 4.45 (d, <i>J</i> = 5.2 Hz, 1H), 3.78 (d, <i>J</i> = 6.9 Hz, 9H).</div><div class="NLM_p last"><b><i>N</i>-(3-(5-((2-Chloro-6-fluorobenzyl)amino)-1<i>H</i>-1,2,4-triazol-3-yl)phenyl)acrylamide (8).</b> The mixture of 3-(3-aminophenyl)-<i>N</i>-(2-chloro-6-fluorobenzyl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>4</b>) (12.0 mg, 0.038 mmol) and trimethylamine (5.0 mg, 0.049 mmol) in tetrahydrofuran (THF) (0.5 mL) was allowed to cool to 0 °C before acryloyl chloride (3.45 mg, 0.038 mmol) was added. Then, the resulting mixture was stirred at room temperature for 3 h before it was quenched with water. The solvent was removed under reduced pressure. The residue was purified by reverse phase HPLC (C<sub>18</sub>) to give <i>N</i>-(3-(5-((2-chloro-6-fluorobenzyl)amino)-1<i>H</i>-1,2,4-triazol-3-yl)phenyl)acrylamide (<b>8</b>) as a white solid (2.6 mg, yield 18.5%). HPLC purity: 98.78%. HRMS <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>15</sub>ClFN<sub>5</sub>O [M + H]<sup>+</sup> 372.0949, 374.0949, found 372.1031, 374.1007. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.12 (s, 1H), 7.77 (s, 1H), 7.73–7.63 (m, 1H), 7.40 (s, 1H), 7.37–7.27 (m, 2H), 7.14 (t, <i>J</i> = 8.1 Hz, 1H), 6.46 (dd, <i>J</i> = 17.0, 9.6 Hz, 1H), 6.38 (dd, <i>J</i> = 17.0, 2.3 Hz, 1H), 5.79 (dd, <i>J</i> = 9.6, 2.3 Hz, 1H), 4.67 (s, 2H).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01075">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60334" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60334" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01075" class="ext-link">10.1021/acs.jmedchem.7b01075</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Structure and activity of tested compounds, representative binding modes of known kinase inhibitors, structural comparison between the predicted binding mode and crystal structure, statistics of crystal structures, chemical similarity analysis, and <sup>1</sup>H NMR, HPLC, and HRMS results of representative compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Compound characterization checklist (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_002.xls" class="ext-link">XLS</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf">jm7b01075_si_001.pdf (4.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_002.xls">jm7b01075_si_002.xls (91.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_003.csv">jm7b01075_si_003.csv (0.77 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes for p38α MAPK bound with <b>1</b> and <b>3</b> are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYX">5XYX</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYY">5XYY</a>. PDB code for BTK bound with <b>8</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYZ">5XYZ</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01075" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiangbing Qi</span> - <span class="hlFld-Affiliation affiliation">National
Institute of Biological Sciences, Beijing, No. 7 Science Park Road, Zhongguancun Life Science
Park, Beijing 102206, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7139-5164" title="Orcid link">http://orcid.org/0000-0002-7139-5164</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5f2e3627363e31383d3631381f31363d2c713e3c713c31"><span class="__cf_email__" data-cfemail="0e7f6776676f60696c6760694e60676c7d206f6d206d60">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niu Huang</span> - <span class="hlFld-Affiliation affiliation">National
Institute of Biological Sciences, Beijing, No. 7 Science Park Road, Zhongguancun Life Science
Park, Beijing 102206, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6912-033X" title="Orcid link">http://orcid.org/0000-0002-6912-033X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6f071a0e010801061a2f01060d1c410e0c410c01"><span class="__cf_email__" data-cfemail="dab2afbbb4bdb4b3af9ab4b3b8a9f4bbb9f4b9b4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanli Wang</span> - <span class="hlFld-Affiliation affiliation">National
Institute of Biological Sciences, Beijing, No. 7 Science Park Road, Zhongguancun Life Science
Park, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuze Sun</span> - <span class="hlFld-Affiliation affiliation">Peking University-Tsinghua
University-National Institute of Biological Sciences Joint Graduate
Program, School of Life Sciences, Tsinghua University, Beijing 100084, China</span>; 
    <span class="hlFld-Affiliation affiliation">National
Institute of Biological Sciences, Beijing, No. 7 Science Park Road, Zhongguancun Life Science
Park, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ran Cao</span> - <span class="hlFld-Affiliation affiliation">National
Institute of Biological Sciences, Beijing, No. 7 Science Park Road, Zhongguancun Life Science
Park, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Liu</span> - <span class="hlFld-Affiliation affiliation">National
Institute of Biological Sciences, Beijing, No. 7 Science Park Road, Zhongguancun Life Science
Park, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuting Xie</span> - <span class="hlFld-Affiliation affiliation">National
Institute of Biological Sciences, Beijing, No. 7 Science Park Road, Zhongguancun Life Science
Park, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Li</span> - <span class="hlFld-Affiliation affiliation">National
Institute of Biological Sciences, Beijing, No. 7 Science Park Road, Zhongguancun Life Science
Park, Beijing 102206, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.W., Y.S., and R.C. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d161e2347-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the staff at the Shanghai Synchrotron Radiation Facility for their assistance in data collection. We also thank Dr. She Chen and Lin Li in the proteomics center at National Institute of Biological Sciences, Beijing for the assistance with LC–MS/MS experiments. Financial support from the Chinese Ministry of Science and Technology “973” Grant 2014CB849802 (to N.H.) is gratefully acknowledged. Computational support was provided by Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase) under Grant U1501501.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i22" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i22"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> Abbreviations Used</h2><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">BTK</td><td class="NLM_def"><p class="first last">bruton tyrosine kinase</p></td></tr><tr><td class="NLM_term">LCK</td><td class="NLM_def"><p class="first last">lymphocyte-specific protein tyrosine kinase</p></td></tr><tr><td class="NLM_term">BCR</td><td class="NLM_def"><p class="first last">B cell antigen receptor</p></td></tr><tr><td class="NLM_term">TCR</td><td class="NLM_def"><p class="first last">T cell antigen receptor</p></td></tr><tr><td class="NLM_term">HB</td><td class="NLM_def"><p class="first last">hydrogen bond</p></td></tr><tr><td class="NLM_term">CLL</td><td class="NLM_def"><p class="first last">chronic lymphocytic leukemia</p></td></tr><tr><td class="NLM_term">MCL</td><td class="NLM_def"><p class="first last">mantle cell lymphoma</p></td></tr><tr><td class="NLM_term">WM</td><td class="NLM_def"><p class="first last">Waldenstrom’s macroglobulinemia</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">RMSD</td><td class="NLM_def"><p class="first last">root-mean-square deviation</p></td></tr><tr><td class="NLM_term">GK</td><td class="NLM_def"><p class="first last">gatekeeper</p></td></tr><tr><td class="NLM_term">MM-PBSA</td><td class="NLM_def"><p class="first last">molecular mechanics Poisson–Boltzmann surface area</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">Pan Assay Interference Compounds</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 68 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hantschel, O.</span><span> </span><span class="NLM_article-title">Unexpected off-targets and paradoxical pathway activation by kinase inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1021/cb500886n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500886n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=234-245&issue=1&author=O.+Hantschel&title=Unexpected+off-targets+and+paradoxical+pathway+activation+by+kinase+inhibitors&doi=10.1021%2Fcb500886n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fcb500886n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500886n%26sid%3Dliteratum%253Aachs%26aulast%3DHantschel%26aufirst%3DO.%26atitle%3DUnexpected%2520off-targets%2520and%2520paradoxical%2520pathway%2520activation%2520by%2520kinase%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D1%26spage%3D234%26epage%3D245%26doi%3D10.1021%2Fcb500886n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">Kinase targets in CNS drug discovery</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.4155/fmc-2016-0214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.4155%2Ffmc-2016-0214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=28176536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Gqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=303-314&issue=3&author=H.+Gunosewoyoauthor=L.+Yuauthor=L.+Munozauthor=M.+Kassiou&title=Kinase+targets+in+CNS+drug+discovery&doi=10.4155%2Ffmc-2016-0214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase targets in CNS drug discovery</span></div><div class="casAuthors">Gunosewoyo, Hendra; Yu, Lifang; Munoz, Lenka; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">303-314</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Originally thought to be nondruggable, kinases represent attractive drug targets for pharmaceutical companies and academia.  To date, there are over 40 kinase inhibitors approved by the US FDA, with 32 of these being small mols., in addn. to the three mammalian target of rapamycin inhibitor macrolides (sirolimus, temsirolimus and everolimus).  Despite the rapid development of kinase inhibitors for cancer, presently none of these agents are approved for CNS indications.  This mini perspective highlights selected kinase targets for CNS disorders, of which brain-permeable small-mol. inhibitors are reported, with demonstrated preclin. proof-of-concept efficacy.  This is followed by a brief discussion on the key challenges of blood-brain barrier penetration and selectivity profiles in developing kinase inhibitors for CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn8aN-OsnhmLVg90H21EOLACvtfcHk0lgaIPctp6n7IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Gqtbc%253D&md5=cd99fdf52b130a92823b58a50ad32fe6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0214%26sid%3Dliteratum%253Aachs%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DKinase%2520targets%2520in%2520CNS%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26issue%3D3%26spage%3D303%26epage%3D314%26doi%3D10.4155%2Ffmc-2016-0214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">High-throughput kinase profiling as a platform for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1038/nrd2541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnrd2541" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=391-397&issue=5&author=D.+M.+Goldsteinauthor=N.+S.+Grayauthor=P.+P.+Zarrinkar&title=High-throughput+kinase+profiling+as+a+platform+for+drug+discovery&doi=10.1038%2Fnrd2541"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd2541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2541%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DHigh-throughput%2520kinase%2520profiling%2520as%2520a%2520platform%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26issue%3D5%26spage%3D391%26epage%3D397%26doi%3D10.1038%2Fnrd2541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Akritopoulou-Zanze, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">5–6</span><span class="NLM_x">) </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.1016/j.drudis.2008.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.drudis.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=19121409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1Sht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=291-297&issue=5%E2%80%936&author=I.+Akritopoulou-Zanzeauthor=P.+J.+Hajduk&title=Kinase-targeted+libraries%3A+the+design+and+synthesis+of+novel%2C+potent%2C+and+selective+kinase+inhibitors&doi=10.1016%2Fj.drudis.2008.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase-targeted libraries: The design and synthesis of novel, potent, and selective kinase inhibitors</span></div><div class="casAuthors">Akritopoulou-Zanze, Irini; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">291-297</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein kinases continue to hold tremendous promise for therapeutic intervention, and the search for novel, safe and efficacious kinase inhibitors has intensified over the past decade.  Given that most kinases are readily inhibited by org. small mols. and that a wealth of structural data exists on kinase-inhibitor complexes, there has been almost universal success in the design and identification of potent kinase inhibitors.  The issues of non-selectivity and congested IP space, however, present formidable challenges for the successful clin. development of these compds.  We describe a systematic approach implemented at Abbott to enable the rapid discovery and design of novel and potent kinase inhibitors that provide addnl. opportunities for targeting new intellectual property space and achieving acceptable selectivity profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq8Zu1uIX67LVg90H21EOLACvtfcHk0lgI8YFkzZwtqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1Sht7s%253D&md5=10f9e32e9bf9e0345fff6613fd578357</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DAkritopoulou-Zanze%26aufirst%3DI.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DKinase-targeted%2520libraries%253A%2520the%2520design%2520and%2520synthesis%2520of%2520novel%252C%2520potent%252C%2520and%2520selective%2520kinase%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26issue%3D5%25E2%2580%25936%26spage%3D291%26epage%3D297%26doi%3D10.1016%2Fj.drudis.2008.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span><span class="refDoi"> DOI: 10.1021/jm800475y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&issue=17&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+based+prediction+of+ligand+binding+modes+and+rational+inhibitor+design+for+kinase+drug+discovery&doi=10.1021%2Fjm800475y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Pippin, Douglas A.; Salvino, Joseph M.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5149-5171</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review describing the use of Protein Data Bank (PDB) entries specifically for kinase inhibitor drug discovery.  Topics discussed include: the current state of structure-aided ligand design, kinase structure queries and extn. from the PDB, alignment of protein structures, structural classification of ligands, anal. of ligands and binding modes, and ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDINDYVE15cbVg90H21EOLACvtfcHk0lggfJ-qsswxKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM&md5=a1afc4d6c7f6fa4dd6aa9da8d78f1ee3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520based%2520prediction%2520of%2520ligand%2520binding%2520modes%2520and%2520rational%2520inhibitor%2520design%2520for%2520kinase%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D17%26spage%3D5149%26epage%3D5171%26doi%3D10.1021%2Fjm800475y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klug-Mcleod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span> </span><span class="NLM_article-title">Kinase hinge binding scaffolds and their hydrogen bond patterns</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">6520</span><span class="NLM_x">–</span> <span class="NLM_lpage">6527</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.bmc.2015.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=26358279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVentr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6520-6527&issue=19&author=L.+Xingauthor=J.+Klug-Mcleodauthor=B.+Raiauthor=E.+A.+Lunney&title=Kinase+hinge+binding+scaffolds+and+their+hydrogen+bond+patterns&doi=10.1016%2Fj.bmc.2015.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase hinge binding scaffolds and their hydrogen bond patterns</span></div><div class="casAuthors">Xing, Li; Klug-Mcleod, Jacquelyn; Rai, Brajesh; Lunney, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6520-6527</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein kinases constitute a major class of intracellular signaling mols., and describe some of the most prominent drug targets.  Kinase inhibitors commonly employ small chem. scaffolds that form hydrogen bonds with the kinase hinge residues connecting the N- and C-terminal lobes of the catalytic domain.  In general the satisfied hydrogen bonds are required for potent inhibition, therefore constituting a conserved feature in the majority of inhibitor-kinase interactions.  From systematically analyzing the kinase scaffolds extd. from Pfizer crystal structure database (CSDb) the authors recognize that large no. of kinase inhibitors of diverse chem. structures are derived from a relatively small no. of common scaffolds.  Depending on specific substitution patterns, scaffolds may demonstrate versatile binding capacities to interact with kinase hinge.  Afforded by thousands of ligand-protein binary complexes, the hinge hydrogen bond patterns were analyzed with a focus on their three-dimensional configurations.  Most of the compds. engage H6 NH for hinge recognition.  Dual hydrogen bonds are commonly obsd. with addnl. recruitment of H4 CO upstream and/or H6 CO downstream.  Triple hydrogen bonds accounts for small no. of binary complexes.  An unusual hydrogen bond with a non-canonical H5 conformation is obsd., requiring a peptide bond flip by a glycine residue at the H6 position.  Addnl. hydrogen bonds to kinase hinge do not necessarily correlate with an increase in potency; conversely they appear to compromise kinase selectivity.  Such learnings could enhance the prospect of successful therapy design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRC-xiTiNvELVg90H21EOLACvtfcHk0ljrPZTrB2HxXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVentr3L&md5=048b4b99628c6e1ae273b00a47ab2377</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DKlug-Mcleod%26aufirst%3DJ.%26aulast%3DRai%26aufirst%3DB.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26atitle%3DKinase%2520hinge%2520binding%2520scaffolds%2520and%2520their%2520hydrogen%2520bond%2520patterns%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26issue%3D19%26spage%3D6520%26epage%3D6527%26doi%3D10.1016%2Fj.bmc.2015.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span><span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&issue=11&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0ljt-zn9QTT8ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26issue%3D11%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1038/nrc2559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&issue=1&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors&doi=10.1038%2Fnrc2559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lhaWFMQ7nFzcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D1%26spage%3D28%26epage%3D39%26doi%3D10.1038%2Fnrc2559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zuccotto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span> </span><span class="NLM_article-title">Through the “gatekeeper door”: exploiting the active kinase conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2681</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span><span class="refDoi"> DOI: 10.1021/jm901443h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901443h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGhtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2681-2694&issue=7&author=F.+Zuccottoauthor=E.+Ardiniauthor=E.+Casaleauthor=M.+Angiolini&title=Through+the+%E2%80%9Cgatekeeper+door%E2%80%9D%3A+exploiting+the+active+kinase+conformation&doi=10.1021%2Fjm901443h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Through the "Gatekeeper Door": Exploiting the Active Kinase Conformation</span></div><div class="casAuthors">Zuccotto, Fabio; Ardini, Elena; Casale, Elena; Angiolini, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2681-2694</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of new kinase inhibitors is still a slow and problematic process.  Generally, type I compds. suffer from widespread cross-reactivity among other members of the kinase target family, and intense medicinal chem. optimization programs are required to modulate their activity.  Also, fierce competition in the development of scaffolds that could mimic ATP has led to a crowded intellectual property space.  The new opportunities opened by the type II compds. created great expectations, as targeting the allosteric site of the ATP pocket offered addnl. opportunities to control selectivity and introduce intellectual property novelty.  However, clin. evaluation of these compds. has highlighted how the acquisition of resistance-causing mutations of the kinase target limits their efficacy in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd_iA7sWS-g7Vg90H21EOLACvtfcHk0lhaWFMQ7nFzcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGhtb3K&md5=5c6acd058bacfec89b1eff2090f0fe67</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm901443h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901443h%26sid%3Dliteratum%253Aachs%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DAngiolini%26aufirst%3DM.%26atitle%3DThrough%2520the%2520%25E2%2580%259Cgatekeeper%2520door%25E2%2580%259D%253A%2520exploiting%2520the%2520active%2520kinase%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2681%26epage%3D2694%26doi%3D10.1021%2Fjm901443h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hendriks, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuvaraj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kil, L. P.</span><span> </span><span class="NLM_article-title">Targeting Bruton’s tyrosine kinase in B cell malignancies</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1038/nrc3702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnrc3702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=24658273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslCqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=219-232&issue=4&author=R.+W.+Hendriksauthor=S.+Yuvarajauthor=L.+P.+Kil&title=Targeting+Bruton%E2%80%99s+tyrosine+kinase+in+B+cell+malignancies&doi=10.1038%2Fnrc3702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Bruton's tyrosine kinase in B cell malignancies</span></div><div class="casAuthors">Hendriks, Rudi W.; Yuvaraj, Saravanan; Kil, Laurens P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-232</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Bruton's tyrosine kinase (BTK) is a key component of B cell receptor (BCR) signalling and functions as an important regulator of cell proliferation and cell survival in various B cell malignancies.  Small-mol. inhibitors of BTK have shown antitumor activity in animal models and, recently, in clin. studies.  High response rates were reported in patients with chronic lymphocytic leukemia and mantle cell lymphoma.  Remarkably, BTK inhibitors have mol. effects that cannot be explained by the classic role of BTK in BCR signalling.  In this Review, we highlight the importance of BTK in various signalling pathways in the context of its therapeutic inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9z_6SqjcVYLVg90H21EOLACvtfcHk0liXUj2mvY1zIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslCqsL4%253D&md5=ed615772c752b64360d0b5c51780e93e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrc3702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3702%26sid%3Dliteratum%253Aachs%26aulast%3DHendriks%26aufirst%3DR.%2BW.%26aulast%3DYuvaraj%26aufirst%3DS.%26aulast%3DKil%26aufirst%3DL.%2BP.%26atitle%3DTargeting%2520Bruton%25E2%2580%2599s%2520tyrosine%2520kinase%2520in%2520B%2520cell%2520malignancies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2014%26volume%3D14%26issue%3D4%26spage%3D219%26epage%3D232%26doi%3D10.1038%2Fnrc3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kracht, M.</span><span> </span><span class="NLM_article-title">Targeting innate immunity protein kinase signalling in inflammation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span><span class="refDoi"> DOI: 10.1038/nrd2829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnrd2829" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=480-499&issue=6&author=M.+Gaestelauthor=A.+Kotlyarovauthor=M.+Kracht&title=Targeting+innate+immunity+protein+kinase+signalling+in+inflammation&doi=10.1038%2Fnrd2829"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd2829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2829%26sid%3Dliteratum%253Aachs%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DKracht%26aufirst%3DM.%26atitle%3DTargeting%2520innate%2520immunity%2520protein%2520kinase%2520signalling%2520in%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26issue%3D6%26spage%3D480%26epage%3D499%26doi%3D10.1038%2Fnrd2829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Buggy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, L.</span><span> </span><span class="NLM_article-title">Bruton tyrosine kinase (BTK) and its role in B-cell malignancy</span> <span class="citation_source-journal">Int. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.3109/08830185.2012.664797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.3109%2F08830185.2012.664797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=22449073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1Omu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=119-132&issue=2&author=J.+J.+Buggyauthor=L.+Elias&title=Bruton+tyrosine+kinase+%28BTK%29+and+its+role+in+B-cell+malignancy&doi=10.3109%2F08830185.2012.664797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Bruton Tyrosine Kinase (BTK) and Its Role in B-cell Malignancy</span></div><div class="casAuthors">Buggy, Joseph J.; Elias, Laurence</div><div class="citationInfo"><span class="NLM_cas:title">International Reviews of Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-132</span>CODEN:
                <span class="NLM_cas:coden">IRIMEH</span>;
        ISSN:<span class="NLM_cas:issn">0883-0185</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  BTK is a kinase that functions downstream of multiple receptors in various hematol. cells.  This review focuses on BTK-dependent pathways that are likely to be involved in maintaining the malignant phenotype in B-cell lymphomas and leukemias.  Survival of various B-cell malignancies requires BTK-dependent signals from the B-cell antigen receptor.  Survival is also dependent on malignant cells homing to and interacting with lymphoid microenvironments, and these interactions are also BTK-dependent due its role in signaling downstream of chemokine and innate immune receptors.  The potential for therapeutic targeting of BTK is currently being tested in clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6a9d-RB2ULVg90H21EOLACvtfcHk0liXUj2mvY1zIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1Omu78%253D&md5=629473bfc4af283fbe1b4522b36f6b79</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3109%2F08830185.2012.664797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08830185.2012.664797%26sid%3Dliteratum%253Aachs%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DElias%26aufirst%3DL.%26atitle%3DBruton%2520tyrosine%2520kinase%2520%2528BTK%2529%2520and%2520its%2520role%2520in%2520B-cell%2520malignancy%26jtitle%3DInt.%2520Rev.%2520Immunol.%26date%3D2012%26volume%3D31%26issue%3D2%26spage%3D119%26epage%3D132%26doi%3D10.3109%2F08830185.2012.664797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rickert, R. C.</span><span> </span><span class="NLM_article-title">New insights into pre-BCR and BCR signalling with relevance to B cell malignancies</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">578</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span><span class="refDoi"> DOI: 10.1038/nri3487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnri3487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23883968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKnt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=578-591&issue=8&author=R.+C.+Rickert&title=New+insights+into+pre-BCR+and+BCR+signalling+with+relevance+to+B+cell+malignancies&doi=10.1038%2Fnri3487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into pre-BCR and BCR signalling with relevance to B cell malignancies</span></div><div class="casAuthors">Rickert, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">578-591</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The B cell receptor (BCR) and its precursor (pre-BCR) control B cell homeostasis, differentiation and function.  Moreover, aberrant pre-BCR and BCR signalling have a central role in B cell neoplasia; for example, enhanced pos. signalling or disrupted neg. signalling downstream of the pre-BCR promotes B cell acute lymphocytic leukemia.  The emerging distinctions between tonic and chronic active BCR signalling have contributed to the identification of oncogenic targets downstream of BCR signalling in mature B cell neoplasms.  Indeed, the encouraging results of several ongoing clin. trials that target the activity of phosphoinositide 3-kinase δ-isoform (PI3Kδ), Bruton tyrosine kinase (BTK) or spleen tyrosine kinase (SYK) downstream of the BCR highlight the therapeutic potential of inhibiting BCR signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEVfPnHXGyE7Vg90H21EOLACvtfcHk0liXUj2mvY1zIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKnt7nK&md5=8ae8c95aff039852282e02f6353979ca</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnri3487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3487%26sid%3Dliteratum%253Aachs%26aulast%3DRickert%26aufirst%3DR.%2BC.%26atitle%3DNew%2520insights%2520into%2520pre-BCR%2520and%2520BCR%2520signalling%2520with%2520relevance%2520to%2520B%2520cell%2520malignancies%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D13%26issue%3D8%26spage%3D578%26epage%3D591%26doi%3D10.1038%2Fnri3487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Palacios, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">48</span><span class="NLM_x">) </span> <span class="NLM_fpage">7990</span><span class="NLM_x">–</span> <span class="NLM_lpage">8000</span><span class="refDoi"> DOI: 10.1038/sj.onc.1208074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fsj.onc.1208074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=7990-8000&issue=48&author=E.+H.+Palaciosauthor=A.+Weiss&title=Function+of+the+Src-family+kinases%2C+Lck+and+Fyn%2C+in+T-cell+development+and+activation&doi=10.1038%2Fsj.onc.1208074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1208074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1208074%26sid%3Dliteratum%253Aachs%26aulast%3DPalacios%26aufirst%3DE.%2BH.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DFunction%2520of%2520the%2520Src-family%2520kinases%252C%2520Lck%2520and%2520Fyn%252C%2520in%2520T-cell%2520development%2520and%2520activation%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26issue%3D48%26spage%3D7990%26epage%3D8000%26doi%3D10.1038%2Fsj.onc.1208074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neininger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1038/10061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2F10061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10559880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVGqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=94-97&issue=2&author=A.+Kotlyarovauthor=A.+Neiningerauthor=C.+Schubertauthor=R.+Eckertauthor=C.+Birchmeierauthor=H.+D.+Volkauthor=M.+Gaestel&title=MAPKAP+kinase+2+is+essential+for+LPS-induced+TNF-alpha+biosynthesis&doi=10.1038%2F10061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis</span></div><div class="casAuthors">Kotlyarov, Alexey; Neininger, Armin; Schubert, Carola; Eckert, Rolf; Birchmeier, Carmen; Volk, Hans-Dieter; Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">94-97</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines Ltd</span>)
        </div><div class="casAbstract">MAPKAP kinase 2 (MK2) is one of several kinases that are regulated through direct phosphorylation by p38 MAP kinase.  By introducing a targeted mutation into the mouse MK2 gene, the authors have detd. the physiol. function of MK2 in vivo.  Mice that lack MK2 show increased stress resistance and survive LPS-induced endotoxic shock.  This is due to a redn. of ∼90% in the prodn. of tumor necrosis factor-α (TNF-α) and not to a change in signaling from the TNF receptor.  The level and stability of TNF-α mRNA is not reduced and TNF-α secretion is not affected.  Thus, MK2 is an essential component in the inflammatory response which regulates biosynthesis of TNF-α at a post-transcriptional level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtiobBLSnV77Vg90H21EOLACvtfcHk0lif8snCVKfdRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVGqsLY%253D&md5=5fb502616639b298341431eea8009cc2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F10061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F10061%26sid%3Dliteratum%253Aachs%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DNeininger%26aufirst%3DA.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DEckert%26aufirst%3DR.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DVolk%26aufirst%3DH.%2BD.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMAPKAP%2520kinase%25202%2520is%2520essential%2520for%2520LPS-induced%2520TNF-alpha%2520biosynthesis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D1999%26volume%3D1%26issue%3D2%26spage%3D94%26epage%3D97%26doi%3D10.1038%2F10061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Brook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sully, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saklatvala, J.</span><span> </span><span class="NLM_article-title">Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1016/S0014-5793(00)02084-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2FS0014-5793%2800%2902084-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2000&pages=57-61&issue=1&author=M.+Brookauthor=G.+Sullyauthor=A.+R.+Clarkauthor=J.+Saklatvala&title=Regulation+of+tumour+necrosis+factor+alpha+mRNA+stability+by+the+mitogen-activated+protein+kinase+p38+signalling+cascade&doi=10.1016%2FS0014-5793%2800%2902084-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2800%2902084-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252800%252902084-6%26sid%3Dliteratum%253Aachs%26aulast%3DBrook%26aufirst%3DM.%26aulast%3DSully%26aufirst%3DG.%26aulast%3DClark%26aufirst%3DA.%2BR.%26aulast%3DSaklatvala%26aufirst%3DJ.%26atitle%3DRegulation%2520of%2520tumour%2520necrosis%2520factor%2520alpha%2520mRNA%2520stability%2520by%2520the%2520mitogen-activated%2520protein%2520kinase%2520p38%2520signalling%2520cascade%26jtitle%3DFEBS%2520Lett.%26date%3D2000%26volume%3D483%26issue%3D1%26spage%3D57%26epage%3D61%26doi%3D10.1016%2FS0014-5793%2800%2902084-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zarubin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span> </span><span class="NLM_article-title">Activation and signaling of the p38 MAP kinase pathway</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1038/sj.cr.7290257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fsj.cr.7290257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=15686620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslGisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=11-18&issue=1&author=T.+Zarubinauthor=J.+Han&title=Activation+and+signaling+of+the+p38+MAP+kinase+pathway&doi=10.1038%2Fsj.cr.7290257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and signaling of the p38 MAP kinase pathway</span></div><div class="casAuthors">Zarubin, Tyler; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-18</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Editorial Office of Cell Research</span>)
        </div><div class="casAbstract">A review.  The family members of the MAP kinases mediate a wide variety of cellular behaviors in response to extracellular stimuli.  One of the 4 main sub-groups, the p38 group of MAP kinases, serve as a nexus for signal transduction and play a vital role in numerous biol. processes.  Here, the authors highlight the known characteristics and components of the p38 pathway along with the mechanism and consequences of p38 activation.  The authors focus on the role of p38 as a signal transduction mediator and examine the evidence linking p38 to inflammation, cell cycle, cell death, development, cell differentiation, senescence, and tumorigenesis in specific cell types.  Upstream and downstream components of p38 are described and questions remaining to be answered are posed.  Finally, the authors propose several directions for future research on p38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIDzDSa5vqULVg90H21EOLACvtfcHk0lif8snCVKfdRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslGisb4%253D&md5=c0f98c8f6db6e10b0a20357c401273d5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.cr.7290257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cr.7290257%26sid%3Dliteratum%253Aachs%26aulast%3DZarubin%26aufirst%3DT.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DActivation%2520and%2520signaling%2520of%2520the%2520p38%2520MAP%2520kinase%2520pathway%26jtitle%3DCell%2520Res.%26date%3D2005%26volume%3D15%26issue%3D1%26spage%3D11%26epage%3D18%26doi%3D10.1038%2Fsj.cr.7290257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cee, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodous, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5671</span><span class="NLM_x">–</span> <span class="NLM_lpage">5686</span><span class="refDoi"> DOI: 10.1021/jm0605482</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0605482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5671-5686&issue=19&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=V.+J.+Ceeauthor=L.+Chaiauthor=H.+L.+Deakauthor=L.+F.+Epsteinauthor=T.+Faustauthor=P.+Gallantauthor=S.+D.+Geuns-Meyerauthor=A.+Goreauthor=Y.+Guauthor=B.+Henkleauthor=B.+L.+Hodousauthor=F.+Hsiehauthor=X.+Huangauthor=J.+L.+Kimauthor=J.+H.+Leeauthor=M.+W.+Martinauthor=C.+E.+Masseauthor=D.+C.+McGowanauthor=D.+Metzauthor=D.+Mohnauthor=K.+A.+Morgensternauthor=A.+Oliveira-dos-Santosauthor=V.+F.+Patelauthor=D.+Powersauthor=P.+E.+Roseauthor=S.+Schneiderauthor=S.+A.+Tomlinsonauthor=Y.+Y.+Tudorauthor=S.+M.+Turciauthor=A.+A.+Welcherauthor=R.+D.+Whiteauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhu&title=Discovery+of+aminoquinazolines+as+potent%2C+orally+bioavailable+inhibitors+of+Lck%3A+synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity&doi=10.1021%2Fjm0605482"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0605482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605482%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%2BD.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DHodous%26aufirst%3DB.%2BL.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMasse%26aufirst%3DC.%2BE.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTomlinson%26aufirst%3DS.%2BA.%26aulast%3DTudor%26aufirst%3DY.%2BY.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520aminoquinazolines%2520as%2520potent%252C%2520orally%2520bioavailable%2520inhibitors%2520of%2520Lck%253A%2520synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D19%26spage%3D5671%26epage%3D5686%26doi%3D10.1021%2Fjm0605482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Stachlewitz, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettencourt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kebede, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waegell, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span> </span><span class="NLM_article-title">A-770041, a novel and selective small-molecule inhibitor of Lck, prevents heart allograft rejection</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1124/jpet.105.089169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1124%2Fjpet.105.089169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=16014572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=36-41&issue=1&author=R.+F.+Stachlewitzauthor=M.+A.+Hartauthor=B.+Bettencourtauthor=T.+Kebedeauthor=A.+Schwartzauthor=S.+E.+Ratnofskyauthor=D.+J.+Calderwoodauthor=W.+O.+Waegellauthor=G.+C.+Hirst&title=A-770041%2C+a+novel+and+selective+small-molecule+inhibitor+of+Lck%2C+prevents+heart+allograft+rejection&doi=10.1124%2Fjpet.105.089169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A-770041, a novel and selective small-molecule inhibitor of Lck, prevents heart allograft rejection</span></div><div class="casAuthors">Stachlewitz, Robert F.; Hart, Michelle A.; Bettencourt, Brian; Kebede, Tegest; Schwartz, Annette; Ratnofsky, Sheldon E.; Calderwood, David J.; Waegell, Wendy O.; Hirst, Gavin C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-41</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lck, one of eight members of the Src family of tyrosine kinases, is activated after T cell stimulation and is required for T-cell proliferation and interleukin (IL)-2 prodn.  Inhibition of Lck has been a target to prevent lymphocyte activation and acute rejection.  Here, we report the pharmacol. characterization of 1-methyl-1H-indole-2-carboxylic acid (4-{1-[4-(4-acetylpiperazin-l-yl)-cyclohexyl]-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxy-phenyl)-amide (A-770041), an orally bioavailable pyrazolo[3,4-d]pyrimidine with increased selectivity for Lck compared with previously reported compds.  A-770041 is a 147 nM inhibitor of Lck (1 mM ATP) and is 300-fold selective against Fyn, the other Src family kinase involved in T-cell signaling.  Con A-stimulated IL-2 prodn. in whole blood is inhibited by A-770041 with an EC50 of approx. 80 nM.  A-770041 is orally bioavailable (F = 34.1 ± 7.2% at 10 mg/kg) and has a t1/2 of 4.1 ± 0.1 h.  Con A-induced IL-2 prodn. in vivo is inhibited by oral administration of A-770041 (in vivo EC50 = 78 ± 28 nM).  Doses of A-770041 at or above 10 mg/kg/day prevent rejection of hearts transplanted heterotopically in rats from Brown Norway donors to Lewis recipients across a major histocompatibility barrier for least 65 days.  Grafts from animals treated with 20 mg/kg/day A-770041 or 10 mg/day Cyclosporin A had minimal microvascular changes or multifocal mononuclear infiltrates.  However, mineralization in myocytes from the grafts from A-770041-treated animals was less than animals treated with Cyclosporin A.  Lck inhibition is an attractive target to prevent acute rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUGRdbGgdcRbVg90H21EOLACvtfcHk0ljMPRPWkP41iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrbE&md5=744e6f81abafe3f7573307abbeeddb37</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.089169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.089169%26sid%3Dliteratum%253Aachs%26aulast%3DStachlewitz%26aufirst%3DR.%2BF.%26aulast%3DHart%26aufirst%3DM.%2BA.%26aulast%3DBettencourt%26aufirst%3DB.%26aulast%3DKebede%26aufirst%3DT.%26aulast%3DSchwartz%26aufirst%3DA.%26aulast%3DRatnofsky%26aufirst%3DS.%2BE.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DWaegell%26aufirst%3DW.%2BO.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26atitle%3DA-770041%252C%2520a%2520novel%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520Lck%252C%2520prevents%2520heart%2520allograft%2520rejection%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26issue%3D1%26spage%3D36%26epage%3D41%26doi%3D10.1124%2Fjpet.105.089169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Vargas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamasy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nore, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. I.</span><span> </span><span class="NLM_article-title">Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseases</span> <span class="citation_source-journal">Scand. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1111/sji.12069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1111%2Fsji.12069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23672610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOit77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=130-139&issue=2&author=L.+Vargasauthor=A.+Hamasyauthor=B.+F.+Noreauthor=C.+I.+Smith&title=Inhibitors+of+BTK+and+ITK%3A+state+of+the+new+drugs+for+cancer%2C+autoimmunity+and+inflammatory+diseases&doi=10.1111%2Fsji.12069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of BTK and ITK: State of the New Drugs for Cancer, Autoimmunity and Inflammatory Diseases</span></div><div class="casAuthors">Vargas, L.; Hamasy, A.; Nore, B. F.; E. Smith, C. I.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-139</span>CODEN:
                <span class="NLM_cas:coden">SJIMAX</span>;
        ISSN:<span class="NLM_cas:issn">0300-9475</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  BTK and ITK are cytoplasmic tyrosine kinases of crucial importance for B and T cell development, with loss-of-function mutations causing X-linked agammaglobulinemia and susceptibility to severe, frequently lethal, Epstein-Barr virus infection, resp.  Over the last few years, considerable efforts have been made in order to develop small-mol. inhibitors for these kinases to treat lymphocyte malignancies, autoimmunity or allergy/hypersensitivity.  The rationale is that even if complete lack of BTK or ITK during development causes severe immunodeficiency, inactivation after birth may result in a less severe phenotype.  Moreover, therapy can be transient or only partially block the activity of BTK or ITK.  Furthermore, a drug-induced B cell deficiency is treatable by gamma globulin substitution therapy.  The newly developed BTK inhibitor PCI-32765, recently renamed Ibrutinib, has already entered several clin. trials for various forms of non-Hodgkin lymphoma as well as for multiple myeloma.  Exptl. animal studies have demonstrated highly promising treatment effects also in autoimmunity.  ITK inhibitors are still under the early developmental phase, but it can be expected that such drugs will also become very useful.  In this study, we present BTK and ITK with their signalling pathways and review the development of the corresponding inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP0_rsdqSDoLVg90H21EOLACvtfcHk0ljMPRPWkP41iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOit77M&md5=f9ba77b041266d4746a7cef27604f11a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fsji.12069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fsji.12069%26sid%3Dliteratum%253Aachs%26aulast%3DVargas%26aufirst%3DL.%26aulast%3DHamasy%26aufirst%3DA.%26aulast%3DNore%26aufirst%3DB.%2BF.%26aulast%3DSmith%26aufirst%3DC.%2BI.%26atitle%3DInhibitors%2520of%2520BTK%2520and%2520ITK%253A%2520state%2520of%2520the%2520new%2520drugs%2520for%2520cancer%252C%2520autoimmunity%2520and%2520inflammatory%2520diseases%26jtitle%3DScand.%2520J.%2520Immunol.%26date%3D2013%26volume%3D78%26issue%3D2%26spage%3D130%26epage%3D139%26doi%3D10.1111%2Fsji.12069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Romagnoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelosi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantagrel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meerwijk, J. P.</span><span> </span><span class="NLM_article-title">A potential role for protein tyrosine kinase p56(lck) in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness</span> <span class="citation_source-journal">Int. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1093/intimm/13.3.305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1093%2Fintimm%2F13.3.305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=11222499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvVOhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=305-312&issue=3&author=P.+Romagnoliauthor=D.+Strahanauthor=M.+Pelosiauthor=A.+Cantagrelauthor=J.+P.+van+Meerwijk&title=A+potential+role+for+protein+tyrosine+kinase+p56%28lck%29+in+rheumatoid+arthritis+synovial+fluid+T+lymphocyte+hyporesponsiveness&doi=10.1093%2Fintimm%2F13.3.305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A potential role for protein tyrosine kinase p56lck in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness</span></div><div class="casAuthors">Romagnoli, Paola; Strahan, Donna; Pelosi, Michele; Cantagrel, Alain; Van Meerwijk, Joost P. M.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-312</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Rheumatoid arthritis (RA) synovial fluid (SF)-T lymphocytes appear relatively inactive in situ and respond only weakly to diverse stimuli ex vivo.  To characterize the mol. defects underlying this hyporesponsiveness the authors analyzed the expression level of several proteins involved in TCR-proximal signal transduction.  As compared to peripheral blood (PB)-T lymphocytes, SF-T cells from some (but not all) of the patients analyzed expressed lower levels of TCRαβ, CD3ε, TCRζ, p56lck and LAT, while p59fyn, phospholipase C-γ1 and ZAP-70 expression was unaltered.  Semi-quant. anal. of T cells from several patients revealed that the degree of TCRζ chain and p56lck modulation correlated statistically significantly with the level of SF-T cell hyporesponsiveness.  The differential reactivity of p56lck specific monoclonal and polyclonal antibodies in SF-T but not PB-T lymphocytes indicated that p56lck modulation consists of a conformational change rather than loss of expression.  Our results indicate that multiple signaling mols. can be modulated in RA SF-T cells and show for the first time a direct quant. correlation between T cell hyporesponsiveness and modulation of TCRζ and of p56lck, a crit. protein tyrosine kinase required for T cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ3UeK56kdLLVg90H21EOLACvtfcHk0ljc4foT7d75IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvVOhtro%253D&md5=0e18afeb1a6714fcaa33031de6cf26ae</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2F13.3.305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252F13.3.305%26sid%3Dliteratum%253Aachs%26aulast%3DRomagnoli%26aufirst%3DP.%26aulast%3DStrahan%26aufirst%3DD.%26aulast%3DPelosi%26aufirst%3DM.%26aulast%3DCantagrel%26aufirst%3DA.%26aulast%3Dvan%2BMeerwijk%26aufirst%3DJ.%2BP.%26atitle%3DA%2520potential%2520role%2520for%2520protein%2520tyrosine%2520kinase%2520p56%2528lck%2529%2520in%2520rheumatoid%2520arthritis%2520synovial%2520fluid%2520T%2520lymphocyte%2520hyporesponsiveness%26jtitle%3DInt.%2520Immunol.%26date%3D2001%26volume%3D13%26issue%3D3%26spage%3D305%26epage%3D312%26doi%3D10.1093%2Fintimm%2F13.3.305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">2979</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span><span class="refDoi"> DOI: 10.2174/092986705774462914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.2174%2F092986705774462914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=16378500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2979-2994&issue=25&author=M.+R.+Leeauthor=C.+Dominguez&title=MAP+kinase+p38+inhibitors%3A+clinical+results+and+an+intimate+look+at+their+interactions+with+p38alpha+protein&doi=10.2174%2F092986705774462914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38α protein</span></div><div class="casAuthors">Lee, Matthew R.; Dominguez, Celia</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2979-2994</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase p38 is a serine/threonine kinase originally isolated from lipopolysaccharide (LPS) stimulated monocytes.  There are four isoforms p38α, p38β, p38γ, and p38δ.  The most thoroughly studied isoform is p38α, whose activation has been obsd. in many hematopoietic and non-hematopoietic cell types upon appropriate stimuli.  Subsequently, p38α kinase has been shown to be involved in the biosynthesis of TNFα and IL-1β at the translational and transcriptional level.  MAP kinase p38α represents a point of convergence for multiple signaling processes that are activated in inflammation and thus a key potential target for the modulation of cytokine prodn.  The discovery and publication of p38α and the pyridinyl-imidazole inhibitor initiated a huge effort by many companies to develop p38α inhibitors as potential treatment for inflammatory diseases.  Herein we provide a brief overview of recent reported clin. results for AMG 548, BIRB 796, VX 702, SCIO 469, and SCIO 323.  However, our focus will be on the binding modes of these inhibitors and other p38 inhibitors in the recent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSldsfUAO6bVg90H21EOLACvtfcHk0ljc4foT7d75IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF&md5=eb21253fcc2df76280cd9a1812ed1015</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F092986705774462914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774462914%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DMAP%2520kinase%2520p38%2520inhibitors%253A%2520clinical%2520results%2520and%2520an%2520intimate%2520look%2520at%2520their%2520interactions%2520with%2520p38alpha%2520protein%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26issue%3D25%26spage%3D2979%26epage%3D2994%26doi%3D10.2174%2F092986705774462914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Honigberg, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisawad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loury, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thamm, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span> </span><span class="NLM_article-title">The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">29</span><span class="NLM_x">) </span> <span class="NLM_fpage">13075</span><span class="NLM_x">–</span> <span class="NLM_lpage">13080</span><span class="refDoi"> DOI: 10.1073/pnas.1004594107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1073%2Fpnas.1004594107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=20615965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=13075-13080&issue=29&author=L.+A.+Honigbergauthor=A.+M.+Smithauthor=M.+Sirisawadauthor=E.+Vernerauthor=D.+Louryauthor=B.+Changauthor=S.+Liauthor=Z.+Panauthor=D.+H.+Thammauthor=R.+A.+Millerauthor=J.+J.+Buggy&title=The+Bruton+tyrosine+kinase+inhibitor+PCI-32765+blocks+B-cell+activation+and+is+efficacious+in+models+of+autoimmune+disease+and+B-cell+malignancy&doi=10.1073%2Fpnas.1004594107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy</span></div><div class="casAuthors">Honigberg, Lee A.; Smith, Ashley M.; Sirisawad, Mint; Verner, Erik; Loury, David; Chang, Betty; Li, Shyr; Pan, Zhengying; Thamm, Douglas H.; Miller, Richard A.; Buggy, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">13075-13080, S13075/1-S13075/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Activation of the B-cell antigen receptor (BCR) signaling pathway contributes to the initiation and maintenance of B-cell malignancies and autoimmune diseases.  The Bruton tyrosine kinase (Btk) is specifically required for BCR signaling as demonstrated by human and mouse mutations that disrupt Btk function and prevent B-cell maturation at steps that require a functional BCR pathway.  Herein we describe a selective and irreversible Btk inhibitor, PCI-32765, that is currently under clin. development in patients with B-cell non-Hodgkin lymphoma.  We have used this inhibitor to investigate the biol. effects of Btk inhibition on mature B-cell function and the progression of B cell-assocd. diseases in vivo.  PCI-32765 blocked BCR signaling in human peripheral B cells at concns. that did not affect T cell receptor signaling.  In mice with collagen-induced arthritis, orally administered PCI-32765 reduced the level of circulating autoantibodies and completely suppressed disease.  PCI-32765 also inhibited autoantibody prodn. and the development of kidney disease in the MRL-Fas(lpr) lupus model.  Occupancy of the Btk active site by PCI-32765 was monitored in vitro and in vivo using a fluorescent affinity probe for Btk.  Active site occupancy of Btk was tightly correlated with the blockade of BCR signaling and in vivo efficacy.  Finally, PCI-32765 induced objective clin. responses in dogs with spontaneous B-cell non-Hodgkin lymphoma.  These findings support Btk inhibition as a therapeutic approach for the treatment of human diseases assocd. with activation of the BCR pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT4OQHme7oHLVg90H21EOLACvtfcHk0ljc4foT7d75IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCrsbk%253D&md5=196ce4a05bb9c622c49cb7e908682e63</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1004594107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1004594107%26sid%3Dliteratum%253Aachs%26aulast%3DHonigberg%26aufirst%3DL.%2BA.%26aulast%3DSmith%26aufirst%3DA.%2BM.%26aulast%3DSirisawad%26aufirst%3DM.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DLoury%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DThamm%26aufirst%3DD.%2BH.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Bruton%2520tyrosine%2520kinase%2520inhibitor%2520PCI-32765%2520blocks%2520B-cell%2520activation%2520and%2520is%2520efficacious%2520in%2520models%2520of%2520autoimmune%2520disease%2520and%2520B-cell%2520malignancy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D29%26spage%3D13075%26epage%3D13080%26doi%3D10.1073%2Fpnas.1004594107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutre, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flinn, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierda, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerema, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukbuntherng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S.</span><span> </span><span class="NLM_article-title">Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1056/NEJMoa1215637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1056%2FNEJMoa1215637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23782158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFygu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=32-42&issue=1&author=J.+C.+Byrdauthor=R.+R.+Furmanauthor=S.+E.+Coutreauthor=I.+W.+Flinnauthor=J.+A.+Burgerauthor=K.+A.+Blumauthor=B.+Grantauthor=J.+P.+Sharmanauthor=M.+Colemanauthor=W.+G.+Wierdaauthor=J.+A.+Jonesauthor=W.+Zhaoauthor=N.+A.+Heeremaauthor=A.+J.+Johnsonauthor=J.+Sukbuntherngauthor=B.+Y.+Changauthor=F.+Clowauthor=E.+Hedrickauthor=J.+J.+Buggyauthor=D.+F.+Jamesauthor=S.+O%E2%80%99Brien&title=Targeting+BTK+with+ibrutinib+in+relapsed+chronic+lymphocytic+leukemia&doi=10.1056%2FNEJMoa1215637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia</span></div><div class="casAuthors">Byrd, John C.; Furman, Richard R.; Coutre, Steven E.; Flinn, Ian W.; Burger, Jan A.; Blum, Kristie A.; Grant, Barbara; Sharman, Jeff P.; Coleman, Morton; Wierda, William G.; Jones, Jeffrey A.; Zhao, Weiqiang; Heerema, Nyla A.; Johnson, Amy J.; Sukbuntherng, Juthamas; Chang, Betty Y.; Clow, Fong; Hedrick, Eric; Buggy, Joseph J.; James, Danelle F.; O'Brien, Susan</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-42</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background The treatment of relapsed chronic lymphocytic leukemia (CLL) has resulted in few durable remissions.  Bruton's tyrosine kinase (BTK), an essential component of B-cell-receptor signaling, mediates interactions with the tumor microenvironment and promotes the survival and proliferation of CLL cells.  Methods We conducted a phase 1b-2 multicenter study to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ibrutinib (PCI-32765), a first-in-class, oral covalent inhibitor of BTK designed for treatment of B-cell cancers, in patients with relapsed or refractory CLL or small lymphocytic lymphoma.  A total of 85 patients, the majority of whom were considered to have high-risk disease, received ibrutinib orally once daily; 51 received 420 mg, and 34 received 840 mg.  Results Toxic effects were predominantly grade 1 or 2 and included transient diarrhea, fatigue, and upper respiratory tract infection; thus, patients could receive extended treatment with minimal hematol. toxic effects.  The overall response rate was the same in the group that received 420 mg and the group that received 840 mg (71%), and an addnl. 20% and 15% of patients in the resp. groups had a partial response with lymphocytosis.  The response was independent of clin. and genomic risk factors present before treatment, including advanced-stage disease, the no. of previous therapies, and the 17p13.1 deletion.  At 26 mo, the estd. progression-free survival rate was 75% and the rate of overall survival was 83%.  Conclusions Ibrutinib was assocd. with a high frequency of durable remissions in patients with relapsed or refractory CLL and small lymphocytic lymphoma, including patients with high-risk genetic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1EhPQxMRz7rVg90H21EOLACvtfcHk0ligYXiIakDNlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFygu7zN&md5=32a5eb6ab06beeecf64d9ada84139925</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1215637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1215637%26sid%3Dliteratum%253Aachs%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DFurman%26aufirst%3DR.%2BR.%26aulast%3DCoutre%26aufirst%3DS.%2BE.%26aulast%3DFlinn%26aufirst%3DI.%2BW.%26aulast%3DBurger%26aufirst%3DJ.%2BA.%26aulast%3DBlum%26aufirst%3DK.%2BA.%26aulast%3DGrant%26aufirst%3DB.%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DColeman%26aufirst%3DM.%26aulast%3DWierda%26aufirst%3DW.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BA.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DHeerema%26aufirst%3DN.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DSukbuntherng%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DB.%2BY.%26aulast%3DClow%26aufirst%3DF.%26aulast%3DHedrick%26aufirst%3DE.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DJames%26aufirst%3DD.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%26atitle%3DTargeting%2520BTK%2520with%2520ibrutinib%2520in%2520relapsed%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26issue%3D1%26spage%3D32%26epage%3D42%26doi%3D10.1056%2FNEJMoa1215637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wang, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rule, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahl, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurczak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Advani, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romaguera, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrientos, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielowska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stilgenbauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jedrzejczak, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurgeon, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newberry, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGreivy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaupre, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, K. A.</span><span> </span><span class="NLM_article-title">Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span><span class="refDoi"> DOI: 10.1056/NEJMoa1306220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1056%2FNEJMoa1306220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23782157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OgtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=507-516&issue=6&author=M.+L.+Wangauthor=S.+Ruleauthor=P.+Martinauthor=A.+Goyauthor=R.+Auerauthor=B.+S.+Kahlauthor=W.+Jurczakauthor=R.+H.+Advaniauthor=J.+E.+Romagueraauthor=M.+E.+Williamsauthor=J.+C.+Barrientosauthor=E.+Chmielowskaauthor=J.+Radfordauthor=S.+Stilgenbauerauthor=M.+Dreylingauthor=W.+W.+Jedrzejczakauthor=P.+Johnsonauthor=S.+E.+Spurgeonauthor=L.+Liauthor=L.+Zhangauthor=K.+Newberryauthor=Z.+Ouauthor=N.+Chengauthor=B.+Fangauthor=J.+McGreivyauthor=F.+Clowauthor=J.+J.+Buggyauthor=B.+Y.+Changauthor=D.+M.+Beaupreauthor=L.+A.+Kunkelauthor=K.+A.+Blum&title=Targeting+BTK+with+ibrutinib+in+relapsed+or+refractory+mantle-cell+lymphoma&doi=10.1056%2FNEJMoa1306220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma</span></div><div class="casAuthors">Wang, Michael L.; Rule, Simon; Martin, Peter; Goy, Andre; Auer, Rebecca; Kahl, Brad S.; Jurczak, Wojciech; Advani, Ranjana H.; Romaguera, Jorge E.; Williams, Michael E.; Barrientos, Jacqueline C.; Chmielowska, Ewa; Radford, John; Stilgenbauer, Stephan; Dreyling, Martin; Jedrzejczak, Wieslaw Wiktor; Johnson, Peter; Spurgeon, Stephen E.; Li, Lei; Zhang, Liang; Newberry, Kate; Ou, Zhishuo; Cheng, Nancy; Fang, Bingliang; McGreivy, Jesse; Clow, Fong; Buggy, Joseph J.; Chang, Betty Y.; Beaupre, Darrin M.; Kunkel, Lori A.; Blum, Kristie A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">507-516</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Bruton's tyrosine kinase (BTK) is a mediator of the B-cell-receptor signaling pathway implicated in the pathogenesis of B-cell cancers.  In a phase 1 study, ibrutinib, a BTK inhibitor, showed antitumor activity in several types of non-Hodgkin's lymphoma, including mantle-cell lymphoma.  METHODS: In this phase 2 study, we investigated oral ibrutinib, at a daily dose of 560 mg, in 111 patients with relapsed or refractory mantle-cell lymphoma.  Patients were enrolled into two groups: those who had previously received at least 2 cycles of bortezomib therapy and those who had received less than 2 complete cycles of bortezomib or had received no prior bortezomib therapy.  The primary end point was the overall response rate.  Secondary end points were duration of response, progression-free survival, overall survival, and safety.  RESULTS: The median age was 68 years, and 86% of patients had intermediate-risk or high-risk mantle-cell lymphoma according to clin. prognostic factors.  Patients had received a median of three prior therapies.  The most common treatment-related adverse events were mild or moderate diarrhea, fatigue, and nausea.  Grade 3 or higher hematol. events were infrequent and included neutropenia (in 16% of patients), thrombocytopenia (in 11%), and anemia (in 10%).  A response rate of 68% (75 patients) was obsd., with a complete response rate of 21% and a partial response rate of 47%; prior treatment with bortezomib had no effect on the response rate.  With an estd. median follow-up of 15.3 mo, the estd. median response duration was 17.5 mo (95% confidence interval [CI], 15.8 to not reached), the estd. median progression-free survival was 13.9 mo (95% CI, 7.0 to not reached), and the median overall survival was not reached.  The estd. rate of overall survival was 58% at 18 mo.  CONCLUSIONS: Ibrutinib shows durable single-agent efficacy in relapsed or refractory mantle-cell lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovUuOKvHS0NrVg90H21EOLACvtfcHk0ligYXiIakDNlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OgtL%252FF&md5=7a92bbd5acf86e614cea96f44503e12b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1306220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1306220%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%2BL.%26aulast%3DRule%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DGoy%26aufirst%3DA.%26aulast%3DAuer%26aufirst%3DR.%26aulast%3DKahl%26aufirst%3DB.%2BS.%26aulast%3DJurczak%26aufirst%3DW.%26aulast%3DAdvani%26aufirst%3DR.%2BH.%26aulast%3DRomaguera%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DM.%2BE.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DChmielowska%26aufirst%3DE.%26aulast%3DRadford%26aufirst%3DJ.%26aulast%3DStilgenbauer%26aufirst%3DS.%26aulast%3DDreyling%26aufirst%3DM.%26aulast%3DJedrzejczak%26aufirst%3DW.%2BW.%26aulast%3DJohnson%26aufirst%3DP.%26aulast%3DSpurgeon%26aufirst%3DS.%2BE.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DOu%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DN.%26aulast%3DFang%26aufirst%3DB.%26aulast%3DMcGreivy%26aufirst%3DJ.%26aulast%3DClow%26aufirst%3DF.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DChang%26aufirst%3DB.%2BY.%26aulast%3DBeaupre%26aufirst%3DD.%2BM.%26aulast%3DKunkel%26aufirst%3DL.%2BA.%26aulast%3DBlum%26aufirst%3DK.%2BA.%26atitle%3DTargeting%2520BTK%2520with%2520ibrutinib%2520in%2520relapsed%2520or%2520refractory%2520mantle-cell%2520lymphoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26issue%3D6%26spage%3D507%26epage%3D516%26doi%3D10.1056%2FNEJMoa1306220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Chang, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francesco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokolove, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magadala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span> </span><span class="NLM_article-title">The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">R115</span><span class="refDoi"> DOI: 10.1186/ar3400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1186%2Far3400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=21752263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFGltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=R115&issue=4&author=B.+Y.+Changauthor=M.+M.+Huangauthor=M.+Francescoauthor=J.+Chenauthor=J.+Sokoloveauthor=P.+Magadalaauthor=W.+H.+Robinsonauthor=J.+J.+Buggy&title=The+Bruton+tyrosine+kinase+inhibitor+PCI-32765+ameliorates+autoimmune+arthritis+by+inhibition+of+multiple+effector+cells&doi=10.1186%2Far3400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells</span></div><div class="casAuthors">Chang, Betty Y.; Huang, Min Mei; Francesco, Michelle; Chen, Jun; Sokolove, Jeremy; Magadala, Padmaja; Robinson, William H.; Buggy, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">R115</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction: The aim was to det. the effect of the Bruton tyrosine kinase (Btk)-selective inhibitor PCI-32765, currently in Phase I/II studies in lymphoma trials, in arthritis and immune-complex (IC) based animal models and describe the underlying cellular mechanisms.  Methods: PCI-32765 was administered in a series of murine IC disease models including collagen-induced arthritis (CIA), collagen antibody-induced arthritis (CAIA), reversed passive anaphylactic reaction (RPA), and passive cutaneous anaphylaxis (PCA).  Clin. and pathol. features characteristic of each model were examd. following treatment.  PCI-32765 was then examd. in assays using immune cells relevant to the pathogenesis of arthritis, and where Btk is thought to play a functional role.  These included proliferation and calcium mobilization in B cells, cytokine and chemokine prodn. in monocytes/macrophages, degranulation of mast cells and its subsequent cytokine/chemokine prodn.  Results: PCI-32765 dose-dependently and potently reversed arthritic inflammation in a therapeutic CIA model with an ED50 of 2.6 mg/kg/day.  PCI-32765 also prevented clin. arthritis in CAIA models.  In both models, infiltration of monocytes and macrophages into the synovium was completely inhibited and importantly, the bone and cartilage integrity of the joints were preserved.  PCI-32765 reduced inflammation in the Arthus and PCA assays.  In vitro, PCI-32765 inhibited BCR-activated primary B cell proliferation (IC50 = 8 nM).  Following FcγR stimulation, PCI-32765 inhibited TNFα, IL-1β and IL-6 prodn. in primary monocytes (IC50 = 2.6, 0.5, 3.9 nM, resp.).  Following Fc.vepsiln.RI stimulation of cultured human mast cells, PCI-32765 inhibited release of histamine, PGD2, TNF-α, IL-8 and MCP-1.  Conclusions: PCI-32765 is efficacious in CIA, and in IC models that do not depend upon autoantibody prodn. from B cells.  Thus PCI-32765 targets not only B lymphocytes but also monocytes, macrophages and mast cells, which are important Btk-expressing effector cells in arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQLy1_wdvr7rVg90H21EOLACvtfcHk0ligYXiIakDNlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFGltrs%253D&md5=ab0d3df5dc8816194c4087a131125744</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2Far3400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far3400%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DB.%2BY.%26aulast%3DHuang%26aufirst%3DM.%2BM.%26aulast%3DFrancesco%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSokolove%26aufirst%3DJ.%26aulast%3DMagadala%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DW.%2BH.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Bruton%2520tyrosine%2520kinase%2520inhibitor%2520PCI-32765%2520ameliorates%2520autoimmune%2520arthritis%2520by%2520inhibition%2520of%2520multiple%2520effector%2520cells%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2011%26volume%3D13%26issue%3D4%26spage%3DR115%26doi%3D10.1186%2Far3400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Evans, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tester, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labenski, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witowski, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lounsbury, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazdiyasni, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubrovskiy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, W. F.</span><span> </span><span class="NLM_article-title">Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span><span class="refDoi"> DOI: 10.1124/jpet.113.203489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1124%2Fjpet.113.203489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23709115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOjsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2013&pages=219-228&issue=2&author=E.+K.+Evansauthor=R.+Testerauthor=S.+Aslanianauthor=R.+Karpauthor=M.+Sheetsauthor=M.+T.+Labenskiauthor=S.+R.+Witowskiauthor=H.+Lounsburyauthor=P.+Chaturvediauthor=H.+Mazdiyasniauthor=Z.+Zhuauthor=M.+Nachtauthor=M.+I.+Freedauthor=R.+C.+Petterauthor=A.+Dubrovskiyauthor=J.+Singhauthor=W.+F.+Westlin&title=Inhibition+of+Btk+with+CC-292+provides+early+pharmacodynamic+assessment+of+activity+in+mice+and+humans&doi=10.1124%2Fjpet.113.203489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans</span></div><div class="casAuthors">Evans, Erica K.; Tester, Richland; Aslanian, Sharon; Karp, Russell; Sheets, Michael; Labenski, Matthew T.; Witowski, Steven R.; Lounsbury, Heather; Chaturvedi, Prasoon; Mazdiyasni, Hormoz; Zhu, Zhendong; Nacht, Mariana; Freed, Martin I.; Petter, Russell C.; Dubrovskiy, Alex; Singh, Juswinder; Westlin, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-228</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Targeted therapies that suppress B cell receptor (BCR) signaling have emerged as promising agents in autoimmune disease and B cell malignancies.  Bruton's tyrosine kinase (Btk) plays a crucial role in B cell development and activation through the BCR signaling pathway and represents a new target for diseases characterized by inappropriate B cell activity.  N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide (CC-292) is a highly selective, covalent Btk inhibitor and a sensitive and quant. assay that measures CC-292-Btk engagement has been developed.  This translational pharmacodynamic assay has accompanied CC-292 through each step of drug discovery and development.  These studies demonstrate the quantity of Btk bound by CC-292 correlates with the efficacy of CC-292 in vitro and in the collagen-induced arthritis model of autoimmune disease.  Recently, CC-292 has entered human clin. trials with a trial design that has provided rapid insight into safety, pharmacokinetics, and pharmacodynamics.  This first-in-human healthy volunteer trial has demonstrated that a single oral dose of 2 mg/kg CC-292 consistently engaged all circulating Btk protein and provides the basis for rational dose selection in future clin. trials.  This targeted covalent drug design approach has enabled the discovery and early clin. development of CC-292 and has provided support for Btk as a valuable drug target for B-cell mediated disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN2l8ZCVqCFLVg90H21EOLACvtfcHk0lizVXGW8a7bpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOjsbbM&md5=95fac997a246e59d943dd554af358a65</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.203489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.203489%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DE.%2BK.%26aulast%3DTester%26aufirst%3DR.%26aulast%3DAslanian%26aufirst%3DS.%26aulast%3DKarp%26aufirst%3DR.%26aulast%3DSheets%26aufirst%3DM.%26aulast%3DLabenski%26aufirst%3DM.%2BT.%26aulast%3DWitowski%26aufirst%3DS.%2BR.%26aulast%3DLounsbury%26aufirst%3DH.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DMazdiyasni%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DNacht%26aufirst%3DM.%26aulast%3DFreed%26aufirst%3DM.%2BI.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DDubrovskiy%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DWestlin%26aufirst%3DW.%2BF.%26atitle%3DInhibition%2520of%2520Btk%2520with%2520CC-292%2520provides%2520early%2520pharmacodynamic%2520assessment%2520of%2520activity%2520in%2520mice%2520and%2520humans%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D346%26issue%3D2%26spage%3D219%26epage%3D228%26doi%3D10.1124%2Fjpet.113.203489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Walter, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rule, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quittet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtenay-Luck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morschhauser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fegan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, G.</span><span> </span><span class="NLM_article-title">A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1182/blood-2015-08-664086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1182%2Fblood-2015-08-664086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2016&pages=411-419&issue=4&author=H.+S.+Walterauthor=S.+A.+Ruleauthor=M.+J.+Dyerauthor=L.+Karlinauthor=C.+Jonesauthor=B.+Cazinauthor=P.+Quittetauthor=N.+Shahauthor=C.+V.+Hutchinsonauthor=H.+Hondaauthor=K.+Duffyauthor=J.+Birkettauthor=V.+Jamiesonauthor=N.+Courtenay-Luckauthor=T.+Yoshizawaauthor=J.+Sharpeauthor=T.+Ohnoauthor=S.+Abeauthor=A.+Nishimuraauthor=G.+Cartronauthor=F.+Morschhauserauthor=C.+Feganauthor=G.+Salles&title=A+phase+1+clinical+trial+of+the+selective+BTK+inhibitor+ONO%2FGS-4059+in+relapsed+and+refractory+mature+B-cell+malignancies&doi=10.1182%2Fblood-2015-08-664086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1182%2Fblood-2015-08-664086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2015-08-664086%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DH.%2BS.%26aulast%3DRule%26aufirst%3DS.%2BA.%26aulast%3DDyer%26aufirst%3DM.%2BJ.%26aulast%3DKarlin%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DCazin%26aufirst%3DB.%26aulast%3DQuittet%26aufirst%3DP.%26aulast%3DShah%26aufirst%3DN.%26aulast%3DHutchinson%26aufirst%3DC.%2BV.%26aulast%3DHonda%26aufirst%3DH.%26aulast%3DDuffy%26aufirst%3DK.%26aulast%3DBirkett%26aufirst%3DJ.%26aulast%3DJamieson%26aufirst%3DV.%26aulast%3DCourtenay-Luck%26aufirst%3DN.%26aulast%3DYoshizawa%26aufirst%3DT.%26aulast%3DSharpe%26aufirst%3DJ.%26aulast%3DOhno%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DA.%26aulast%3DCartron%26aufirst%3DG.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DFegan%26aufirst%3DC.%26aulast%3DSalles%26aufirst%3DG.%26atitle%3DA%2520phase%25201%2520clinical%2520trial%2520of%2520the%2520selective%2520BTK%2520inhibitor%2520ONO%252FGS-4059%2520in%2520relapsed%2520and%2520refractory%2520mature%2520B-cell%2520malignancies%26jtitle%3DBlood%26date%3D2016%26volume%3D127%26issue%3D4%26spage%3D411%26epage%3D419%26doi%3D10.1182%2Fblood-2015-08-664086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Tam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigg, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbertson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicorleto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimovski, B.</span><span> </span><span class="NLM_article-title">The BTK inhibitor, Bgb-3111, is safe, tolerable, and highly active in patients with relapsed/refractory B-cell malignancies: initial report of a phase 1 first-in-human trial</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">832</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=832&issue=23&author=C.+Tamauthor=A.+P.+Griggauthor=S.+Opatauthor=M.+Kuauthor=M.+Gilbertsonauthor=M.+A.+Andersonauthor=J.+F.+Seymourauthor=D.+S.+Ritchieauthor=C.+Dicorletoauthor=B.+Dimovski&title=The+BTK+inhibitor%2C+Bgb-3111%2C+is+safe%2C+tolerable%2C+and+highly+active+in+patients+with+relapsed%2Frefractory+B-cell+malignancies%3A+initial+report+of+a+phase+1+first-in-human+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DC.%26aulast%3DGrigg%26aufirst%3DA.%2BP.%26aulast%3DOpat%26aufirst%3DS.%26aulast%3DKu%26aufirst%3DM.%26aulast%3DGilbertson%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DM.%2BA.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DRitchie%26aufirst%3DD.%2BS.%26aulast%3DDicorleto%26aufirst%3DC.%26aulast%3DDimovski%26aufirst%3DB.%26atitle%3DThe%2520BTK%2520inhibitor%252C%2520Bgb-3111%252C%2520is%2520safe%252C%2520tolerable%252C%2520and%2520highly%2520active%2520in%2520patients%2520with%2520relapsed%252Frefractory%2520B-cell%2520malignancies%253A%2520initial%2520report%2520of%2520a%2520phase%25201%2520first-in-human%2520trial%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26issue%3D23%26spage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachlewitz, R. F.</span><span> </span><span class="NLM_article-title">Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.09.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.bmcl.2005.09.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=118-122&issue=1&author=A.+Burchatauthor=D.+W.+Borhaniauthor=D.+J.+Calderwoodauthor=G.+C.+Hirstauthor=B.+Liauthor=R.+F.+Stachlewitz&title=Discovery+of+A-770041%2C+a+src-family+selective+orally+active+lck+inhibitor+that+prevents+organ+allograft+rejection&doi=10.1016%2Fj.bmcl.2005.09.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.09.039%26sid%3Dliteratum%253Aachs%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DStachlewitz%26aufirst%3DR.%2BF.%26atitle%3DDiscovery%2520of%2520A-770041%252C%2520a%2520src-family%2520selective%2520orally%2520active%2520lck%2520inhibitor%2520that%2520prevents%2520organ%2520allograft%2520rejection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D1%26spage%3D118%26epage%3D122%26doi%3D10.1016%2Fj.bmcl.2005.09.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">Evaluation and application of MD-PB/SA in structure-based hierarchical virtual screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1996</span><span class="refDoi"> DOI: 10.1021/ci5003203</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci5003203" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKnsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=1987-1996&issue=7&author=R.+Caoauthor=N.+Huangauthor=Y.+Wang&title=Evaluation+and+application+of+MD-PB%2FSA+in+structure-based+hierarchical+virtual+screening&doi=10.1021%2Fci5003203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and Application of MD-PB/SA in Structure-Based Hierarchical Virtual Screening</span></div><div class="casAuthors">Cao, Ran; Huang, Niu; Wang, Yanli</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1987-1996</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. dynamics (MD) based mol. mechanics Poisson-Boltzmann and surface area (MM-PB/SA) calcn. (MD-PB/SA) has been widely used to est. binding free energies for receptor-ligand complexes.  While numerous reports have focused on assessing accuracy and efficiency, fewer studies have paid attention to performance in lead discovery.  In the present study, we report a crit. evaluation of MD-PB/SA in hierarchical virtual screening (HVS) both theor. and practically.  It is shown that based on native poses, MD-PB/SA could be well applied to predict the relative binding energy for both congeneric and diverse ligands for different protein targets.  However, there is a limitation for MD-PB/SA to distinguish the native pose of one ligand from the artificial pose of another when a huge difference exists between two mols.  By combining a physics-based scoring function with a knowledge-based structural filter, we improve the predictability and validate the practical use of MD-PB/SA in lead discovery by identifying novel inhibitors of p38 MAP kinase.  We also expand our study to other protein targets such as HIV-1 RT and NA to assess the general validity of MD-PB/SA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkOfWO0vnXUbVg90H21EOLACvtfcHk0lgjvGz0yAp9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKnsbzJ&md5=323706ee0576c4ba0e04b95ba5c353af</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fci5003203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci5003203%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DEvaluation%2520and%2520application%2520of%2520MD-PB%252FSA%2520in%2520structure-based%2520hierarchical%2520virtual%2520screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26issue%3D7%26spage%3D1987%26epage%3D1996%26doi%3D10.1021%2Fci5003203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">The maximal affinity of ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">9997</span><span class="NLM_x">–</span> <span class="NLM_lpage">10002</span><span class="refDoi"> DOI: 10.1073/pnas.96.18.9997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1073%2Fpnas.96.18.9997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10468550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=9997-10002&issue=18&author=I.+D.+Kuntzauthor=K.+Chenauthor=K.+A.+Sharpauthor=P.+A.+Kollman&title=The+maximal+affinity+of+ligands&doi=10.1073%2Fpnas.96.18.9997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The maximal affinity of ligands</span></div><div class="casAuthors">Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9997-10002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We explore the question of what are the best ligands for macromol. targets.  A survey of exptl. data on a large no. of the strongest-binding ligands indicates that the free energy of binding increases with the no. of nonhydrogen atoms with an initial slope of ≈-1.5 kcal/mol (1 cal = 4.18 J) per atom.  For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative mol. mass.  This nonlinearity is largely ascribed to nonthermodynamic factors.  An anal. of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands.  Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L6KZhR0TxbVg90H21EOLACvtfcHk0lgjvGz0yAp9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D&md5=46fe894b016f3041831a2f0b71f812b1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.9997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.9997%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520maximal%2520affinity%2520of%2520ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26issue%3D18%26spage%3D9997%26epage%3D10002%26doi%3D10.1073%2Fpnas.96.18.9997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&issue=10&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ebshVvR4hQE_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26issue%3D10%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Karcher, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Successful structure-based design of recent p38 MAP kinase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.2174/156802609789007363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.2174%2F156802609789007363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=19689372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=655-676&issue=7&author=S.+C.+Karcherauthor=S.+A.+Laufer&title=Successful+structure-based+design+of+recent+p38+MAP+kinase+inhibitors&doi=10.2174%2F156802609789007363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Successful structure-based design of recent p38 MAP kinase inhibitors</span></div><div class="casAuthors">Karcher, Solveigh C.; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">655-676</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Inflammation is a complex immune response to cellular and tissue damage caused by phys., chem., immunol., or microbial stimuli.  Prior to the successful launch of the anti-cytokine biologist, therapeutic approaches for the treatment of chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease were assocd. with severe side effects.  Although biol. agents have revolutionized the treatment of inflammatory disorders, the high costs and inconvenient dosing regimens would greatly benefit from novel safe and effective orally active inhibitors of tumor necrosis factor (TNF) α and interleukin (IL) 1β.  The clin. benefit of anti-cytokine therapy and the central role of the p38 mitogen-activated protein (MAP) kinase in up-regulation of proinflammatory cytokines such as IL-1β and TNF-α suggest that p38 MAP kinase is a promising target for antiinflammatory therapy.  Since 1993 an immense no. of inhibitors of p38 MAP kinase have been characterized.  To date, aside from the well known pyridinylimidazoles, multiple novel scaffolds have been identified, but only a small no. have advanced into clin. phase II studies, probably due to high toxicity and poor selectivity.  To gain safe drug profiles, high potency, marginal CYP450 (cytochrome P 450) interaction and toxicity, as well as high levels of selectivity would be desirable.  This review will summarize current knowledge on p38 MAP kinase inhibitors and will critically discuss proceedings and strategies toward achieving selectivity and potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1YpMV6vHn37Vg90H21EOLACvtfcHk0lguIxCN_lnU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjK&md5=597b42a2f0a0cb61db7aa0146450796b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F156802609789007363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789007363%26sid%3Dliteratum%253Aachs%26aulast%3DKarcher%26aufirst%3DS.%2BC.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DSuccessful%2520structure-based%2520design%2520of%2520recent%2520p38%2520MAP%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26issue%3D7%26spage%3D655%26epage%3D676%26doi%3D10.2174%2F156802609789007363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellecchia, M.</span><span> </span><span class="NLM_article-title">A fragment-based approach for the discovery of isoform-specific p38alpha inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.1021/cb700025j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb700025j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=329-336&issue=5&author=J.+Chenauthor=Z.+Zhangauthor=J.+L.+Stebbinsauthor=X.+Zhangauthor=R.+Hoffmanauthor=A.+Mooreauthor=M.+Pellecchia&title=A+fragment-based+approach+for+the+discovery+of+isoform-specific+p38alpha+inhibitors&doi=10.1021%2Fcb700025j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcb700025j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb700025j%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DStebbins%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHoffman%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DA%2520fragment-based%2520approach%2520for%2520the%2520discovery%2520of%2520isoform-specific%2520p38alpha%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2007%26volume%3D2%26issue%3D5%26spage%3D329%26epage%3D336%26doi%3D10.1021%2Fcb700025j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ostrem, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x"> (</span><span class="NLM_issue">7477</span><span class="NLM_x">) </span> <span class="NLM_fpage">548</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span><span class="refDoi"> DOI: 10.1038/nature12796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnature12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=24256730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=548-551&issue=7477&author=J.+M.+Ostremauthor=U.+Petersauthor=M.+L.+Sosauthor=J.+A.+Wellsauthor=K.+M.+Shokat&title=K-Ras%28G12C%29+inhibitors+allosterically+control+GTP+affinity+and+effector+interactions&doi=10.1038%2Fnature12796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span></div><div class="casAuthors">Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Wells, James A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7477</span>),
    <span class="NLM_cas:pages">548-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally assocd. with poor response to std. therapies.  Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP and the absence of known allosteric regulatory sites.  Oncogenic mutations result in functional activation of Ras family proteins by impairing GTP hydrolysis.  With diminished regulation by GTPase activity, the nucleotide state of Ras becomes more dependent on relative nucleotide affinity and concn.  This gives GTP an advantage over GDP and increases the proportion of active GTP-bound Ras.  Here we report the development of small mols. that irreversibly bind to a common oncogenic mutant, K-Ras(G12C).  These compds. rely on the mutant cysteine for binding and therefore do not affect the wild-type protein.  Crystallog. studies reveal the formation of a new pocket that is not apparent in previous structures of Ras, beneath the effector binding switch-II region.  Binding of these inhibitors to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favor GDP over GTP and impairing binding to Raf.  Our data provide structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkgcVXuBn_rVg90H21EOLACvtfcHk0lguIxCN_lnU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO&md5=27c1e7d8ef6b7e4b2919e9f00a073923</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12796%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DK-Ras%2528G12C%2529%2520inhibitors%2520allosterically%2520control%2520GTP%2520affinity%2520and%2520effector%2520interactions%26jtitle%3DNature%26date%3D2013%26volume%3D503%26issue%3D7477%26spage%3D548%26epage%3D551%26doi%3D10.1038%2Fnature12796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Huang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyanaraman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span> </span><span class="NLM_article-title">Physics-based scoring of protein-ligand complexes: enrichment of known inhibitors in large-scale virtual screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1021/ci0502855</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci0502855" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2ku77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=243-253&issue=1&author=N.+Huangauthor=C.+Kalyanaramanauthor=J.+J.+Irwinauthor=M.+P.+Jacobson&title=Physics-based+scoring+of+protein-ligand+complexes%3A+enrichment+of+known+inhibitors+in+large-scale+virtual+screening&doi=10.1021%2Fci0502855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Physics-Based Scoring of Protein-Ligand Complexes: Enrichment of Known Inhibitors in Large-Scale Virtual Screening</span></div><div class="casAuthors">Huang, Niu; Kalyanaraman, Chakrapani; Irwin, John J.; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">243-253</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors demonstrate that using an all-atom mol. mechanics force field combined with an implicit solvent model for scoring protein-ligand complexes is a promising approach for improving inhibitor enrichment in the virtual screening of large compd. databases.  The rescoring method is evaluated by the extent to which known binders for nine diverse, therapeutically relevant enzymes are enriched against a background of ∼100 000 drug-like decoys.  The improvement in enrichment is most robust and dramatic within the top 1% of the ranked database, i.e., the first thousand compds.; below the first few percent of the ranked database, there is little overall improvement.  The improved early enrichment is likely due to the more realistic treatment of ligand and receptor desolvation in the rescoring procedure.  We also present anecdotal but encouraging results assessing the ability of the rescoring method to predict specificity of inhibitors for structurally related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUqkz9N6IErLVg90H21EOLACvtfcHk0lhBOhYFHljY_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2ku77N&md5=cf636695aca21a87e050e0f39286ea1d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fci0502855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci0502855%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DPhysics-based%2520scoring%2520of%2520protein-ligand%2520complexes%253A%2520enrichment%2520of%2520known%2520inhibitors%2520in%2520large-scale%2520virtual%2520screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2006%26volume%3D46%26issue%3D1%26spage%3D243%26epage%3D253%26doi%3D10.1021%2Fci0502855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Huang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyanaraman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernacki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span> </span><span class="NLM_article-title">Molecular mechanics methods for predicting protein-ligand binding</span> <span class="citation_source-journal">Phys. Chem. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">44</span><span class="NLM_x">) </span> <span class="NLM_fpage">5166</span><span class="NLM_x">–</span> <span class="NLM_lpage">5177</span><span class="refDoi"> DOI: 10.1039/B608269F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1039%2FB608269F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=17203140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFyit7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=5166-5177&issue=44&author=N.+Huangauthor=C.+Kalyanaramanauthor=K.+Bernackiauthor=M.+P.+Jacobson&title=Molecular+mechanics+methods+for+predicting+protein-ligand+binding&doi=10.1039%2FB608269F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanics methods for predicting protein-ligand binding</span></div><div class="casAuthors">Huang, Niu; Kalyanaraman, Chakrapani; Bernacki, Katarzyna; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">5166-5177</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review with some new data.  Ligand binding affinity prediction is one of the most important applications of computational chem.  However, accurately ranking compds. with respect to their estd. binding affinities to a biomol. target remains highly challenging.  The authors provide an overview of recent work using mol. mechanics energy functions to address this challenge.  The authors briefly review methods that use mol. dynamics and Monte Carlo simulations to predict abs. and relative ligand binding free energies, as well as the authors' own work in which they have developed a physics-based scoring method that can be applied to hundreds of thousands of compds. by invoking a no. of simplifying approxns.  In the authors' previous studies, they have demonstrated that their scoring method is a promising approach for improving the discrimination between ligands that are known to bind and those that are presumed not to, in virtual screening of large compd. databases.  In new results presented here, the authors explore several improvements to their computational method including modifying the dielec. const. used for the protein and ligand interiors, and empirically scaling energy terms to compensate for deficiencies in the energy model.  Future directions for further improving the authors' physics-based scoring method are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrog6pXfJmCo7Vg90H21EOLACvtfcHk0lhBOhYFHljY_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFyit7nP&md5=427d48383280229c26a55a8c31c4cc5e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2FB608269F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB608269F%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DBernacki%26aufirst%3DK.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DMolecular%2520mechanics%2520methods%2520for%2520predicting%2520protein-ligand%2520binding%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2006%26volume%3D8%26issue%3D44%26spage%3D5166%26epage%3D5177%26doi%3D10.1039%2FB608269F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, N.</span><span> </span><span class="NLM_article-title">Discovery of 2-acylaminothiophene-3-carboxamides as multitarget inhibitors for BCR-ABL kinase and microtubules</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2435</span><span class="NLM_x">–</span> <span class="NLM_lpage">2442</span><span class="refDoi"> DOI: 10.1021/acs.jcim.5b00540</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00540" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslSrtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=2435-2442&issue=11&author=R.+Caoauthor=Y.+Wangauthor=N.+Huang&title=Discovery+of+2-acylaminothiophene-3-carboxamides+as+multitarget+inhibitors+for+BCR-ABL+kinase+and+microtubules&doi=10.1021%2Facs.jcim.5b00540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-Acylaminothiophene-3-Carboxamides as Multitarget Inhibitors for BCR-ABL Kinase and Microtubules</span></div><div class="casAuthors">Cao, Ran; Wang, Yanli; Huang, Niu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2435-2442</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of drug resistance of the BCR-ABL kinase inhibitor imatinib, esp. toward the T315I gatekeeper mutation, poses a great challenge to targeted therapy in treating chronic myeloid leukemia (CML) patients.  To discover novel inhibitors against drug-resistant CML bearing T315I mutation, we applied a physics-based hierarchical virtual screening approach to dock a large chem. library against ATP binding pockets of both wild-type (WT) and T315I mutant ABL kinases in a combinatorial fashion.  This strategy automatically resulted in 87 compds. satisfying structural and energetic criteria of both WT and T315I mutant kinases.  Among them, nine compds., which share a common thiophene-based scaffold and adopt similar binding poses, were chosen for exptl. testing and one of them was shown to have low micromolar inhibition activities against both WT and mutant ABL kinases.  Structure-activity relationship anal. with a series of structural modifications based on 2-acylaminothiophene-3-carboxamide scaffold supports our predicted binding mode.  Interestingly, the same chem. scaffold was also enriched in our previous virtual screening campaign against colchicine site of microtubules using the same computational protocol, which suggests our virtual screening strategy is capable of discovering small-mol. ligands targeting distinct protein binding sites without sharing any sequential and structural similarity.  Furthermore, the multitarget inhibition activity of this class of compds. was assessed in cellular expts.  We expect that the 2-acylaminothiophene-3-carboxamide scaffold may serve as a promising starting point for developing multitarget inhibitors in cancer treatment by targeting both kinases and microtubules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpld0oaDA-WjrVg90H21EOLACvtfcHk0lhBOhYFHljY_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslSrtb7M&md5=3678e2f00328d7a6c5b351f24dadc458</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00540%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25202-acylaminothiophene-3-carboxamides%2520as%2520multitarget%2520inhibitors%2520for%2520BCR-ABL%2520kinase%2520and%2520microtubules%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26issue%3D11%26spage%3D2435%26epage%3D2442%26doi%3D10.1021%2Facs.jcim.5b00540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, N.</span><span> </span><span class="NLM_article-title">Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2730</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/ci300302c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci300302c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKltrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2730-2740&issue=10&author=R.+Caoauthor=M.+Liuauthor=M.+Yinauthor=Q.+Liuauthor=Y.+Wangauthor=N.+Huang&title=Discovery+of+novel+tubulin+inhibitors+via+structure-based+hierarchical+virtual+screening&doi=10.1021%2Fci300302c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Tubulin Inhibitors via Structure-Based Hierarchical Virtual Screening</span></div><div class="casAuthors">Cao, Ran; Liu, Minyu; Yin, Min; Liu, Quanhai; Wang, Yanli; Huang, Niu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2730-2740</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To discover novel tubulin inhibitors, we performed structure-based virtual screening against the colchicine binding pocket.  In combination with a hierarchical docking and scoring procedure, the structural information of an addnl. subpocket in colchicine site was applied to filter out the undesired docking hits.  This strategy automatically resulted in 63 candidates meeting the structural and energetic criteria from a screening library contg. approx. 100 000 diverse druglike compds.  Among them, nine mols. were chosen for exptl. validation, which all share the similar binding pose and contain an enriched scaffold bearing thiophene core.  Encouragingly, five compds. are active in tubulin polymn. assay.  The most potent inhibitor, 2-(2-fluorobenzamido)-3-carboxamide-4,5-dimethylthiophene, is structurally distinct to any known colchicine site binders and has higher ligand efficiency than colchicine.  On the basis of its predicted binding pose, we systematically probed its binding characteristics by testing series of structural modifications.  The obtained structure-activity relationship results are consistent with our binding model, and the inhibition activities of two analogs are improved by 2-fold.  We expect that the novel structure discovered in the present study may serve as a starting point for developing tubulin inhibitors with improved efficacy and fewer side effects.  We also expect that our hierarchical strategy may be generally applicable in structure-based virtual screening campaigns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeoH-2Mo3J0LVg90H21EOLACvtfcHk0lhUqZoC66YmZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKltrzJ&md5=ddc129d0a8e5baa601f3e0076a184bbf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fci300302c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300302c%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520novel%2520tubulin%2520inhibitors%2520via%2520structure-based%2520hierarchical%2520virtual%2520screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26issue%3D10%26spage%3D2730%26epage%3D2740%26doi%3D10.1021%2Fci300302c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Aldrich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merz, K. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepartz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">The ecstasy and agony of assay interference compounds</span> <span class="citation_source-journal">ACS Cent. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span><span class="refDoi"> DOI: 10.1021/acscentsci.7b00069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.7b00069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=143-147&issue=3&author=C.+Aldrichauthor=C.+Bertozziauthor=G.+I.+Georgauthor=L.+Kiesslingauthor=C.+Lindsleyauthor=D.+Liottaauthor=K.+M.+Merzauthor=A.+Schepartzauthor=S.+Wang&title=The+ecstasy+and+agony+of+assay+interference+compounds&doi=10.1021%2Facscentsci.7b00069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The Ecstasy and Agony of Assay Interference Compounds</span></div><div class="casAuthors">Aldrich, Courtney; Bertozzi, Carolyn; Georg, Gunda I.; Kiessling, Laura; Lindsley, Craig; Liotta, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">143-147</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu6WoIK7zSJ7Vg90H21EOLACvtfcHk0lhUqZoC66YmZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsL0%253D&md5=faf234b3422df9d9bd0d5ace6db46bfc</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.7b00069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.7b00069%26sid%3Dliteratum%253Aachs%26aulast%3DAldrich%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DC.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DKiessling%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DSchepartz%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DThe%2520ecstasy%2520and%2520agony%2520of%2520assay%2520interference%2520compounds%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2017%26volume%3D3%26issue%3D3%26spage%3D143%26epage%3D147%26doi%3D10.1021%2Facscentsci.7b00069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Martz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baur, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schattel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goettert, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer-Wrangowski, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Targeting the hinge glycine flip and the activation loop: novel approach to potent p38alpha inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">7862</span><span class="NLM_x">–</span> <span class="NLM_lpage">7874</span><span class="refDoi"> DOI: 10.1021/jm300951u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300951u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7862-7874&issue=17&author=K.+E.+Martzauthor=A.+Dornauthor=B.+Baurauthor=V.+Schattelauthor=M.+I.+Goettertauthor=S.+C.+Mayer-Wrangowskiauthor=D.+Rauhauthor=S.+A.+Laufer&title=Targeting+the+hinge+glycine+flip+and+the+activation+loop%3A+novel+approach+to+potent+p38alpha+inhibitors&doi=10.1021%2Fjm300951u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm300951u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300951u%26sid%3Dliteratum%253Aachs%26aulast%3DMartz%26aufirst%3DK.%2BE.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DBaur%26aufirst%3DB.%26aulast%3DSchattel%26aufirst%3DV.%26aulast%3DGoettert%26aufirst%3DM.%2BI.%26aulast%3DMayer-Wrangowski%26aufirst%3DS.%2BC.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DTargeting%2520the%2520hinge%2520glycine%2520flip%2520and%2520the%2520activation%2520loop%253A%2520novel%2520approach%2520to%2520potent%2520p38alpha%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D17%26spage%3D7862%26epage%3D7874%26doi%3D10.1021%2Fjm300951u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Huang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span> </span><span class="NLM_article-title">Physics-based methods for studying protein-ligand interactions</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=17554859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVWls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=325-331&issue=3&author=N.+Huangauthor=M.+P.+Jacobson&title=Physics-based+methods+for+studying+protein-ligand+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Physics-based methods for studying protein-ligand interactions</span></div><div class="casAuthors">Huang, Niu; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-331</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The accurate prediction of relative or abs. ligand-binding affinities is challenging in both theor. and practical aspects.  However, with the aid of advanced computing power and sophisticated methodol. development, physics-based free-energy calcns., which can be used to predict ligand-binding affinities, have become increasingly utilized in the field of structure-based drug design.  This review summarizes recent progress made in developing and applying physics-based methods to studying protein-ligand interactions, focusing on methods using mol. mechanics force fields.  Applications of these methods include predicting ligand binding poses, enriching binders in virtual screening, and calcg. relative and abs. binding free energies.  Future directions for further improving current physics-based methods are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH-FuHDbblC7Vg90H21EOLACvtfcHk0lhUqZoC66YmZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVWls7o%253D&md5=3aaf948edd0254cc81a44645cbe05a6b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DPhysics-based%2520methods%2520for%2520studying%2520protein-ligand%2520interactions%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26issue%3D3%26spage%3D325%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Bukhtiyarova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northrop, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpusas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springman, E.</span><span> </span><span class="NLM_article-title">Improved expression, purification, and crystallization of p38alpha MAP kinase</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span><span class="refDoi"> DOI: 10.1016/j.pep.2004.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.pep.2004.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=15294293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Clsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2004&pages=154-161&issue=1&author=M.+Bukhtiyarovaauthor=K.+Northropauthor=X.+Chaiauthor=D.+Casperauthor=M.+Karpusasauthor=E.+Springman&title=Improved+expression%2C+purification%2C+and+crystallization+of+p38alpha+MAP+kinase&doi=10.1016%2Fj.pep.2004.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Improved expression, purification, and crystallization of p38α MAP kinase</span></div><div class="casAuthors">Bukhtiyarova, Marina; Northrop, Katrina; Chai, Xiaomei; Casper, David; Karpusas, Michael; Springman, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154-161</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">P38α mitogen-activated protein (MAP) kinase is widely expressed in many mammalian tissues and is activated as a part of signal transduction cascades that respond to inflammatory stimuli.  The activation of p38 is known to trigger various biol. effects, including cell death, differentiation, and proliferation.  The central role played by p38α in cellular signaling events, including those that control a wide range of inflammatory and autoimmune diseases, makes it an attractive drug target.  To develop optimized small mol. therapeutics targeting p38α, different techniques must be employed for the detailed biochem., biophys., and structural characterization of the interactions of p38α with lead compds.  These methods typically require large quantities of highly purified p38α protein.  We describe here an improved expression and purifn. method for recombinant p38α prodn. that reproducibly yields over 70 mg of highly purified protein per L of shake flask bacterial culture.  This yield is significantly higher than that previously reported for p38α prodn. in Escherichia coli.  We achieved a significant increase in sol. p38α protein expression by using the genetically modified E. coli strain BL21 DE3 Rosetta, which is optimized for expression of eukaryotic proteins with codons rarely used in E. coli.  The p38α protein was purified to near homogeneity using a simple two-step procedure including nickel-chelating Sepharose chromatog. followed by anion-exchange chromatog. using MonoQ resin.  Purified p38α was characterized using the std. com. available small mol. inhibitor SB-203580.  The binding assocn. and dissocn. rate consts. detd. by Biacore are in excellent agreement with previously reported values.  The purified p38α protein was efficiently activated by MKK6 kinase to yield phosphorylated p38α.  Purified p38α protein was also successfully crystd., producing crystals diffracting to 1.9 A, exceeding the highest resoln. for p38α reported in the Protein DataBank.  The simplicity and efficiency of this approach should prove useful for many labs. that are interested in prodn. of p38α for biochem. and biophys. studies and structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohVxPQ6n4uUrVg90H21EOLACvtfcHk0ljlyR6emuHNig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Clsrs%253D&md5=c754c7e367e0502c024622989154879b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2004.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2004.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DBukhtiyarova%26aufirst%3DM.%26aulast%3DNorthrop%26aufirst%3DK.%26aulast%3DChai%26aufirst%3DX.%26aulast%3DCasper%26aufirst%3DD.%26aulast%3DKarpusas%26aufirst%3DM.%26aulast%3DSpringman%26aufirst%3DE.%26atitle%3DImproved%2520expression%252C%2520purification%252C%2520and%2520crystallization%2520of%2520p38alpha%2520MAP%2520kinase%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2004%26volume%3D37%26issue%3D1%26spage%3D154%26epage%3D161%26doi%3D10.1016%2Fj.pep.2004.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saluste, C. G.</span><span> </span><span class="NLM_article-title">Structure-based design of novel 2-amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1637</span><span class="NLM_x">–</span> <span class="NLM_lpage">1648</span><span class="refDoi"> DOI: 10.1021/jm701095m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701095m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1637-1648&issue=6&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=C.+Boucherauthor=L.+Chaiauthor=L.+F.+Epsteinauthor=T.+Faustauthor=S.+Floresauthor=P.+Gallantauthor=A.+Goreauthor=Y.+Guauthor=F.+Hsiehauthor=X.+Huangauthor=J.+L.+Kimauthor=S.+Middletonauthor=K.+Morgensternauthor=A.+Oliveira-dos-Santosauthor=V.+F.+Patelauthor=D.+Powersauthor=P.+Roseauthor=Y.+Tudorauthor=S.+M.+Turciauthor=A.+A.+Welcherauthor=D.+Zackauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhuauthor=C.+Ghironauthor=M.+Ermannauthor=D.+Johnstonauthor=C.+G.+Saluste&title=Structure-based+design+of+novel+2-amino-6-phenyl-pyrimido%5B5%E2%80%B2%2C4%E2%80%B2%3A5%2C6%5Dpyrimido%5B1%2C2-a%5Dbenzimidazol-5%286H%29-ones+as+potent+and+orally+active+inhibitors+of+lymphocyte+specific+kinase+%28Lck%29%3A+synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity&doi=10.1021%2Fjm701095m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm701095m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701095m%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DFlores%26aufirst%3DS.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DTudor%26aufirst%3DY.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DZack%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DJohnston%26aufirst%3DD.%26aulast%3DSaluste%26aufirst%3DC.%2BG.%26atitle%3DStructure-based%2520design%2520of%2520novel%25202-amino-6-phenyl-pyrimido%255B5%25E2%2580%25B2%252C4%25E2%2580%25B2%253A5%252C6%255Dpyrimido%255B1%252C2-a%255Dbenzimidazol-5%25286H%2529-ones%2520as%2520potent%2520and%2520orally%2520active%2520inhibitors%2520of%2520lymphocyte%2520specific%2520kinase%2520%2528Lck%2529%253A%2520synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D6%26spage%3D1637%26epage%3D1648%26doi%3D10.1021%2Fjm701095m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maderna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnute, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashiro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lussier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrocklage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soutter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunussi-Joannopoulos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douhan, J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">6258</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.bmcl.2011.09.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6258-6263&issue=21&author=K.+H.+Kimauthor=A.+Madernaauthor=M.+E.+Schnuteauthor=M.+Hegenauthor=S.+Mohanauthor=J.+Miyashiroauthor=L.+Linauthor=E.+Liauthor=S.+Keeganauthor=J.+Lussierauthor=C.+Wrocklageauthor=C.+L.+Nickerson-Nutterauthor=A.+J.+Wittwerauthor=H.+Soutterauthor=N.+Caspersauthor=S.+Hanauthor=R.+Kurumbailauthor=K.+Dunussi-Joannopoulosauthor=J.+Douhanauthor=A.+Wissner&title=Imidazo%5B1%2C5-a%5Dquinoxalines+as+irreversible+BTK+inhibitors+for+the+treatment+of+rheumatoid+arthritis&doi=10.1016%2Fj.bmcl.2011.09.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DMaderna%26aufirst%3DA.%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DMiyashiro%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DE.%26aulast%3DKeegan%26aufirst%3DS.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DWrocklage%26aufirst%3DC.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DSoutter%26aufirst%3DH.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DDunussi-Joannopoulos%26aufirst%3DK.%26aulast%3DDouhan%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DImidazo%255B1%252C5-a%255Dquinoxalines%2520as%2520irreversible%2520BTK%2520inhibitors%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D21%26spage%3D6258%26epage%3D6263%26doi%3D10.1016%2Fj.bmcl.2011.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhrlage, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Developing irreversible inhibitors of the protein kinase cysteinome</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2012.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.chembiol.2012.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23438744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=146-159&issue=2&author=Q.+Liuauthor=Y.+Sabnisauthor=Z.+Zhaoauthor=T.+Zhangauthor=S.+J.+Buhrlageauthor=L.+H.+Jonesauthor=N.+S.+Gray&title=Developing+irreversible+inhibitors+of+the+protein+kinase+cysteinome&doi=10.1016%2Fj.chembiol.2012.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Irreversible Inhibitors of the Protein Kinase Cysteinome</span></div><div class="casAuthors">Liu, Qingsong; Sabnis, Yogesh; Zhao, Zheng; Zhang, Tinghu; Buhrlage, Sara J.; Jones, Lyn H.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-159</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a large family of approx. 530 highly conserved enzymes that transfer a γ-phosphate group from ATP to a variety of amino acid residues, such as tyrosine, serine, and threonine, that serves as a ubiquitous mechanism for cellular signal transduction.  The clin. success of a no. of kinase-directed drugs and the frequent observation of disease causing mutations in protein kinases suggest that a large no. of kinases may represent therapeutically relevant targets.  To date, the majority of clin. and preclin. kinase inhibitors are ATP competitive, noncovalent inhibitors that achieve selectivity through recognition of unique features of particular protein kinases.  Recently, there has been renewed interest in the development of irreversible inhibitors that form covalent bonds with cysteine or other nucleophilic residues in the ATP-binding pocket.  Irreversible kinase inhibitors have a no. of potential advantages including prolonged pharmacodynamics, suitability for rational design, high potency, and ability to validate pharmacol. specificity through mutation of the reactive cysteine residue.  Here, we review recent efforts to develop cysteine-targeted irreversible protein kinase inhibitors and discuss their modes of recognizing the ATP-binding pocket and their biol. activity profiles.  In addn., we provided an informatics assessment of the potential "kinase cysteinome" and discuss strategies for the efficient development of new covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVGD7TX3oIeLVg90H21EOLACvtfcHk0lipisAx3yFq1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D&md5=cef80823123bae88362e816a0a638133</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSabnis%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDeveloping%2520irreversible%2520inhibitors%2520of%2520the%2520protein%2520kinase%2520cysteinome%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26issue%3D2%26spage%3D146%26epage%3D159%26doi%3D10.1016%2Fj.chembiol.2012.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devereux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaves, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierda, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awan, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillmen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrientos, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaptein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannutti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGreivy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamdy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothbaum, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diacovo, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, R. R.</span><span> </span><span class="NLM_article-title">Acalabrutinib (ACP-196) in relapsed chronic lymphocytic Leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1056/NEJMoa1509981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1056%2FNEJMoa1509981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=26641137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOlur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2016&pages=323-332&issue=4&author=J.+C.+Byrdauthor=B.+Harringtonauthor=S.+O%E2%80%99Brienauthor=J.+A.+Jonesauthor=A.+Schuhauthor=S.+Devereuxauthor=J.+Chavesauthor=W.+G.+Wierdaauthor=F.+T.+Awanauthor=J.+R.+Brownauthor=P.+Hillmenauthor=D.+M.+Stephensauthor=P.+Ghiaauthor=J.+C.+Barrientosauthor=J.+M.+Pagelauthor=J.+Woyachauthor=D.+Johnsonauthor=J.+Huangauthor=X.+Wangauthor=A.+Kapteinauthor=B.+J.+Lannuttiauthor=T.+Coveyauthor=M.+Fardisauthor=J.+McGreivyauthor=A.+Hamdyauthor=W.+Rothbaumauthor=R.+Izumiauthor=T.+G.+Diacovoauthor=A.+J.+Johnsonauthor=R.+R.+Furman&title=Acalabrutinib+%28ACP-196%29+in+relapsed+chronic+lymphocytic+Leukemia&doi=10.1056%2FNEJMoa1509981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia</span></div><div class="casAuthors">Byrd, John C.; Harrington, Bonnie; O'Brien, Susan; Jones, Jeffrey A.; Schuh, Anna; Devereux, Steve; Chaves, Jorge; Wierda, William G.; Awan, Farrukh T.; Brown, Jennifer R.; Hillmen, Peter; Stephens, Deborah M.; Ghia, Paolo; Barrientos, Jacqueline C.; Pagel, John M.; Woyach, Jennifer; Johnson, Dave; Huang, Jane; Wang, Xiaolin; Kaptein, Allard; Lannutti, Brian J.; Covey, Todd; Fardis, Maria; McGreivy, Jesse; Hamdy, Ahmed; Rothbaum, Wayne; Izumi, Raquel; Diacovo, Thomas G.; Johnson, Amy J.; Furman, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-332</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Irreversible inhibition of Bruton's tyrosine kinase (BTK) by ibrutinib represents an important therapeutic advance for the treatment of chronic lymphocytic leukemia (CLL).  However, ibrutinib also irreversibly inhibits alternative kinase targets, which potentially compromises its therapeutic index.  Acalabrutinib (ACP-196) is a more selective, irreversible BTK inhibitor that is specifically designed to improve on the safety and efficacy of first-generation BTK inhibitors.  In this uncontrolled, phase 1-2, multicenter study, we administered oral acalabrutinib to 61 patients who had relapsed CLL to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of acalabrutinib.  Patients were treated with acalabrutinib at a dose of 100 to 400 mg once daily in the dose-escalation (phase 1) portion of the study and 100 mg twice daily in the expansion (phase 2) portion.  The median age of the patients was 62 years, and patients had received a median of three previous therapies for CLL; 31% had chromosome 17p13.1 deletion, and 75% had unmutated Ig heavy-chain variable genes.  No dose-limiting toxic effects occurred during the dose-escalation portion of the study.  The most common adverse events obsd. were headache (in 43% of the patients), diarrhea (in 39%), and in- creased wt. (in 26%).  Most adverse events were of grade 1 or 2.  At a median follow- up of 14.3 mo, the overall response rate was 95%, including 85% with a partial response and 10% with a partial response with lymphocytosis; the remaining 5% of patients had stable disease.  Among patients with chromosome 17p13.1 deletion, the overall response rate was 100%.  No cases of Richter's transformation (CLL that has evolved into large-cell lymphoma) and only one case of CLL progression have occurred.  In this study, the selective BTK inhibitor acalabrutinib had promising safety and efficacy profiles in patients with relapsed CLL, including those with chromosome 17p13.1 deletion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGHCPciF9hPrVg90H21EOLACvtfcHk0lipisAx3yFq1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOlur%252FI&md5=d20e0158f9ea308b9d06fa668154516e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1509981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1509981%26sid%3Dliteratum%253Aachs%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DHarrington%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DJ.%2BA.%26aulast%3DSchuh%26aufirst%3DA.%26aulast%3DDevereux%26aufirst%3DS.%26aulast%3DChaves%26aufirst%3DJ.%26aulast%3DWierda%26aufirst%3DW.%2BG.%26aulast%3DAwan%26aufirst%3DF.%2BT.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DHillmen%26aufirst%3DP.%26aulast%3DStephens%26aufirst%3DD.%2BM.%26aulast%3DGhia%26aufirst%3DP.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DWoyach%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKaptein%26aufirst%3DA.%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26aulast%3DCovey%26aufirst%3DT.%26aulast%3DFardis%26aufirst%3DM.%26aulast%3DMcGreivy%26aufirst%3DJ.%26aulast%3DHamdy%26aufirst%3DA.%26aulast%3DRothbaum%26aufirst%3DW.%26aulast%3DIzumi%26aufirst%3DR.%26aulast%3DDiacovo%26aufirst%3DT.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DFurman%26aufirst%3DR.%2BR.%26atitle%3DAcalabrutinib%2520%2528ACP-196%2529%2520in%2520relapsed%2520chronic%2520lymphocytic%2520Leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2016%26volume%3D374%26issue%3D4%26spage%3D323%26epage%3D332%26doi%3D10.1056%2FNEJMoa1509981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Wilson, W. H.</span><span> </span><span class="NLM_article-title">Progress in chronic lymphocytic leukemia with targeted therapy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1056/NEJMe1515235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1056%2FNEJMe1515235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=26816016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A280%3ADC%252BC28nltVGqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2016&pages=386-388&issue=4&author=W.+H.+Wilson&title=Progress+in+chronic+lymphocytic+leukemia+with+targeted+therapy&doi=10.1056%2FNEJMe1515235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in Chronic Lymphocytic Leukemia with Targeted Therapy</span></div><div class="casAuthors">Wilson Wyndham H</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">386-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPkuFuFUBzrkkUaC_kzhvyfW6udTcc2ea3kCoyRhEXlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nltVGqsg%253D%253D&md5=acec7b19b9ac62546de92789e615d8b5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1515235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1515235%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DW.%2BH.%26atitle%3DProgress%2520in%2520chronic%2520lymphocytic%2520leukemia%2520with%2520targeted%2520therapy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2016%26volume%3D374%26issue%3D4%26spage%3D386%26epage%3D388%26doi%3D10.1056%2FNEJMe1515235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Levade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michallet, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ysebaert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payrastre, B.</span><span> </span><span class="NLM_article-title">Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">3991</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span><span class="refDoi"> DOI: 10.1182/blood-2014-06-583294</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1182%2Fblood-2014-06-583294" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3991-3995&issue=26&author=M.+Levadeauthor=E.+Davidauthor=C.+Garciaauthor=P.+A.+Laurentauthor=S.+Cadotauthor=A.+S.+Michalletauthor=J.+C.+Bordetauthor=C.+Tamauthor=P.+Sieauthor=L.+Ysebaertauthor=B.+Payrastre&title=Ibrutinib+treatment+affects+collagen+and+von+Willebrand+factor-dependent+platelet+functions&doi=10.1182%2Fblood-2014-06-583294"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-06-583294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-06-583294%26sid%3Dliteratum%253Aachs%26aulast%3DLevade%26aufirst%3DM.%26aulast%3DDavid%26aufirst%3DE.%26aulast%3DGarcia%26aufirst%3DC.%26aulast%3DLaurent%26aufirst%3DP.%2BA.%26aulast%3DCadot%26aufirst%3DS.%26aulast%3DMichallet%26aufirst%3DA.%2BS.%26aulast%3DBordet%26aufirst%3DJ.%2BC.%26aulast%3DTam%26aufirst%3DC.%26aulast%3DSie%26aufirst%3DP.%26aulast%3DYsebaert%26aufirst%3DL.%26aulast%3DPayrastre%26aufirst%3DB.%26atitle%3DIbrutinib%2520treatment%2520affects%2520collagen%2520and%2520von%2520Willebrand%2520factor-dependent%2520platelet%2520functions%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26issue%3D26%26spage%3D3991%26epage%3D3995%26doi%3D10.1182%2Fblood-2014-06-583294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, I. D.</span><span> </span><span class="NLM_article-title">Automated docking with grid-based energy evaluation</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span><span class="refDoi"> DOI: 10.1002/jcc.540130412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1002%2Fjcc.540130412" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=505-524&issue=4&author=E.+C.+Mengauthor=B.+K.+Shoichetauthor=I.+D.+Kuntz&title=Automated+docking+with+grid-based+energy+evaluation&doi=10.1002%2Fjcc.540130412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Fjcc.540130412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.540130412%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26atitle%3DAutomated%2520docking%2520with%2520grid-based%2520energy%2520evaluation%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1992%26volume%3D13%26issue%3D4%26spage%3D505%26epage%3D524%26doi%3D10.1002%2Fjcc.540130412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Lorber, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Hierarchical docking of databases of multiple ligand conformations</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.2174/1568026054637683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.2174%2F1568026054637683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=16101414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFGht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=739-749&issue=8&author=D.+M.+Lorberauthor=B.+K.+Shoichet&title=Hierarchical+docking+of+databases+of+multiple+ligand+conformations&doi=10.2174%2F1568026054637683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Hierarchical docking of databases of multiple ligand conformations</span></div><div class="casAuthors">Lorber, David M.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">739-749</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Ligand flexibility is an important problem in mol. docking and virtual screening.  To address this challenge, we investigate a hierarchical pre-organization of multiple conformations of small mols.  Such organization of pre-calcd. conformations removes the exploration of ligand conformational space from the docking calcn. and allows for concise representation of what can be thousands of conformations.  The hierarchy also recognizes and prunes incompatible conformations early in the calcn., eliminating redundant calcns. of fit.  We investigate the method by docking the MDL Drug Data Report (MDDR), an annotated database of 100,000 mols., into apo and holo forms of 7 unrelated targets.  This annotated database allows us to track the ranking of tens to hundreds of annotated ligands in each of the docking systems.  The binding sites and database are prepd. in an automated fashion in an attempt to remove some human bias from the calcns.  Many thousands of explicit and implicit ligand conformations may be docked in calcns. not much longer than required for single conformer docking.  As long as internal energies are not considered, recombination with the hierarchy is additive as the no. of degrees of freedom is increased.  Mols. with even millions of conformations can be docked in a few minutes on a single desktop computer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJZ_iMnNjm9LVg90H21EOLACvtfcHk0liuRLuUPPVGvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFGht74%253D&md5=25c833b5608e5faedc1af3ad38fdfa06</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.2174%2F1568026054637683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054637683%26sid%3Dliteratum%253Aachs%26aulast%3DLorber%26aufirst%3DD.%2BM.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DHierarchical%2520docking%2520of%2520databases%2520of%2520multiple%2520ligand%2520conformations%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26issue%3D8%26spage%3D739%26epage%3D749%26doi%3D10.2174%2F1568026054637683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Wei, B. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baase, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">A model binding site for testing scoring functions in molecular docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1016/S0022-2836(02)00777-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2FS0022-2836%2802%2900777-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=12217695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1Wqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2002&pages=339-355&issue=2&author=B.+Q.+Weiauthor=W.+A.+Baaseauthor=L.+H.+Weaverauthor=B.+W.+Matthewsauthor=B.+K.+Shoichet&title=A+model+binding+site+for+testing+scoring+functions+in+molecular+docking&doi=10.1016%2FS0022-2836%2802%2900777-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A Model Binding Site for Testing Scoring Functions in Molecular Docking</span></div><div class="casAuthors">Wei, Binqing Q.; Baase, Walter A.; Weaver, Larry H.; Matthews, Brian W.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-355</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Prediction of interaction energies between ligands and their receptors remains a major challenge for structure-based inhibitor discovery.  Much effort has been devoted to developing scoring schemes that can successfully rank the affinities of a diverse set of possible ligands to a binding site for which the structure is known.  To test these scoring functions, well-characterized exptl. systems can be very useful.  Here, mutation-created binding sites in T4 lysozyme were used to investigate how the quality of at. charges and solvation energies affects mol. docking.  At. charges and solvation energies were calcd. for 172,118 mols. in the Available Chems.  Directory using a semi-empirical quantum mech. approach by the program AMSOL.  The database was first screened against the apolar cavity site created by the mutation Leu99Ala (L99A).  Compared to the electronegativity-based charges that are widely used, the new charges and desolvation energies improved ranking of known apolar ligands, and better distinguished them from more polar isosteres that are not obsd. to bind.  To investigate whether the new charges had predictive value, the non-polar residue Met102, which forms part of the binding site, was changed to the polar residue glutamine.  The structure of the resulting Leu99 Ala and Met102 Gln double mutant of T4 lysozyme (L99A/M102Q) was detd. and the docking calcn. was repeated for the new site.  Seven representative polar mols. that preferentially docked to the polar vs. the apolar binding site were tested exptl.  All seven bind to the polar cavity (L99A/M102Q) but do not detectably bind to the apolar cavity (L99A).  Five ligand-bound structures of L99A/M102Q were detd. by X-ray crystallog.  Docking predictions corresponded to the crystallog. results to within 0.4 A RMSD.  Improved treatment of partial at. charges and desolvation energies in database docking appears feasible and leads to better distinction of true ligands.  Simple model binding sites, such as L99A and its more polar variants, may find broad use in the development and testing of docking algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGral4WDhJW6jbVg90H21EOLACvtfcHk0linGZhlzlCzAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1Wqsrs%253D&md5=040e009b33f125ab4abbb322cf32d2c9</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2802%2900777-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252802%252900777-5%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DB.%2BQ.%26aulast%3DBaase%26aufirst%3DW.%2BA.%26aulast%3DWeaver%26aufirst%3DL.%2BH.%26aulast%3DMatthews%26aufirst%3DB.%2BW.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DA%2520model%2520binding%2520site%2520for%2520testing%2520scoring%2520functions%2520in%2520molecular%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D322%26issue%3D2%26spage%3D339%26epage%3D355%26doi%3D10.1016%2FS0022-2836%2802%2900777-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapp, C. S.</span><span> </span><span class="NLM_article-title">Force field validation using protein side chain prediction</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x"> (</span><span class="NLM_issue">44</span><span class="NLM_x">) </span> <span class="NLM_fpage">11673</span><span class="NLM_x">–</span> <span class="NLM_lpage">11680</span><span class="refDoi"> DOI: 10.1021/jp021564n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp021564n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2002&pages=11673-11680&issue=44&author=M.+P.+Jacobsonauthor=G.+A.+Kaminskiauthor=R.+A.+Friesnerauthor=C.+S.+Rapp&title=Force+field+validation+using+protein+side+chain+prediction&doi=10.1021%2Fjp021564n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjp021564n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp021564n%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26atitle%3DForce%2520field%2520validation%2520using%2520protein%2520side%2520chain%2520prediction%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2002%26volume%3D106%26issue%3D44%26spage%3D11673%26epage%3D11680%26doi%3D10.1021%2Fjp021564n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pincus, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapp, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">A hierarchical approach to all-atom protein loop prediction</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1002/prot.10613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1002%2Fprot.10613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=15048827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=351-367&issue=2&author=M.+P.+Jacobsonauthor=D.+L.+Pincusauthor=C.+S.+Rappauthor=T.+J.+Dayauthor=B.+Honigauthor=D.+E.+Shawauthor=R.+A.+Friesner&title=A+hierarchical+approach+to+all-atom+protein+loop+prediction&doi=10.1002%2Fprot.10613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A hierarchical approach to all-atom protein loop prediction</span></div><div class="casAuthors">Jacobson, Matthew P.; Pincus, David L.; Rapp, Chaya S.; Day, Tyler J. F.; Honig, Barry; Shaw, David E.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The application of all-atom force fields (and explicit or implicit solvent models) to protein homol.-modeling tasks such as side-chain and loop prediction remains challenging both because of the expense of the individual energy calcns. and because of the difficulty of sampling the rugged all-atom energy surface.  Here the authors address this challenge for the problem of loop prediction through the development of numerous new algorithms, with an emphasis on multiscale and hierarchical techniques.  As a first step in evaluating the performance of the authors' loop prediction algorithm, the authors have applied it to the problem of reconstructing loops in native structures; the authors also explicitly include crystal packing to provide a fair comparison with crystal structures.  In brief, large nos. of loops are generated by using a dihedral angle-based buildup procedure followed by iterative cycles of clustering, side-chain optimization, and complete energy minimization of selected loop structures.  The authors evaluate this method by the largest test set yet used for validation of a loop prediction method, with a total of 833 loops ranging from 4 to 12 residues in length.  Av./median backbone root-mean-square deviations (RMSDs) to the native structures (superimposing the body of the protein, not the loop itself) are 0.42/0.24 Å for 5 residue loops, 1.00/0.44 Å for 8 residue loops, and 2.47/1.83 Å for 11 residue loops.  Median RMSDs are substantially lower than the avs. because of a small no. of outliers; the causes of these failures are examd. in some detail, and many can be attributed to errors in assignment of protonation states of titratable residues, omission of ligands from the simulation, and, in a few cases, probable errors in the exptl. detd. structures.  When these obvious problems in the data sets are filtered out, av. RMSDs to the native structures improve to 0.43 Å for 5 residue loops, 0.84 Å for 8 residue loops, and 1.63 Å for 11 residue loops.  In the vast majority of cases, the method locates energy min. that are lower than or equal to that of the minimized native loop, thus indicating that sampling rarely limits prediction accuracy.  The overall results are, to the authors' knowledge, the best reported to date, and the authors attribute this success to the combination of an accurate all-atom energy function, efficient methods for loop buildup and side-chain optimization, and, esp. for the longer loops, the hierarchical refinement protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqYMnqaWXvLVg90H21EOLACvtfcHk0li-QETneSH7nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D&md5=e0eff655eeefb30ea00ae041ea9099c8</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fprot.10613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10613%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DPincus%26aufirst%3DD.%2BL.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26aulast%3DDay%26aufirst%3DT.%2BJ.%26aulast%3DHonig%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DA%2520hierarchical%2520approach%2520to%2520all-atom%2520protein%2520loop%2520prediction%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2004%26volume%3D55%26issue%3D2%26spage%3D351%26epage%3D367%26doi%3D10.1002%2Fprot.10613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">High-resolution prediction of protein helix positions and orientations</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span><span class="refDoi"> DOI: 10.1002/prot.20014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1002%2Fprot.20014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=368-382&issue=2&author=X.+Liauthor=M.+P.+Jacobsonauthor=R.+A.+Friesner&title=High-resolution+prediction+of+protein+helix+positions+and+orientations&doi=10.1002%2Fprot.20014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fprot.20014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20014%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DHigh-resolution%2520prediction%2520of%2520protein%2520helix%2520positions%2520and%2520orientations%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2004%26volume%3D55%26issue%3D2%26spage%3D368%26epage%3D382%26doi%3D10.1002%2Fprot.20014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Case, D. A.; Darden, T. A.; Cheatham, I. T. E.; Simmerling, C. L.; Wang, J.; Duke, R. E.; Luo, R.; Crowley, M.; Walker, R. C.; Zhang, W.; Merz, K. M.; Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Kolossváry, I.; Wong, K. F.; Paesani, F.; Vanicek, J.; Wu, X.; Brozell, S. R.; Steinbrecher, T.; Gohlke, H.</span> <span class="citation_source-book">AMBER 10</span>; <span class="NLM_publisher-name">University of California</span>, <span class="NLM_publisher-loc">San Francisco</span>.<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+A.+Case&author=T.+A.+Darden&author=I.+T.+E.+Cheatham&author=C.+L.+Simmerling&author=J.+Wang&author=R.+E.+Duke&author=R.+Luo&author=M.+Crowley&author=R.+C.+Walker&author=W.+Zhang&author=K.+M.+Merz&author=B.+Wang&author=S.+Hayik&author=A.+Roitberg&author=G.+Seabra&author=I.+Kolossv%C3%A1ry&author=K.+F.+Wong&author=F.+Paesani&author=J.+Vanicek&author=X.+Wu&author=S.+R.+Brozell&author=T.+Steinbrecher&author=H.+Gohlke&title=AMBER+10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26btitle%3DAMBER%252010%26pub%3DUniversity%2520of%2520California%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieplak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span><span class="refDoi"> DOI: 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1049-1074&issue=12&author=J.+Wangauthor=P.+Cieplakauthor=P.+A.+Kollman&title=How+well+does+a+restrained+electrostatic+potential+%28RESP%29+model+perform+in+calculating+conformational+energies+of+organic+and+biological+molecules%3F&doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span></div><div class="casAuthors">Wang, Junmei; Cieplak, Piotr; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1049-1074</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors present conformational energies for a mol. mech. model (Parm99) developed for org. and biol. mols. using the restrained electrostatic potential (RESP) approach to derive the partial charges.  This approach uses the simple generic force field model (Parm94), and attempts to add a minimal no. of extra Fourier components to the torsional energies, but doing so only when there is a phys. justification.  The results are quite encouraging, not only for the 34-mol. set that was studied by both the highest level ab initio model (GVB/LMP2) and expt., but also for the 55-mol. set for which high-quality exptl. data are available.  Considering the 55 mols. studied by all the force field models for which there are exptl. data, the av. abs. errors (AAEs) are 0.28 (this model), 0.52 (MM3), 0.57 (CHARMm [MSI]), and 0.43 kcal/mol (MMFF).  For the 34-mol. set, the AAEs of this model vs. expt. and ab initio are 0.28 and 0.27 kcal/mol, resp.  This is a lower error than found with MM3 and CHARMm, and is comparable to that found with MMFF (0.31 and 0.22 kcal/mol).  The authors also present 2 examples of how well the torsional parameters are transferred from the training set to the test set.  The abs. errors of mols. in the test set are only slightly larger than in the training set (differences of <0.1 kcal/mol).  Therefore, a simple generic force field with a limited no. of specific torsional parameters can describe intra- and intermol. interactions, although all comparison mols. were selected from 82-compd. training set.  Also this effective 2-body model can be extended for use with a nonadditive force field (NAFF), both with and without lone pairs.  Without changing the torsional parameters, the use of more accurate charges and polarization increases av. abs. error compared with expt., but adjustment of the parameters restores the level of agreement found with the additive model.  After reoptimizing the Ψ, Φ torsional parameters in peptides using alanine dipeptide (6 conformational pairs) and alanine tetrapeptide (11 conformational pairs), the new model gives better energies than the Cornell et al. force field.  The av. abs. error of this model for high-level ab initio calcn. is 0.82 kcal/mol for alanine dipeptide and tetrapeptide as compared with 1.80 kcal/mol for the Cornell et al. model.  For nucleosides, the new model also gives improved energies compared with the Cornell et al. model.  To optimize force field parameters, the authors developed a program called parmscan, which can iteratively scan the torsional parameters in a systematic manner and finally obtain the vest torsional potentials.  Besides the org. mols. in test set, parmscan was also successful in optimizing the Ψ, Φ torsional parameters in peptides to significantly improve agreement between mol. mech. and high-level ab initio energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0dHME9_PfT7Vg90H21EOLACvtfcHk0lh8moVZjn08pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D&md5=c81631289cf58f63917e2a9fa9547ab6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-987X%2528200009%252921%253A12%253C1049%253A%253AAID-JCC3%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DHow%2520well%2520does%2520a%2520restrained%2520electrostatic%2520potential%2520%2528RESP%2529%2520model%2520perform%2520in%2520calculating%2520conformational%2520energies%2520of%2520organic%2520and%2520biological%2520molecules%253F%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2000%26volume%3D21%26issue%3D12%26spage%3D1049%26epage%3D1074%26doi%3D10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, D. A.</span><span> </span><span class="NLM_article-title">Development and testing of a general amber force field</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1174</span><span class="refDoi"> DOI: 10.1002/jcc.20035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1002%2Fjcc.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=15116359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1157-1174&issue=9&author=J.+Wangauthor=R.+M.+Wolfauthor=J.+W.+Caldwellauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Development+and+testing+of+a+general+amber+force+field&doi=10.1002%2Fjcc.20035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development and testing of a general Amber force field</span></div><div class="casAuthors">Wang, Junmei; Wolf, Romain M.; Caldwell, James W.; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1174</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe here a general Amber force field (GAFF) for org. mols.  GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most org. and pharmaceutical mols. that are composed of H, C, N, O, S, P, and halogens.  It uses a simple functional form and a limited no. of atom types, but incorporates both empirical and heuristic models to est. force consts. and partial at. charges.  The performance of GAFF in test cases is encouraging.  In test I, 74 crystallog. structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 Å, which is comparable to that of the Tripos 5.2 force field (0.25 Å) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 Å, resp.).  In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermol. energies were compared to MP2/6-31G* results.  The RMS of displacements and relative energies were 0.25 Å and 1.2 kcal/mol, resp.  These data are comparable to results from Parm99/RESP (0.16 Å and 1.18 kcal/mol, resp.), which were parameterized to these base pairs.  Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field.  The RMS error in relative energies (compared to expt.) is about 0.5 kcal/mol.  GAFF can be applied to wide range of mols. in an automatic fashion, making it suitable for rational drug design and database searching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW8Gsf8IiW7Vg90H21EOLACvtfcHk0lgLdyuMs8lHEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D&md5=2992017a8cf51f89290ae2562403b115</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520a%2520general%2520amber%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26issue%3D9%26spage%3D1157%26epage%3D1174%26doi%3D10.1002%2Fjcc.20035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Bradshaw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paavilainen, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisconte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughhead, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunn, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karr, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritsen, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunton, J.</span><span> </span><span class="NLM_article-title">Prolonged and tunable residence time using reversible covalent kinase inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span><span class="refDoi"> DOI: 10.1038/nchembio.1817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnchembio.1817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=26006010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=525-531&issue=7&author=J.+M.+Bradshawauthor=J.+M.+McFarlandauthor=V.+O.+Paavilainenauthor=A.+Bisconteauthor=D.+Tamauthor=V.+T.+Phanauthor=S.+Romanovauthor=D.+Finkleauthor=J.+Shuauthor=V.+Patelauthor=T.+Tonauthor=X.+Liauthor=D.+G.+Loughheadauthor=P.+A.+Nunnauthor=D.+E.+Karrauthor=M.+E.+Gerritsenauthor=J.+O.+Funkauthor=T.+D.+Owensauthor=E.+Vernerauthor=K.+A.+Brameldauthor=R.+J.+Hillauthor=D.+M.+Goldsteinauthor=J.+Taunton&title=Prolonged+and+tunable+residence+time+using+reversible+covalent+kinase+inhibitors&doi=10.1038%2Fnchembio.1817"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged and tunable residence time using reversible covalent kinase inhibitors</span></div><div class="casAuthors">Bradshaw, J. Michael; McFarland, Jesse M.; Paavilainen, Ville O.; Bisconte, Angelina; Tam, Danny; Phan, Vernon T.; Romanov, Sergei; Finkle, David; Shu, Jin; Patel, Vaishali; Ton, Tony; Li, Xiaoyan; Loughhead, David G.; Nunn, Philip A.; Karr, Dane E.; Gerritsen, Mary E.; Funk, Jens Oliver; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Hill, Ronald J.; Goldstein, David M.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">525-531</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drugs with prolonged on-target residence times often show superior efficacy, yet general strategies for optimizing drug-target residence time are lacking.  Here the authors made progress toward this elusive goal by targeting a noncatalytic cysteine in Bruton's tyrosine kinase (BTK) with reversible covalent inhibitors.  Using an inverted orientation of the cysteine-reactive cyanoacrylamide electrophile, the authors identified potent and selective BTK inhibitors that demonstrated biochem. residence times spanning from minutes to 7 d.  An inverted cyanoacrylamide with prolonged residence time in vivo remained bound to BTK for more than 18 h after clearance from the circulation.  The inverted cyanoacrylamide strategy was further used to discover fibroblast growth factor receptor (FGFR) kinase inhibitors with residence times of several days, demonstrating the generalizability of the approach.  Targeting of noncatalytic cysteines with inverted cyanoacrylamides may serve as a broadly applicable platform that facilitates 'residence time by design', the ability to modulate and improve the duration of target engagement in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXCpNprhn6kLVg90H21EOLACvtfcHk0ljz_awlYiGFQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE&md5=85a73d9ecd62695d03166f7009c68dd8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1817%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DPaavilainen%26aufirst%3DV.%2BO.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DPhan%26aufirst%3DV.%2BT.%26aulast%3DRomanov%26aufirst%3DS.%26aulast%3DFinkle%26aufirst%3DD.%26aulast%3DShu%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DTon%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLoughhead%26aufirst%3DD.%2BG.%26aulast%3DNunn%26aufirst%3DP.%2BA.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DGerritsen%26aufirst%3DM.%2BE.%26aulast%3DFunk%26aufirst%3DJ.%2BO.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DProlonged%2520and%2520tunable%2520residence%2520time%2520using%2520reversible%2520covalent%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D7%26spage%3D525%26epage%3D531%26doi%3D10.1038%2Fnchembio.1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Jasinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwolak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borja-Cacho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, A. Z.</span><span> </span><span class="NLM_article-title">MT477 acts in tumor cells as an AURKA inhibitor and strongly induces NRF-2 signaling</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1181</span><span class="NLM_x">–</span> <span class="NLM_lpage">1187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=21508363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A280%3ADC%252BC3Mvlt1ahuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=1181-1187&issue=4&author=P.+Jasinskiauthor=P.+Zwolakauthor=K.+Teraiauthor=R.+I.+Vogelauthor=D.+Borja-Cachoauthor=A.+Z.+Dudek&title=MT477+acts+in+tumor+cells+as+an+AURKA+inhibitor+and+strongly+induces+NRF-2+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">MT477 acts in tumor cells as an AURKA inhibitor and strongly induces NRF-2 signaling</span></div><div class="casAuthors">Jasinski Piotr; Zwolak Pawel; Terai Kaoru; Vogel Rachel Isaksson; Borja-Cacho Daniel; Dudek Arkadiusz Z</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1181-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The novel compound thiopyrano [2,3-c]quinoline (MT477) has been shown to exhibit antitumor activity in both in vitro and in vivo studies.  The present study examined the expression levels of 10,000 genes and how they changed after MT477 treatment in three cancer cell lines: H226, MDA231 and MiaPaCa-2.  Materials and Methods/  RESULTS:  Molecular function analysis revealed changes in genes involved in cell death, cell-cycle progression and cellular growth and proliferation in all three cancer cell lines.  Canonical pathway analysis showed the involvement of the NRF2-mediated oxidative stress response, glucocorticoid, p53, RXR-VDR, G(1)/S checkpoint regulation, ERK, SAPK/JNK and JAS/Stat signaling.  Analysis of 234 kinases and phosphatases using a kinase inhibition assay demonstrated a strong inhibitory effect for MAPK14 (104 ± 2%), AMPK A2/B1/G1 (89%) and FGR (83 ± 2%).  AURKA was inhibited at 77 ± 1%.  MiaPaCa-2 tumor xenograft studies showed a 49.5 ±1 4.8% inhibitory effect in mice treated with 100 μg/kg MT477 compared to untreated mice (p=0.0021).  CONCLUSION:  MT477 induces molecular mechanisms related to cell death, survival, and inhibition of cellular growth in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSocJNnCvcebFWTCLT8lX9SfW6udTcc2eb4DykPy2V7Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mvlt1ahuw%253D%253D&md5=910c126d01738133ad34eebe6bd5b727</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJasinski%26aufirst%3DP.%26aulast%3DZwolak%26aufirst%3DP.%26aulast%3DTerai%26aufirst%3DK.%26aulast%3DVogel%26aufirst%3DR.%2BI.%26aulast%3DBorja-Cacho%26aufirst%3DD.%26aulast%3DDudek%26aufirst%3DA.%2BZ.%26atitle%3DMT477%2520acts%2520in%2520tumor%2520cells%2520as%2520an%2520AURKA%2520inhibitor%2520and%2520strongly%2520induces%2520NRF-2%2520signaling%26jtitle%3DAnticancer%2520Res.%26date%3D2011%26volume%3D31%26issue%3D4%26spage%3D1181%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">McGovern, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helfand, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">A specific mechanism of nonspecific inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">4265</span><span class="NLM_x">–</span> <span class="NLM_lpage">4272</span><span class="refDoi"> DOI: 10.1021/jm030266r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030266r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFamsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4265-4272&issue=20&author=S.+L.+McGovernauthor=B.+T.+Helfandauthor=B.+Fengauthor=B.+K.+Shoichet&title=A+specific+mechanism+of+nonspecific+inhibition&doi=10.1021%2Fjm030266r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A Specific Mechanism of Nonspecific Inhibition</span></div><div class="casAuthors">McGovern, Susan L.; Helfand, Brian T.; Feng, Brian; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4265-4272</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Promiscuous small mols. plague screening libraries and hit lists.  Previous work has found that several nonspecific compds. form submicrometer aggregates, and it has been suggested that this aggregate species is responsible for the inhibition of many different enzymes.  It is not understood how aggregates inhibit their targets.  To address this question, biophys., kinetic, and microscopy methods were used to study the interaction of promiscuous, aggregate-forming inhibitors with model proteins.  By use of centrifugation and gel electrophoresis, aggregates and protein were found to directly interact.  This is consistent with a subsequent observation from confocal fluorescence microscopy that aggregates conc. green fluorescent protein.  β-Lactamase mutants with increased or decreased thermodn. stability relative to wild-type enzyme were equally inhibited by an aggregate-forming compd., suggesting that denaturation by unfolding was not the primary mechanism of interaction.  Instead, visualization by electron microscopy revealed that enzyme assocs. with the surface of inhibitor aggregates.  This assocn. could be reversed or prevented by the addn. of Triton X-100.  These observations suggest that the aggregates formed by promiscuous compds. reversibly sequester enzyme, resulting in apparent inhibition.  They also suggest a simple method to identify or reverse the action of aggregate-based inhibitors, which appear to be widespread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppdLVG_GeLZbVg90H21EOLACvtfcHk0lgmDaM2Ffsttg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFamsbs%253D&md5=cd0fd6bf0a64ceb7d7219dae2406dd21</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm030266r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030266r%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DHelfand%26aufirst%3DB.%2BT.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DA%2520specific%2520mechanism%2520of%2520nonspecific%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D20%26spage%3D4265%26epage%3D4272%26doi%3D10.1021%2Fjm030266r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Feng, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">A detergent-based assay for the detection of promiscuous inhibitors</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">550</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1038/nprot.2006.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnprot.2006.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=17191086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOitLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=550-553&issue=2&author=B.+Y.+Fengauthor=B.+K.+Shoichet&title=A+detergent-based+assay+for+the+detection+of+promiscuous+inhibitors&doi=10.1038%2Fnprot.2006.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">A detergent-based assay for the detection of promiscuous inhibitors</span></div><div class="casAuthors">Feng, Brian Y.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">550-553</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">At micromolar concns., many small mols. self-assoc. into colloidal aggregates that non-specifically inhibit enzymes and other proteins.  Here the authors describe a protocol for identifying aggregate-based inhibitors and distinguishing them from small mols. that inhibit via specific mechanisms.  As a convenient proxy for promiscuous, aggregate-based inhibition, the authors monitor inhibition of β-lactamase in the absence and presence of detergent.  Inhibition that is attenuated in the presence of detergent is characteristic of an aggregate-based mechanism.  In the 96-well-format assay described here, about 200 mols. can be tested, in duplicate, per h for detergent-dependent sensitivity.  Furthermore, the authors also describe simple expts. that can offer addnl. confirmation of aggregate-based inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplGQSBvMgM-7Vg90H21EOLACvtfcHk0ljJO3q0PbALNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOitLjO&md5=8aa7562b5f69c896af7e133ecc35e6de</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.77%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%2BY.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DA%2520detergent-based%2520assay%2520for%2520the%2520detection%2520of%2520promiscuous%2520inhibitors%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26issue%3D2%26spage%3D550%26epage%3D553%26doi%3D10.1038%2Fnprot.2006.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Anastassiadis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devarajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. R.</span><span> </span><span class="NLM_article-title">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1045</span><span class="refDoi"> DOI: 10.1038/nbt.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnbt.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=22037377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1039-1045&issue=11&author=T.+Anastassiadisauthor=S.+W.+Deaconauthor=K.+Devarajanauthor=H.+Maauthor=J.+R.+Peterson&title=Comprehensive+assay+of+kinase+catalytic+activity+reveals+features+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span></div><div class="casAuthors">Anastassiadis, Theonie; Deacon, Sean W.; Devarajan, Karthik; Ma, Haiching; Peterson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1045</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. protein kinase inhibitors are widely used to elucidate cellular signaling pathways and are promising therapeutic agents.  Owing to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases.  Interpretation of expts. that use these compds. is confounded by a lack of data on the comprehensive kinase selectivity of most inhibitors.  Here we used functional assays to profile the activity of 178 com. available kinase inhibitors against a panel of 300 recombinant protein kinases.  Quant. anal. revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity.  Many off-target interactions occur with seemingly unrelated kinases, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases.  The results have implications for drug development and provide a resource for selecting compds. to elucidate kinase function and for interpreting the results of expts. involving kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUljWIhZGPkrVg90H21EOLACvtfcHk0lg8QKO3EqhNng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E&md5=b2f705509b0e09afa46b01d4669f0515</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2017%26sid%3Dliteratum%253Aachs%26aulast%3DAnastassiadis%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%2BW.%26aulast%3DDevarajan%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DJ.%2BR.%26atitle%3DComprehensive%2520assay%2520of%2520kinase%2520catalytic%2520activity%2520reveals%2520features%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26issue%3D11%26spage%3D1039%26epage%3D1045%26doi%3D10.1038%2Fnbt.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Wang, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earnest, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J. H.</span><span> </span><span class="NLM_article-title">The macromolecular crystallography beamline of SSRF</span> <span class="citation_source-journal">Nucl. Sci. Tech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.13538/j.1001-8042/nst.26.010102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.13538%2Fj.1001-8042%2Fnst.26.010102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=12-17&issue=1&author=Q.+S.+Wangauthor=F.+Yuauthor=S.+Huangauthor=B.+Sunauthor=K.+H.+Zhangauthor=K.+Liuauthor=Z.+J.+Wangauthor=C.+Y.+Xuauthor=S.+S.+Wangauthor=L.+F.+Yangauthor=Q.+Y.+Panauthor=L.+Liauthor=H.+Zhouauthor=Y.+Cuiauthor=Q.+Xuauthor=T.+Earnestauthor=J.+H.+He&title=The+macromolecular+crystallography+beamline+of+SSRF&doi=10.13538%2Fj.1001-8042%2Fnst.26.010102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.13538%2Fj.1001-8042%2Fnst.26.010102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.13538%252Fj.1001-8042%252Fnst.26.010102%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%2BS.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DK.%2BH.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%2BJ.%26aulast%3DXu%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DS.%2BS.%26aulast%3DYang%26aufirst%3DL.%2BF.%26aulast%3DPan%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DEarnest%26aufirst%3DT.%26aulast%3DHe%26aufirst%3DJ.%2BH.%26atitle%3DThe%2520macromolecular%2520crystallography%2520beamline%2520of%2520SSRF%26jtitle%3DNucl.%2520Sci.%2520Tech.%26date%3D2015%26volume%3D26%26issue%3D1%26spage%3D12%26epage%3D17%26doi%3D10.13538%2Fj.1001-8042%2Fnst.26.010102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span><span class="refDoi"> DOI: 10.1016/S0076-6879(97)76066-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode&doi=10.1016%2FS0076-6879%2897%2976066-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0liiyE82iPZy7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326%26doi%3D10.1016%2FS0076-6879%2897%2976066-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liiyE82iPZy7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D4%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skubak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&issue=4&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lhk0HBw1WnQrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26issue%3D4%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zheng Zheng, Oleg Y. Borbulevych, Hao Liu, Jianpeng Deng, Roger I. Martin, <span class="NLM_string-name hlFld-ContribAuthor">Lance M. Westerhoff</span>. </span><span class="cited-content_cbyCitation_article-title">MovableType Software for Fast Free Energy-Based Virtual Screening: Protocol Development, Deployment, Validation, and Assessment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (11)
                                     , 5437-5456. <a href="https://doi.org/10.1021/acs.jcim.0c00618" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DMovableType%252BSoftware%252Bfor%252BFast%252BFree%252BEnergy-Based%252BVirtual%252BScreening%25253A%252BProtocol%252BDevelopment%25252C%252BDeployment%25252C%252BValidation%25252C%252Band%252BAssessment%26aulast%3DZheng%26aufirst%3DZheng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02062020%26date%3D11092020%26date%3D13082020%26volume%3D60%26issue%3D11%26spage%3D5437%26epage%3D5456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lin Wei, Wuqiang Wen, Li Rao, Yunyuan Huang, Mengting Lei, Kai Liu, Saiya Hu, Rongrong Song, Yanliang Ren, <span class="NLM_string-name hlFld-ContribAuthor">Jian Wan</span>. </span><span class="cited-content_cbyCitation_article-title">Cov_FB3D: A De Novo Covalent Drug Design Protocol Integrating the BA-SAMP Strategy and Machine-Learning-Based Synthetic Tractability Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (9)
                                     , 4388-4402. <a href="https://doi.org/10.1021/acs.jcim.9b01197" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b01197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b01197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b01197%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DCov_FB3D%25253A%252BA%252BDe%252BNovo%252BCovalent%252BDrug%252BDesign%252BProtocol%252BIntegrating%252Bthe%252BBA-SAMP%252BStrategy%252Band%252BMachine-Learning-Based%252BSynthetic%252BTractability%252BEvaluation%26aulast%3DWei%26aufirst%3DLin%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D27122019%26date%3D09042020%26date%3D01042020%26volume%3D60%26issue%3D9%26spage%3D4388%26epage%3D4402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rama K. Mishra, Kristine K. Deibler, Matthew R. Clutter, Purav P. Vagadia, Matthew O’Connor, Gary E. Schiltz, Raymond Bergan, <span class="NLM_string-name hlFld-ContribAuthor">Karl A. Scheidt</span>. </span><span class="cited-content_cbyCitation_article-title">Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential Charges. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (10)
                                     , 4460-4466. <a href="https://doi.org/10.1021/acs.jcim.9b00490" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00490%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DModeling%252BMEK4%252BKinase%252BInhibitors%252Bthrough%252BPerturbed%252BElectrostatic%252BPotential%252BCharges%26aulast%3DMishra%26aufirst%3DRama%2BK.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12062019%26date%3D14102019%26date%3D30092019%26volume%3D59%26issue%3D10%26spage%3D4460%26epage%3D4466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min-Wu  Chao</span>, <span class="hlFld-ContribAuthor ">Tony Eight  Lin</span>, <span class="hlFld-ContribAuthor ">Wei-Chun  HuangFu</span>, <span class="hlFld-ContribAuthor ">Chao-Di  Chang</span>, <span class="hlFld-ContribAuthor ">Huang-Ju  Tu</span>, <span class="hlFld-ContribAuthor ">Liang-Chieh  Chen</span>, <span class="hlFld-ContribAuthor ">Shih-Chung  Yen</span>, <span class="hlFld-ContribAuthor ">Tzu-Ying  Sung</span>, <span class="hlFld-ContribAuthor ">Wei-Jan  Huang</span>, <span class="hlFld-ContribAuthor ">Chia-Ron  Yang</span>, <span class="hlFld-ContribAuthor ">Shiow-Lin  Pan</span>, <span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 98-108. <a href="https://doi.org/10.1080/14756366.2020.1843452" title="DOI URL">https://doi.org/10.1080/14756366.2020.1843452</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1843452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1843452%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252Bdual%252BTAOK1%252Band%252BMAP4K5%252Binhibitor%252Busing%252Ba%252Bstructure-based%252Bvirtual%252Bscreening%252Bapproach%26aulast%3DChao%26aufirst%3DMin-Wu%26date%3D2021%26date%3D2020%26volume%3D36%26issue%3D1%26spage%3D98%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Elkamhawy</span>, <span class="hlFld-ContribAuthor ">Eslam M. H.  Ali</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011–2021) focussing on structure–activity relationship (SAR) and docking insights. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 1574-1602. <a href="https://doi.org/10.1080/14756366.2021.1937143" title="DOI URL">https://doi.org/10.1080/14756366.2021.1937143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1937143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1937143%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bhorizons%252Bin%252Bdrug%252Bdiscovery%252Bof%252Blymphocyte-specific%252Bprotein%252Btyrosine%252Bkinase%252B%252528Lck%252529%252Binhibitors%25253A%252Ba%252Bdecade%252Breview%252B%2525282011%2525E2%252580%2525932021%252529%252Bfocussing%252Bon%252Bstructure%2525E2%252580%252593activity%252Brelationship%252B%252528SAR%252529%252Band%252Bdocking%252Binsights%26aulast%3DElkamhawy%26aufirst%3DAhmed%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D1574%26epage%3D1602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy  Ariey‐Bonnet</span>, <span class="hlFld-ContribAuthor ">Kendall  Carrasco</span>, <span class="hlFld-ContribAuthor ">Marion  Le Grand</span>, <span class="hlFld-ContribAuthor ">Laurent  Hoffer</span>, <span class="hlFld-ContribAuthor ">Stéphane  Betzi</span>, <span class="hlFld-ContribAuthor ">Mikael  Feracci</span>, <span class="hlFld-ContribAuthor ">Philipp  Tsvetkov</span>, <span class="hlFld-ContribAuthor ">Francois  Devred</span>, <span class="hlFld-ContribAuthor ">Yves  Collette</span>, <span class="hlFld-ContribAuthor ">Xavier  Morelli</span>, <span class="hlFld-ContribAuthor ">Pedro  Ballester</span>, <span class="hlFld-ContribAuthor ">Eddy  Pasquier</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Oncology</span><span> <strong>2020,</strong> <em>14 </em>
                                    (12)
                                     , 3083-3099. <a href="https://doi.org/10.1002/1878-0261.12810" title="DOI URL">https://doi.org/10.1002/1878-0261.12810</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/1878-0261.12810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F1878-0261.12810%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Oncology%26atitle%3DIn%252Bsilico%252Bmolecular%252Btarget%252Bprediction%252Bunveils%252Bmebendazole%252Bas%252Ba%252Bpotent%252BMAPK14%252Binhibitor%26aulast%3DAriey%25E2%2580%2590Bonnet%26aufirst%3DJeremy%26date%3D2020%26date%3D2020%26volume%3D14%26issue%3D12%26spage%3D3083%26epage%3D3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kasem  Chanjitwiriya</span>, <span class="hlFld-ContribAuthor ">Sittiruk  Roytrakul</span>, <span class="hlFld-ContribAuthor ">Duangkamol  Kunthalert</span>, . </span><span class="cited-content_cbyCitation_article-title">Quercetin negatively regulates IL-1β production in Pseudomonas aeruginosa-infected human macrophages through the inhibition of MAPK/NLRP3 inflammasome pathways. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2020,</strong> <em>15 </em>
                                    (8)
                                     , e0237752. <a href="https://doi.org/10.1371/journal.pone.0237752" title="DOI URL">https://doi.org/10.1371/journal.pone.0237752</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0237752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0237752%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DQuercetin%252Bnegatively%252Bregulates%252BIL-1%2525CE%2525B2%252Bproduction%252Bin%252BPseudomonas%252Baeruginosa-infected%252Bhuman%252Bmacrophages%252Bthrough%252Bthe%252Binhibition%252Bof%252BMAPK%25252FNLRP3%252Binflammasome%252Bpathways%26aulast%3DChanjitwiriya%26aufirst%3DKasem%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D8%26spage%3De0237752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayah  Abdeldayem</span>, <span class="hlFld-ContribAuthor ">Yasir S.  Raouf</span>, <span class="hlFld-ContribAuthor ">Stefan N.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in covalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2020,</strong> <em>49 </em>
                                    (9)
                                     , 2617-2687. <a href="https://doi.org/10.1039/C9CS00720B" title="DOI URL">https://doi.org/10.1039/C9CS00720B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CS00720B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CS00720B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAdvances%252Bin%252Bcovalent%252Bkinase%252Binhibitors%26aulast%3DAbdeldayem%26aufirst%3DAyah%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D9%26spage%3D2617%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jincai  Yang</span>, <span class="hlFld-ContribAuthor ">Cheng  Shen</span>, <span class="hlFld-ContribAuthor ">Niu  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Predicting or Pretending: Artificial Intelligence for Protein-Ligand Interactions Lack of Sufficiently Large and Unbiased Datasets. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00069" title="DOI URL">https://doi.org/10.3389/fphar.2020.00069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00069%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DPredicting%252Bor%252BPretending%25253A%252BArtificial%252BIntelligence%252Bfor%252BProtein-Ligand%252BInteractions%252BLack%252Bof%252BSufficiently%252BLarge%252Band%252BUnbiased%252BDatasets%26aulast%3DYang%26aufirst%3DJincai%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Quattrini</span>, <span class="hlFld-ContribAuthor ">Vito  Coviello</span>, <span class="hlFld-ContribAuthor ">Stefania  Sartini</span>, <span class="hlFld-ContribAuthor ">Teresa  Di Desidero</span>, <span class="hlFld-ContribAuthor ">Paola  Orlandi</span>, <span class="hlFld-ContribAuthor ">Yi-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Kai-Lun  Liu</span>, <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>, <span class="hlFld-ContribAuthor ">Guido  Bocci</span>, <span class="hlFld-ContribAuthor ">Concettina  La Motta</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-46287-5" title="DOI URL">https://doi.org/10.1038/s41598-019-46287-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-46287-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-46287-5%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDual%252BKit%25252FAur%252BInhibitors%252Bas%252BChemosensitizing%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BMelanoma%25253A%252BDesign%25252C%252BSynthesis%25252C%252BDocking%252BStudies%252Band%252BFunctional%252BInvestigation%26aulast%3DQuattrini%26aufirst%3DLuca%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olivia  Slater</span>, <span class="hlFld-ContribAuthor ">Maria  Kontoyianni</span>. </span><span class="cited-content_cbyCitation_article-title">The compromise of virtual screening and its impact on drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (7)
                                     , 619-637. <a href="https://doi.org/10.1080/17460441.2019.1604677" title="DOI URL">https://doi.org/10.1080/17460441.2019.1604677</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1604677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1604677%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Bcompromise%252Bof%252Bvirtual%252Bscreening%252Band%252Bits%252Bimpact%252Bon%252Bdrug%252Bdiscovery%26aulast%3DSlater%26aufirst%3DOlivia%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D7%26spage%3D619%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Budaganaboyina  Prasad</span>, <span class="hlFld-ContribAuthor ">V.  Lakshma Nayak</span>, <span class="hlFld-ContribAuthor ">P.S.  Srikanth</span>, <span class="hlFld-ContribAuthor ">Mirza Feroz  Baig</span>, <span class="hlFld-ContribAuthor ">N.V.  Subba Reddy</span>, <span class="hlFld-ContribAuthor ">Korrapati Suresh  Babu</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 1-benzyl-N-(2-(phenylamino)pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamides as antimitotic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>83 </em>, 535-548. <a href="https://doi.org/10.1016/j.bioorg.2018.11.002" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.11.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B1-benzyl-N-%2525282-%252528phenylamino%252529pyridin-3-yl%252529-1H-1%25252C2%25252C3-triazole-4-carboxamides%252Bas%252Bantimitotic%252Bagents%26aulast%3DPrasad%26aufirst%3DBudaganaboyina%26date%3D2019%26volume%3D83%26spage%3D535%26epage%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manpreet  Kaur</span>, <span class="hlFld-ContribAuthor ">Palwinder  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting tyrosine kinase: Development of acridone – pyrrole – oxindole hybrids against human breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (1)
                                     , 32-35. <a href="https://doi.org/10.1016/j.bmcl.2018.11.021" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.11.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.11.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTargeting%252Btyrosine%252Bkinase%25253A%252BDevelopment%252Bof%252Bacridone%252B%2525E2%252580%252593%252Bpyrrole%252B%2525E2%252580%252593%252Boxindole%252Bhybrids%252Bagainst%252Bhuman%252Bbreast%252Bcancer%26aulast%3DKaur%26aufirst%3DManpreet%26date%3D2019%26volume%3D29%26issue%3D1%26spage%3D32%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative hinge-binding scaffolds collected from literature.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Hydrogen bonds forming between kinase hinge region and ligand are highlighted in red. The residues of the hinge region are annotated based on its position to the gatekeeper residue (gk).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Workflow of hierarchical virtual screening campaign against p38α MAPK. (B) Predicted binding pose of lead compound in p38α MAPK ATP-site. Potential hydrogen bonds are represented with orange lines. (C) Dose-dependent inhibition of p38α MAPK kinase activity by the lead compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Crystal complex structure of p38α MAPK bound with the lead compound. Protein and the lead compound structures are colored in white and pink, respectively. Hydrogen bonds are represented with orange and cyan lines. The 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density map (contoured at 1σ) around the inhibitor is shown as purple mesh. (B) Schematic representation of the unique binding mode of the lead compound with a focus on the hinge-binding motif 1,2,4-triazol-5-amine and (C) active-conformation and (D) inactive-conformation binding modes of representative kinase inhibitors containing a 5-amine-pyrazole fragment. Hydrogen bonds between kinase hinge and ligand are highlighted with red circles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Superposition of crystal complex structures of p38α MAPK bound with <b>1</b> and LCK complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BYM">3BYM</a>). (B) Superposition of crystal structures of p38α MAPK bound with <b>1</b> and BTK complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T9T">3T9T</a>). (C) Strategies of structural modification for potent selective kinase inhibitors against LCK and BTK on the structural basis of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Crystal structure of p38α MAPK in complex with <b>3</b>. (B) Crystal structure of BTK in complex with <b>8</b>. Protein and ligand structures are colored in white and hot pink, respectively. Hydrogen bonds are represented with cyan dash lines. The 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density map (contoured at 1σ) around the inhibitor is shown as purple mesh.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. On-target inhibition of BTK and LCK by <b>1</b>, <b>7</b>, and <b>8</b> in B and T cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/medium/jm-2017-01075j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Route for the Synthesis<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01075/20171020/images/large/jm-2017-01075j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01075&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) when X = Cl, aminoguanidine nitrate, acyl chloride, NaOH, MeCN, 0 °C, then H<sub>2</sub>O reflux; (2) when X = OH, carboxylic acid, CDI, aminoguanidine nitrate, base, solvent, 0–100 °C; (b) (1) 2-chloro-6-fluorobenzaldehyde, solvent, reflux; (2) NaBH<sub>3</sub>CN, acetic acid, room temperature; (c) trifluoroacetic acid, THF, 0 °C; (d) hydrazine hydrate, Raney Ni, ethanol, 60 °C; (e) acryloyl chloride, trimethylamine, THF, 0 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 68 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hantschel, O.</span><span> </span><span class="NLM_article-title">Unexpected off-targets and paradoxical pathway activation by kinase inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1021/cb500886n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500886n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=234-245&issue=1&author=O.+Hantschel&title=Unexpected+off-targets+and+paradoxical+pathway+activation+by+kinase+inhibitors&doi=10.1021%2Fcb500886n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fcb500886n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500886n%26sid%3Dliteratum%253Aachs%26aulast%3DHantschel%26aufirst%3DO.%26atitle%3DUnexpected%2520off-targets%2520and%2520paradoxical%2520pathway%2520activation%2520by%2520kinase%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D1%26spage%3D234%26epage%3D245%26doi%3D10.1021%2Fcb500886n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">Kinase targets in CNS drug discovery</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.4155/fmc-2016-0214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.4155%2Ffmc-2016-0214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=28176536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Gqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=303-314&issue=3&author=H.+Gunosewoyoauthor=L.+Yuauthor=L.+Munozauthor=M.+Kassiou&title=Kinase+targets+in+CNS+drug+discovery&doi=10.4155%2Ffmc-2016-0214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase targets in CNS drug discovery</span></div><div class="casAuthors">Gunosewoyo, Hendra; Yu, Lifang; Munoz, Lenka; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">303-314</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Originally thought to be nondruggable, kinases represent attractive drug targets for pharmaceutical companies and academia.  To date, there are over 40 kinase inhibitors approved by the US FDA, with 32 of these being small mols., in addn. to the three mammalian target of rapamycin inhibitor macrolides (sirolimus, temsirolimus and everolimus).  Despite the rapid development of kinase inhibitors for cancer, presently none of these agents are approved for CNS indications.  This mini perspective highlights selected kinase targets for CNS disorders, of which brain-permeable small-mol. inhibitors are reported, with demonstrated preclin. proof-of-concept efficacy.  This is followed by a brief discussion on the key challenges of blood-brain barrier penetration and selectivity profiles in developing kinase inhibitors for CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn8aN-OsnhmLVg90H21EOLACvtfcHk0lgiI5tUkmFW7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Gqtbc%253D&md5=cd99fdf52b130a92823b58a50ad32fe6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0214%26sid%3Dliteratum%253Aachs%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DKinase%2520targets%2520in%2520CNS%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26issue%3D3%26spage%3D303%26epage%3D314%26doi%3D10.4155%2Ffmc-2016-0214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">High-throughput kinase profiling as a platform for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1038/nrd2541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnrd2541" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=391-397&issue=5&author=D.+M.+Goldsteinauthor=N.+S.+Grayauthor=P.+P.+Zarrinkar&title=High-throughput+kinase+profiling+as+a+platform+for+drug+discovery&doi=10.1038%2Fnrd2541"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd2541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2541%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DHigh-throughput%2520kinase%2520profiling%2520as%2520a%2520platform%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26issue%3D5%26spage%3D391%26epage%3D397%26doi%3D10.1038%2Fnrd2541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Akritopoulou-Zanze, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">5–6</span><span class="NLM_x">) </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.1016/j.drudis.2008.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.drudis.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=19121409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1Sht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=291-297&issue=5%E2%80%936&author=I.+Akritopoulou-Zanzeauthor=P.+J.+Hajduk&title=Kinase-targeted+libraries%3A+the+design+and+synthesis+of+novel%2C+potent%2C+and+selective+kinase+inhibitors&doi=10.1016%2Fj.drudis.2008.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase-targeted libraries: The design and synthesis of novel, potent, and selective kinase inhibitors</span></div><div class="casAuthors">Akritopoulou-Zanze, Irini; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">291-297</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein kinases continue to hold tremendous promise for therapeutic intervention, and the search for novel, safe and efficacious kinase inhibitors has intensified over the past decade.  Given that most kinases are readily inhibited by org. small mols. and that a wealth of structural data exists on kinase-inhibitor complexes, there has been almost universal success in the design and identification of potent kinase inhibitors.  The issues of non-selectivity and congested IP space, however, present formidable challenges for the successful clin. development of these compds.  We describe a systematic approach implemented at Abbott to enable the rapid discovery and design of novel and potent kinase inhibitors that provide addnl. opportunities for targeting new intellectual property space and achieving acceptable selectivity profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq8Zu1uIX67LVg90H21EOLACvtfcHk0lhu2vIrHO8big"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1Sht7s%253D&md5=10f9e32e9bf9e0345fff6613fd578357</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DAkritopoulou-Zanze%26aufirst%3DI.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DKinase-targeted%2520libraries%253A%2520the%2520design%2520and%2520synthesis%2520of%2520novel%252C%2520potent%252C%2520and%2520selective%2520kinase%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26issue%3D5%25E2%2580%25936%26spage%3D291%26epage%3D297%26doi%3D10.1016%2Fj.drudis.2008.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span><span class="refDoi"> DOI: 10.1021/jm800475y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&issue=17&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+based+prediction+of+ligand+binding+modes+and+rational+inhibitor+design+for+kinase+drug+discovery&doi=10.1021%2Fjm800475y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Pippin, Douglas A.; Salvino, Joseph M.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5149-5171</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review describing the use of Protein Data Bank (PDB) entries specifically for kinase inhibitor drug discovery.  Topics discussed include: the current state of structure-aided ligand design, kinase structure queries and extn. from the PDB, alignment of protein structures, structural classification of ligands, anal. of ligands and binding modes, and ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDINDYVE15cbVg90H21EOLACvtfcHk0lhu2vIrHO8big"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM&md5=a1afc4d6c7f6fa4dd6aa9da8d78f1ee3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520based%2520prediction%2520of%2520ligand%2520binding%2520modes%2520and%2520rational%2520inhibitor%2520design%2520for%2520kinase%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D17%26spage%3D5149%26epage%3D5171%26doi%3D10.1021%2Fjm800475y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klug-Mcleod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span> </span><span class="NLM_article-title">Kinase hinge binding scaffolds and their hydrogen bond patterns</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">6520</span><span class="NLM_x">–</span> <span class="NLM_lpage">6527</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.bmc.2015.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=26358279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVentr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6520-6527&issue=19&author=L.+Xingauthor=J.+Klug-Mcleodauthor=B.+Raiauthor=E.+A.+Lunney&title=Kinase+hinge+binding+scaffolds+and+their+hydrogen+bond+patterns&doi=10.1016%2Fj.bmc.2015.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase hinge binding scaffolds and their hydrogen bond patterns</span></div><div class="casAuthors">Xing, Li; Klug-Mcleod, Jacquelyn; Rai, Brajesh; Lunney, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6520-6527</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein kinases constitute a major class of intracellular signaling mols., and describe some of the most prominent drug targets.  Kinase inhibitors commonly employ small chem. scaffolds that form hydrogen bonds with the kinase hinge residues connecting the N- and C-terminal lobes of the catalytic domain.  In general the satisfied hydrogen bonds are required for potent inhibition, therefore constituting a conserved feature in the majority of inhibitor-kinase interactions.  From systematically analyzing the kinase scaffolds extd. from Pfizer crystal structure database (CSDb) the authors recognize that large no. of kinase inhibitors of diverse chem. structures are derived from a relatively small no. of common scaffolds.  Depending on specific substitution patterns, scaffolds may demonstrate versatile binding capacities to interact with kinase hinge.  Afforded by thousands of ligand-protein binary complexes, the hinge hydrogen bond patterns were analyzed with a focus on their three-dimensional configurations.  Most of the compds. engage H6 NH for hinge recognition.  Dual hydrogen bonds are commonly obsd. with addnl. recruitment of H4 CO upstream and/or H6 CO downstream.  Triple hydrogen bonds accounts for small no. of binary complexes.  An unusual hydrogen bond with a non-canonical H5 conformation is obsd., requiring a peptide bond flip by a glycine residue at the H6 position.  Addnl. hydrogen bonds to kinase hinge do not necessarily correlate with an increase in potency; conversely they appear to compromise kinase selectivity.  Such learnings could enhance the prospect of successful therapy design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRC-xiTiNvELVg90H21EOLACvtfcHk0lhu2vIrHO8big"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVentr3L&md5=048b4b99628c6e1ae273b00a47ab2377</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DKlug-Mcleod%26aufirst%3DJ.%26aulast%3DRai%26aufirst%3DB.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26atitle%3DKinase%2520hinge%2520binding%2520scaffolds%2520and%2520their%2520hydrogen%2520bond%2520patterns%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26issue%3D19%26spage%3D6520%26epage%3D6527%26doi%3D10.1016%2Fj.bmc.2015.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span><span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&issue=11&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lh4jmveAMhQcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26issue%3D11%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1038/nrc2559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&issue=1&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors&doi=10.1038%2Fnrc2559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lh4jmveAMhQcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D1%26spage%3D28%26epage%3D39%26doi%3D10.1038%2Fnrc2559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zuccotto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span> </span><span class="NLM_article-title">Through the “gatekeeper door”: exploiting the active kinase conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2681</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span><span class="refDoi"> DOI: 10.1021/jm901443h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901443h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGhtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2681-2694&issue=7&author=F.+Zuccottoauthor=E.+Ardiniauthor=E.+Casaleauthor=M.+Angiolini&title=Through+the+%E2%80%9Cgatekeeper+door%E2%80%9D%3A+exploiting+the+active+kinase+conformation&doi=10.1021%2Fjm901443h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Through the "Gatekeeper Door": Exploiting the Active Kinase Conformation</span></div><div class="casAuthors">Zuccotto, Fabio; Ardini, Elena; Casale, Elena; Angiolini, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2681-2694</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of new kinase inhibitors is still a slow and problematic process.  Generally, type I compds. suffer from widespread cross-reactivity among other members of the kinase target family, and intense medicinal chem. optimization programs are required to modulate their activity.  Also, fierce competition in the development of scaffolds that could mimic ATP has led to a crowded intellectual property space.  The new opportunities opened by the type II compds. created great expectations, as targeting the allosteric site of the ATP pocket offered addnl. opportunities to control selectivity and introduce intellectual property novelty.  However, clin. evaluation of these compds. has highlighted how the acquisition of resistance-causing mutations of the kinase target limits their efficacy in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd_iA7sWS-g7Vg90H21EOLACvtfcHk0lhgMl-9tre7aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGhtb3K&md5=5c6acd058bacfec89b1eff2090f0fe67</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm901443h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901443h%26sid%3Dliteratum%253Aachs%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DAngiolini%26aufirst%3DM.%26atitle%3DThrough%2520the%2520%25E2%2580%259Cgatekeeper%2520door%25E2%2580%259D%253A%2520exploiting%2520the%2520active%2520kinase%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2681%26epage%3D2694%26doi%3D10.1021%2Fjm901443h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hendriks, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuvaraj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kil, L. P.</span><span> </span><span class="NLM_article-title">Targeting Bruton’s tyrosine kinase in B cell malignancies</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1038/nrc3702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnrc3702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=24658273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslCqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=219-232&issue=4&author=R.+W.+Hendriksauthor=S.+Yuvarajauthor=L.+P.+Kil&title=Targeting+Bruton%E2%80%99s+tyrosine+kinase+in+B+cell+malignancies&doi=10.1038%2Fnrc3702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Bruton's tyrosine kinase in B cell malignancies</span></div><div class="casAuthors">Hendriks, Rudi W.; Yuvaraj, Saravanan; Kil, Laurens P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-232</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Bruton's tyrosine kinase (BTK) is a key component of B cell receptor (BCR) signalling and functions as an important regulator of cell proliferation and cell survival in various B cell malignancies.  Small-mol. inhibitors of BTK have shown antitumor activity in animal models and, recently, in clin. studies.  High response rates were reported in patients with chronic lymphocytic leukemia and mantle cell lymphoma.  Remarkably, BTK inhibitors have mol. effects that cannot be explained by the classic role of BTK in BCR signalling.  In this Review, we highlight the importance of BTK in various signalling pathways in the context of its therapeutic inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9z_6SqjcVYLVg90H21EOLACvtfcHk0lhgMl-9tre7aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslCqsL4%253D&md5=ed615772c752b64360d0b5c51780e93e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrc3702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3702%26sid%3Dliteratum%253Aachs%26aulast%3DHendriks%26aufirst%3DR.%2BW.%26aulast%3DYuvaraj%26aufirst%3DS.%26aulast%3DKil%26aufirst%3DL.%2BP.%26atitle%3DTargeting%2520Bruton%25E2%2580%2599s%2520tyrosine%2520kinase%2520in%2520B%2520cell%2520malignancies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2014%26volume%3D14%26issue%3D4%26spage%3D219%26epage%3D232%26doi%3D10.1038%2Fnrc3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kracht, M.</span><span> </span><span class="NLM_article-title">Targeting innate immunity protein kinase signalling in inflammation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span><span class="refDoi"> DOI: 10.1038/nrd2829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnrd2829" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=480-499&issue=6&author=M.+Gaestelauthor=A.+Kotlyarovauthor=M.+Kracht&title=Targeting+innate+immunity+protein+kinase+signalling+in+inflammation&doi=10.1038%2Fnrd2829"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd2829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2829%26sid%3Dliteratum%253Aachs%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DKracht%26aufirst%3DM.%26atitle%3DTargeting%2520innate%2520immunity%2520protein%2520kinase%2520signalling%2520in%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26issue%3D6%26spage%3D480%26epage%3D499%26doi%3D10.1038%2Fnrd2829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Buggy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, L.</span><span> </span><span class="NLM_article-title">Bruton tyrosine kinase (BTK) and its role in B-cell malignancy</span> <span class="citation_source-journal">Int. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.3109/08830185.2012.664797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.3109%2F08830185.2012.664797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=22449073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1Omu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=119-132&issue=2&author=J.+J.+Buggyauthor=L.+Elias&title=Bruton+tyrosine+kinase+%28BTK%29+and+its+role+in+B-cell+malignancy&doi=10.3109%2F08830185.2012.664797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Bruton Tyrosine Kinase (BTK) and Its Role in B-cell Malignancy</span></div><div class="casAuthors">Buggy, Joseph J.; Elias, Laurence</div><div class="citationInfo"><span class="NLM_cas:title">International Reviews of Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-132</span>CODEN:
                <span class="NLM_cas:coden">IRIMEH</span>;
        ISSN:<span class="NLM_cas:issn">0883-0185</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  BTK is a kinase that functions downstream of multiple receptors in various hematol. cells.  This review focuses on BTK-dependent pathways that are likely to be involved in maintaining the malignant phenotype in B-cell lymphomas and leukemias.  Survival of various B-cell malignancies requires BTK-dependent signals from the B-cell antigen receptor.  Survival is also dependent on malignant cells homing to and interacting with lymphoid microenvironments, and these interactions are also BTK-dependent due its role in signaling downstream of chemokine and innate immune receptors.  The potential for therapeutic targeting of BTK is currently being tested in clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6a9d-RB2ULVg90H21EOLACvtfcHk0ljmb_h1KrT4DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1Omu78%253D&md5=629473bfc4af283fbe1b4522b36f6b79</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3109%2F08830185.2012.664797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08830185.2012.664797%26sid%3Dliteratum%253Aachs%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DElias%26aufirst%3DL.%26atitle%3DBruton%2520tyrosine%2520kinase%2520%2528BTK%2529%2520and%2520its%2520role%2520in%2520B-cell%2520malignancy%26jtitle%3DInt.%2520Rev.%2520Immunol.%26date%3D2012%26volume%3D31%26issue%3D2%26spage%3D119%26epage%3D132%26doi%3D10.3109%2F08830185.2012.664797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rickert, R. C.</span><span> </span><span class="NLM_article-title">New insights into pre-BCR and BCR signalling with relevance to B cell malignancies</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">578</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span><span class="refDoi"> DOI: 10.1038/nri3487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnri3487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23883968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKnt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=578-591&issue=8&author=R.+C.+Rickert&title=New+insights+into+pre-BCR+and+BCR+signalling+with+relevance+to+B+cell+malignancies&doi=10.1038%2Fnri3487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into pre-BCR and BCR signalling with relevance to B cell malignancies</span></div><div class="casAuthors">Rickert, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">578-591</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The B cell receptor (BCR) and its precursor (pre-BCR) control B cell homeostasis, differentiation and function.  Moreover, aberrant pre-BCR and BCR signalling have a central role in B cell neoplasia; for example, enhanced pos. signalling or disrupted neg. signalling downstream of the pre-BCR promotes B cell acute lymphocytic leukemia.  The emerging distinctions between tonic and chronic active BCR signalling have contributed to the identification of oncogenic targets downstream of BCR signalling in mature B cell neoplasms.  Indeed, the encouraging results of several ongoing clin. trials that target the activity of phosphoinositide 3-kinase δ-isoform (PI3Kδ), Bruton tyrosine kinase (BTK) or spleen tyrosine kinase (SYK) downstream of the BCR highlight the therapeutic potential of inhibiting BCR signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEVfPnHXGyE7Vg90H21EOLACvtfcHk0ljmb_h1KrT4DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKnt7nK&md5=8ae8c95aff039852282e02f6353979ca</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnri3487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3487%26sid%3Dliteratum%253Aachs%26aulast%3DRickert%26aufirst%3DR.%2BC.%26atitle%3DNew%2520insights%2520into%2520pre-BCR%2520and%2520BCR%2520signalling%2520with%2520relevance%2520to%2520B%2520cell%2520malignancies%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D13%26issue%3D8%26spage%3D578%26epage%3D591%26doi%3D10.1038%2Fnri3487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Palacios, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">48</span><span class="NLM_x">) </span> <span class="NLM_fpage">7990</span><span class="NLM_x">–</span> <span class="NLM_lpage">8000</span><span class="refDoi"> DOI: 10.1038/sj.onc.1208074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fsj.onc.1208074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=7990-8000&issue=48&author=E.+H.+Palaciosauthor=A.+Weiss&title=Function+of+the+Src-family+kinases%2C+Lck+and+Fyn%2C+in+T-cell+development+and+activation&doi=10.1038%2Fsj.onc.1208074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1208074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1208074%26sid%3Dliteratum%253Aachs%26aulast%3DPalacios%26aufirst%3DE.%2BH.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DFunction%2520of%2520the%2520Src-family%2520kinases%252C%2520Lck%2520and%2520Fyn%252C%2520in%2520T-cell%2520development%2520and%2520activation%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26issue%3D48%26spage%3D7990%26epage%3D8000%26doi%3D10.1038%2Fsj.onc.1208074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neininger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1038/10061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2F10061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10559880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVGqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=94-97&issue=2&author=A.+Kotlyarovauthor=A.+Neiningerauthor=C.+Schubertauthor=R.+Eckertauthor=C.+Birchmeierauthor=H.+D.+Volkauthor=M.+Gaestel&title=MAPKAP+kinase+2+is+essential+for+LPS-induced+TNF-alpha+biosynthesis&doi=10.1038%2F10061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis</span></div><div class="casAuthors">Kotlyarov, Alexey; Neininger, Armin; Schubert, Carola; Eckert, Rolf; Birchmeier, Carmen; Volk, Hans-Dieter; Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">94-97</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines Ltd</span>)
        </div><div class="casAbstract">MAPKAP kinase 2 (MK2) is one of several kinases that are regulated through direct phosphorylation by p38 MAP kinase.  By introducing a targeted mutation into the mouse MK2 gene, the authors have detd. the physiol. function of MK2 in vivo.  Mice that lack MK2 show increased stress resistance and survive LPS-induced endotoxic shock.  This is due to a redn. of ∼90% in the prodn. of tumor necrosis factor-α (TNF-α) and not to a change in signaling from the TNF receptor.  The level and stability of TNF-α mRNA is not reduced and TNF-α secretion is not affected.  Thus, MK2 is an essential component in the inflammatory response which regulates biosynthesis of TNF-α at a post-transcriptional level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtiobBLSnV77Vg90H21EOLACvtfcHk0liI-v7qNiKjTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVGqsLY%253D&md5=5fb502616639b298341431eea8009cc2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F10061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F10061%26sid%3Dliteratum%253Aachs%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DNeininger%26aufirst%3DA.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DEckert%26aufirst%3DR.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DVolk%26aufirst%3DH.%2BD.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMAPKAP%2520kinase%25202%2520is%2520essential%2520for%2520LPS-induced%2520TNF-alpha%2520biosynthesis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D1999%26volume%3D1%26issue%3D2%26spage%3D94%26epage%3D97%26doi%3D10.1038%2F10061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Brook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sully, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saklatvala, J.</span><span> </span><span class="NLM_article-title">Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1016/S0014-5793(00)02084-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2FS0014-5793%2800%2902084-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2000&pages=57-61&issue=1&author=M.+Brookauthor=G.+Sullyauthor=A.+R.+Clarkauthor=J.+Saklatvala&title=Regulation+of+tumour+necrosis+factor+alpha+mRNA+stability+by+the+mitogen-activated+protein+kinase+p38+signalling+cascade&doi=10.1016%2FS0014-5793%2800%2902084-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2800%2902084-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252800%252902084-6%26sid%3Dliteratum%253Aachs%26aulast%3DBrook%26aufirst%3DM.%26aulast%3DSully%26aufirst%3DG.%26aulast%3DClark%26aufirst%3DA.%2BR.%26aulast%3DSaklatvala%26aufirst%3DJ.%26atitle%3DRegulation%2520of%2520tumour%2520necrosis%2520factor%2520alpha%2520mRNA%2520stability%2520by%2520the%2520mitogen-activated%2520protein%2520kinase%2520p38%2520signalling%2520cascade%26jtitle%3DFEBS%2520Lett.%26date%3D2000%26volume%3D483%26issue%3D1%26spage%3D57%26epage%3D61%26doi%3D10.1016%2FS0014-5793%2800%2902084-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zarubin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span> </span><span class="NLM_article-title">Activation and signaling of the p38 MAP kinase pathway</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1038/sj.cr.7290257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fsj.cr.7290257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=15686620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslGisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=11-18&issue=1&author=T.+Zarubinauthor=J.+Han&title=Activation+and+signaling+of+the+p38+MAP+kinase+pathway&doi=10.1038%2Fsj.cr.7290257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and signaling of the p38 MAP kinase pathway</span></div><div class="casAuthors">Zarubin, Tyler; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-18</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Editorial Office of Cell Research</span>)
        </div><div class="casAbstract">A review.  The family members of the MAP kinases mediate a wide variety of cellular behaviors in response to extracellular stimuli.  One of the 4 main sub-groups, the p38 group of MAP kinases, serve as a nexus for signal transduction and play a vital role in numerous biol. processes.  Here, the authors highlight the known characteristics and components of the p38 pathway along with the mechanism and consequences of p38 activation.  The authors focus on the role of p38 as a signal transduction mediator and examine the evidence linking p38 to inflammation, cell cycle, cell death, development, cell differentiation, senescence, and tumorigenesis in specific cell types.  Upstream and downstream components of p38 are described and questions remaining to be answered are posed.  Finally, the authors propose several directions for future research on p38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIDzDSa5vqULVg90H21EOLACvtfcHk0liI-v7qNiKjTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslGisb4%253D&md5=c0f98c8f6db6e10b0a20357c401273d5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.cr.7290257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cr.7290257%26sid%3Dliteratum%253Aachs%26aulast%3DZarubin%26aufirst%3DT.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DActivation%2520and%2520signaling%2520of%2520the%2520p38%2520MAP%2520kinase%2520pathway%26jtitle%3DCell%2520Res.%26date%3D2005%26volume%3D15%26issue%3D1%26spage%3D11%26epage%3D18%26doi%3D10.1038%2Fsj.cr.7290257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cee, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodous, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5671</span><span class="NLM_x">–</span> <span class="NLM_lpage">5686</span><span class="refDoi"> DOI: 10.1021/jm0605482</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0605482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5671-5686&issue=19&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=V.+J.+Ceeauthor=L.+Chaiauthor=H.+L.+Deakauthor=L.+F.+Epsteinauthor=T.+Faustauthor=P.+Gallantauthor=S.+D.+Geuns-Meyerauthor=A.+Goreauthor=Y.+Guauthor=B.+Henkleauthor=B.+L.+Hodousauthor=F.+Hsiehauthor=X.+Huangauthor=J.+L.+Kimauthor=J.+H.+Leeauthor=M.+W.+Martinauthor=C.+E.+Masseauthor=D.+C.+McGowanauthor=D.+Metzauthor=D.+Mohnauthor=K.+A.+Morgensternauthor=A.+Oliveira-dos-Santosauthor=V.+F.+Patelauthor=D.+Powersauthor=P.+E.+Roseauthor=S.+Schneiderauthor=S.+A.+Tomlinsonauthor=Y.+Y.+Tudorauthor=S.+M.+Turciauthor=A.+A.+Welcherauthor=R.+D.+Whiteauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhu&title=Discovery+of+aminoquinazolines+as+potent%2C+orally+bioavailable+inhibitors+of+Lck%3A+synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity&doi=10.1021%2Fjm0605482"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0605482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605482%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%2BD.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DHodous%26aufirst%3DB.%2BL.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMasse%26aufirst%3DC.%2BE.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTomlinson%26aufirst%3DS.%2BA.%26aulast%3DTudor%26aufirst%3DY.%2BY.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520aminoquinazolines%2520as%2520potent%252C%2520orally%2520bioavailable%2520inhibitors%2520of%2520Lck%253A%2520synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D19%26spage%3D5671%26epage%3D5686%26doi%3D10.1021%2Fjm0605482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Stachlewitz, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettencourt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kebede, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waegell, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span> </span><span class="NLM_article-title">A-770041, a novel and selective small-molecule inhibitor of Lck, prevents heart allograft rejection</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1124/jpet.105.089169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1124%2Fjpet.105.089169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=16014572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=36-41&issue=1&author=R.+F.+Stachlewitzauthor=M.+A.+Hartauthor=B.+Bettencourtauthor=T.+Kebedeauthor=A.+Schwartzauthor=S.+E.+Ratnofskyauthor=D.+J.+Calderwoodauthor=W.+O.+Waegellauthor=G.+C.+Hirst&title=A-770041%2C+a+novel+and+selective+small-molecule+inhibitor+of+Lck%2C+prevents+heart+allograft+rejection&doi=10.1124%2Fjpet.105.089169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A-770041, a novel and selective small-molecule inhibitor of Lck, prevents heart allograft rejection</span></div><div class="casAuthors">Stachlewitz, Robert F.; Hart, Michelle A.; Bettencourt, Brian; Kebede, Tegest; Schwartz, Annette; Ratnofsky, Sheldon E.; Calderwood, David J.; Waegell, Wendy O.; Hirst, Gavin C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-41</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lck, one of eight members of the Src family of tyrosine kinases, is activated after T cell stimulation and is required for T-cell proliferation and interleukin (IL)-2 prodn.  Inhibition of Lck has been a target to prevent lymphocyte activation and acute rejection.  Here, we report the pharmacol. characterization of 1-methyl-1H-indole-2-carboxylic acid (4-{1-[4-(4-acetylpiperazin-l-yl)-cyclohexyl]-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxy-phenyl)-amide (A-770041), an orally bioavailable pyrazolo[3,4-d]pyrimidine with increased selectivity for Lck compared with previously reported compds.  A-770041 is a 147 nM inhibitor of Lck (1 mM ATP) and is 300-fold selective against Fyn, the other Src family kinase involved in T-cell signaling.  Con A-stimulated IL-2 prodn. in whole blood is inhibited by A-770041 with an EC50 of approx. 80 nM.  A-770041 is orally bioavailable (F = 34.1 ± 7.2% at 10 mg/kg) and has a t1/2 of 4.1 ± 0.1 h.  Con A-induced IL-2 prodn. in vivo is inhibited by oral administration of A-770041 (in vivo EC50 = 78 ± 28 nM).  Doses of A-770041 at or above 10 mg/kg/day prevent rejection of hearts transplanted heterotopically in rats from Brown Norway donors to Lewis recipients across a major histocompatibility barrier for least 65 days.  Grafts from animals treated with 20 mg/kg/day A-770041 or 10 mg/day Cyclosporin A had minimal microvascular changes or multifocal mononuclear infiltrates.  However, mineralization in myocytes from the grafts from A-770041-treated animals was less than animals treated with Cyclosporin A.  Lck inhibition is an attractive target to prevent acute rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUGRdbGgdcRbVg90H21EOLACvtfcHk0liJj1ivY52pmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrbE&md5=744e6f81abafe3f7573307abbeeddb37</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.089169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.089169%26sid%3Dliteratum%253Aachs%26aulast%3DStachlewitz%26aufirst%3DR.%2BF.%26aulast%3DHart%26aufirst%3DM.%2BA.%26aulast%3DBettencourt%26aufirst%3DB.%26aulast%3DKebede%26aufirst%3DT.%26aulast%3DSchwartz%26aufirst%3DA.%26aulast%3DRatnofsky%26aufirst%3DS.%2BE.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DWaegell%26aufirst%3DW.%2BO.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26atitle%3DA-770041%252C%2520a%2520novel%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520Lck%252C%2520prevents%2520heart%2520allograft%2520rejection%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26issue%3D1%26spage%3D36%26epage%3D41%26doi%3D10.1124%2Fjpet.105.089169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Vargas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamasy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nore, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. I.</span><span> </span><span class="NLM_article-title">Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseases</span> <span class="citation_source-journal">Scand. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1111/sji.12069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1111%2Fsji.12069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23672610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOit77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=130-139&issue=2&author=L.+Vargasauthor=A.+Hamasyauthor=B.+F.+Noreauthor=C.+I.+Smith&title=Inhibitors+of+BTK+and+ITK%3A+state+of+the+new+drugs+for+cancer%2C+autoimmunity+and+inflammatory+diseases&doi=10.1111%2Fsji.12069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of BTK and ITK: State of the New Drugs for Cancer, Autoimmunity and Inflammatory Diseases</span></div><div class="casAuthors">Vargas, L.; Hamasy, A.; Nore, B. F.; E. Smith, C. I.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-139</span>CODEN:
                <span class="NLM_cas:coden">SJIMAX</span>;
        ISSN:<span class="NLM_cas:issn">0300-9475</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  BTK and ITK are cytoplasmic tyrosine kinases of crucial importance for B and T cell development, with loss-of-function mutations causing X-linked agammaglobulinemia and susceptibility to severe, frequently lethal, Epstein-Barr virus infection, resp.  Over the last few years, considerable efforts have been made in order to develop small-mol. inhibitors for these kinases to treat lymphocyte malignancies, autoimmunity or allergy/hypersensitivity.  The rationale is that even if complete lack of BTK or ITK during development causes severe immunodeficiency, inactivation after birth may result in a less severe phenotype.  Moreover, therapy can be transient or only partially block the activity of BTK or ITK.  Furthermore, a drug-induced B cell deficiency is treatable by gamma globulin substitution therapy.  The newly developed BTK inhibitor PCI-32765, recently renamed Ibrutinib, has already entered several clin. trials for various forms of non-Hodgkin lymphoma as well as for multiple myeloma.  Exptl. animal studies have demonstrated highly promising treatment effects also in autoimmunity.  ITK inhibitors are still under the early developmental phase, but it can be expected that such drugs will also become very useful.  In this study, we present BTK and ITK with their signalling pathways and review the development of the corresponding inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP0_rsdqSDoLVg90H21EOLACvtfcHk0liJj1ivY52pmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOit77M&md5=f9ba77b041266d4746a7cef27604f11a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fsji.12069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fsji.12069%26sid%3Dliteratum%253Aachs%26aulast%3DVargas%26aufirst%3DL.%26aulast%3DHamasy%26aufirst%3DA.%26aulast%3DNore%26aufirst%3DB.%2BF.%26aulast%3DSmith%26aufirst%3DC.%2BI.%26atitle%3DInhibitors%2520of%2520BTK%2520and%2520ITK%253A%2520state%2520of%2520the%2520new%2520drugs%2520for%2520cancer%252C%2520autoimmunity%2520and%2520inflammatory%2520diseases%26jtitle%3DScand.%2520J.%2520Immunol.%26date%3D2013%26volume%3D78%26issue%3D2%26spage%3D130%26epage%3D139%26doi%3D10.1111%2Fsji.12069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Romagnoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelosi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantagrel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meerwijk, J. P.</span><span> </span><span class="NLM_article-title">A potential role for protein tyrosine kinase p56(lck) in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness</span> <span class="citation_source-journal">Int. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1093/intimm/13.3.305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1093%2Fintimm%2F13.3.305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=11222499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvVOhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=305-312&issue=3&author=P.+Romagnoliauthor=D.+Strahanauthor=M.+Pelosiauthor=A.+Cantagrelauthor=J.+P.+van+Meerwijk&title=A+potential+role+for+protein+tyrosine+kinase+p56%28lck%29+in+rheumatoid+arthritis+synovial+fluid+T+lymphocyte+hyporesponsiveness&doi=10.1093%2Fintimm%2F13.3.305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A potential role for protein tyrosine kinase p56lck in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness</span></div><div class="casAuthors">Romagnoli, Paola; Strahan, Donna; Pelosi, Michele; Cantagrel, Alain; Van Meerwijk, Joost P. M.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-312</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Rheumatoid arthritis (RA) synovial fluid (SF)-T lymphocytes appear relatively inactive in situ and respond only weakly to diverse stimuli ex vivo.  To characterize the mol. defects underlying this hyporesponsiveness the authors analyzed the expression level of several proteins involved in TCR-proximal signal transduction.  As compared to peripheral blood (PB)-T lymphocytes, SF-T cells from some (but not all) of the patients analyzed expressed lower levels of TCRαβ, CD3ε, TCRζ, p56lck and LAT, while p59fyn, phospholipase C-γ1 and ZAP-70 expression was unaltered.  Semi-quant. anal. of T cells from several patients revealed that the degree of TCRζ chain and p56lck modulation correlated statistically significantly with the level of SF-T cell hyporesponsiveness.  The differential reactivity of p56lck specific monoclonal and polyclonal antibodies in SF-T but not PB-T lymphocytes indicated that p56lck modulation consists of a conformational change rather than loss of expression.  Our results indicate that multiple signaling mols. can be modulated in RA SF-T cells and show for the first time a direct quant. correlation between T cell hyporesponsiveness and modulation of TCRζ and of p56lck, a crit. protein tyrosine kinase required for T cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ3UeK56kdLLVg90H21EOLACvtfcHk0ljMODgXeScfng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvVOhtro%253D&md5=0e18afeb1a6714fcaa33031de6cf26ae</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2F13.3.305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252F13.3.305%26sid%3Dliteratum%253Aachs%26aulast%3DRomagnoli%26aufirst%3DP.%26aulast%3DStrahan%26aufirst%3DD.%26aulast%3DPelosi%26aufirst%3DM.%26aulast%3DCantagrel%26aufirst%3DA.%26aulast%3Dvan%2BMeerwijk%26aufirst%3DJ.%2BP.%26atitle%3DA%2520potential%2520role%2520for%2520protein%2520tyrosine%2520kinase%2520p56%2528lck%2529%2520in%2520rheumatoid%2520arthritis%2520synovial%2520fluid%2520T%2520lymphocyte%2520hyporesponsiveness%26jtitle%3DInt.%2520Immunol.%26date%3D2001%26volume%3D13%26issue%3D3%26spage%3D305%26epage%3D312%26doi%3D10.1093%2Fintimm%2F13.3.305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">2979</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span><span class="refDoi"> DOI: 10.2174/092986705774462914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.2174%2F092986705774462914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=16378500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2979-2994&issue=25&author=M.+R.+Leeauthor=C.+Dominguez&title=MAP+kinase+p38+inhibitors%3A+clinical+results+and+an+intimate+look+at+their+interactions+with+p38alpha+protein&doi=10.2174%2F092986705774462914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38α protein</span></div><div class="casAuthors">Lee, Matthew R.; Dominguez, Celia</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2979-2994</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase p38 is a serine/threonine kinase originally isolated from lipopolysaccharide (LPS) stimulated monocytes.  There are four isoforms p38α, p38β, p38γ, and p38δ.  The most thoroughly studied isoform is p38α, whose activation has been obsd. in many hematopoietic and non-hematopoietic cell types upon appropriate stimuli.  Subsequently, p38α kinase has been shown to be involved in the biosynthesis of TNFα and IL-1β at the translational and transcriptional level.  MAP kinase p38α represents a point of convergence for multiple signaling processes that are activated in inflammation and thus a key potential target for the modulation of cytokine prodn.  The discovery and publication of p38α and the pyridinyl-imidazole inhibitor initiated a huge effort by many companies to develop p38α inhibitors as potential treatment for inflammatory diseases.  Herein we provide a brief overview of recent reported clin. results for AMG 548, BIRB 796, VX 702, SCIO 469, and SCIO 323.  However, our focus will be on the binding modes of these inhibitors and other p38 inhibitors in the recent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSldsfUAO6bVg90H21EOLACvtfcHk0ljMODgXeScfng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF&md5=eb21253fcc2df76280cd9a1812ed1015</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F092986705774462914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774462914%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DMAP%2520kinase%2520p38%2520inhibitors%253A%2520clinical%2520results%2520and%2520an%2520intimate%2520look%2520at%2520their%2520interactions%2520with%2520p38alpha%2520protein%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26issue%3D25%26spage%3D2979%26epage%3D2994%26doi%3D10.2174%2F092986705774462914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Honigberg, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisawad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loury, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thamm, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span> </span><span class="NLM_article-title">The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">29</span><span class="NLM_x">) </span> <span class="NLM_fpage">13075</span><span class="NLM_x">–</span> <span class="NLM_lpage">13080</span><span class="refDoi"> DOI: 10.1073/pnas.1004594107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1073%2Fpnas.1004594107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=20615965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=13075-13080&issue=29&author=L.+A.+Honigbergauthor=A.+M.+Smithauthor=M.+Sirisawadauthor=E.+Vernerauthor=D.+Louryauthor=B.+Changauthor=S.+Liauthor=Z.+Panauthor=D.+H.+Thammauthor=R.+A.+Millerauthor=J.+J.+Buggy&title=The+Bruton+tyrosine+kinase+inhibitor+PCI-32765+blocks+B-cell+activation+and+is+efficacious+in+models+of+autoimmune+disease+and+B-cell+malignancy&doi=10.1073%2Fpnas.1004594107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy</span></div><div class="casAuthors">Honigberg, Lee A.; Smith, Ashley M.; Sirisawad, Mint; Verner, Erik; Loury, David; Chang, Betty; Li, Shyr; Pan, Zhengying; Thamm, Douglas H.; Miller, Richard A.; Buggy, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">13075-13080, S13075/1-S13075/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Activation of the B-cell antigen receptor (BCR) signaling pathway contributes to the initiation and maintenance of B-cell malignancies and autoimmune diseases.  The Bruton tyrosine kinase (Btk) is specifically required for BCR signaling as demonstrated by human and mouse mutations that disrupt Btk function and prevent B-cell maturation at steps that require a functional BCR pathway.  Herein we describe a selective and irreversible Btk inhibitor, PCI-32765, that is currently under clin. development in patients with B-cell non-Hodgkin lymphoma.  We have used this inhibitor to investigate the biol. effects of Btk inhibition on mature B-cell function and the progression of B cell-assocd. diseases in vivo.  PCI-32765 blocked BCR signaling in human peripheral B cells at concns. that did not affect T cell receptor signaling.  In mice with collagen-induced arthritis, orally administered PCI-32765 reduced the level of circulating autoantibodies and completely suppressed disease.  PCI-32765 also inhibited autoantibody prodn. and the development of kidney disease in the MRL-Fas(lpr) lupus model.  Occupancy of the Btk active site by PCI-32765 was monitored in vitro and in vivo using a fluorescent affinity probe for Btk.  Active site occupancy of Btk was tightly correlated with the blockade of BCR signaling and in vivo efficacy.  Finally, PCI-32765 induced objective clin. responses in dogs with spontaneous B-cell non-Hodgkin lymphoma.  These findings support Btk inhibition as a therapeutic approach for the treatment of human diseases assocd. with activation of the BCR pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT4OQHme7oHLVg90H21EOLACvtfcHk0ljfeEuMXPQaXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCrsbk%253D&md5=196ce4a05bb9c622c49cb7e908682e63</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1004594107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1004594107%26sid%3Dliteratum%253Aachs%26aulast%3DHonigberg%26aufirst%3DL.%2BA.%26aulast%3DSmith%26aufirst%3DA.%2BM.%26aulast%3DSirisawad%26aufirst%3DM.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DLoury%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DThamm%26aufirst%3DD.%2BH.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Bruton%2520tyrosine%2520kinase%2520inhibitor%2520PCI-32765%2520blocks%2520B-cell%2520activation%2520and%2520is%2520efficacious%2520in%2520models%2520of%2520autoimmune%2520disease%2520and%2520B-cell%2520malignancy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D29%26spage%3D13075%26epage%3D13080%26doi%3D10.1073%2Fpnas.1004594107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutre, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flinn, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierda, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerema, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukbuntherng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S.</span><span> </span><span class="NLM_article-title">Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1056/NEJMoa1215637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1056%2FNEJMoa1215637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23782158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFygu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=32-42&issue=1&author=J.+C.+Byrdauthor=R.+R.+Furmanauthor=S.+E.+Coutreauthor=I.+W.+Flinnauthor=J.+A.+Burgerauthor=K.+A.+Blumauthor=B.+Grantauthor=J.+P.+Sharmanauthor=M.+Colemanauthor=W.+G.+Wierdaauthor=J.+A.+Jonesauthor=W.+Zhaoauthor=N.+A.+Heeremaauthor=A.+J.+Johnsonauthor=J.+Sukbuntherngauthor=B.+Y.+Changauthor=F.+Clowauthor=E.+Hedrickauthor=J.+J.+Buggyauthor=D.+F.+Jamesauthor=S.+O%E2%80%99Brien&title=Targeting+BTK+with+ibrutinib+in+relapsed+chronic+lymphocytic+leukemia&doi=10.1056%2FNEJMoa1215637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia</span></div><div class="casAuthors">Byrd, John C.; Furman, Richard R.; Coutre, Steven E.; Flinn, Ian W.; Burger, Jan A.; Blum, Kristie A.; Grant, Barbara; Sharman, Jeff P.; Coleman, Morton; Wierda, William G.; Jones, Jeffrey A.; Zhao, Weiqiang; Heerema, Nyla A.; Johnson, Amy J.; Sukbuntherng, Juthamas; Chang, Betty Y.; Clow, Fong; Hedrick, Eric; Buggy, Joseph J.; James, Danelle F.; O'Brien, Susan</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-42</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background The treatment of relapsed chronic lymphocytic leukemia (CLL) has resulted in few durable remissions.  Bruton's tyrosine kinase (BTK), an essential component of B-cell-receptor signaling, mediates interactions with the tumor microenvironment and promotes the survival and proliferation of CLL cells.  Methods We conducted a phase 1b-2 multicenter study to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ibrutinib (PCI-32765), a first-in-class, oral covalent inhibitor of BTK designed for treatment of B-cell cancers, in patients with relapsed or refractory CLL or small lymphocytic lymphoma.  A total of 85 patients, the majority of whom were considered to have high-risk disease, received ibrutinib orally once daily; 51 received 420 mg, and 34 received 840 mg.  Results Toxic effects were predominantly grade 1 or 2 and included transient diarrhea, fatigue, and upper respiratory tract infection; thus, patients could receive extended treatment with minimal hematol. toxic effects.  The overall response rate was the same in the group that received 420 mg and the group that received 840 mg (71%), and an addnl. 20% and 15% of patients in the resp. groups had a partial response with lymphocytosis.  The response was independent of clin. and genomic risk factors present before treatment, including advanced-stage disease, the no. of previous therapies, and the 17p13.1 deletion.  At 26 mo, the estd. progression-free survival rate was 75% and the rate of overall survival was 83%.  Conclusions Ibrutinib was assocd. with a high frequency of durable remissions in patients with relapsed or refractory CLL and small lymphocytic lymphoma, including patients with high-risk genetic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1EhPQxMRz7rVg90H21EOLACvtfcHk0ljfeEuMXPQaXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFygu7zN&md5=32a5eb6ab06beeecf64d9ada84139925</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1215637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1215637%26sid%3Dliteratum%253Aachs%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DFurman%26aufirst%3DR.%2BR.%26aulast%3DCoutre%26aufirst%3DS.%2BE.%26aulast%3DFlinn%26aufirst%3DI.%2BW.%26aulast%3DBurger%26aufirst%3DJ.%2BA.%26aulast%3DBlum%26aufirst%3DK.%2BA.%26aulast%3DGrant%26aufirst%3DB.%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DColeman%26aufirst%3DM.%26aulast%3DWierda%26aufirst%3DW.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BA.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DHeerema%26aufirst%3DN.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DSukbuntherng%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DB.%2BY.%26aulast%3DClow%26aufirst%3DF.%26aulast%3DHedrick%26aufirst%3DE.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DJames%26aufirst%3DD.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%26atitle%3DTargeting%2520BTK%2520with%2520ibrutinib%2520in%2520relapsed%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26issue%3D1%26spage%3D32%26epage%3D42%26doi%3D10.1056%2FNEJMoa1215637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wang, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rule, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahl, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurczak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Advani, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romaguera, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrientos, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielowska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stilgenbauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jedrzejczak, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurgeon, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newberry, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGreivy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaupre, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, K. A.</span><span> </span><span class="NLM_article-title">Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span><span class="refDoi"> DOI: 10.1056/NEJMoa1306220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1056%2FNEJMoa1306220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23782157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OgtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=507-516&issue=6&author=M.+L.+Wangauthor=S.+Ruleauthor=P.+Martinauthor=A.+Goyauthor=R.+Auerauthor=B.+S.+Kahlauthor=W.+Jurczakauthor=R.+H.+Advaniauthor=J.+E.+Romagueraauthor=M.+E.+Williamsauthor=J.+C.+Barrientosauthor=E.+Chmielowskaauthor=J.+Radfordauthor=S.+Stilgenbauerauthor=M.+Dreylingauthor=W.+W.+Jedrzejczakauthor=P.+Johnsonauthor=S.+E.+Spurgeonauthor=L.+Liauthor=L.+Zhangauthor=K.+Newberryauthor=Z.+Ouauthor=N.+Chengauthor=B.+Fangauthor=J.+McGreivyauthor=F.+Clowauthor=J.+J.+Buggyauthor=B.+Y.+Changauthor=D.+M.+Beaupreauthor=L.+A.+Kunkelauthor=K.+A.+Blum&title=Targeting+BTK+with+ibrutinib+in+relapsed+or+refractory+mantle-cell+lymphoma&doi=10.1056%2FNEJMoa1306220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma</span></div><div class="casAuthors">Wang, Michael L.; Rule, Simon; Martin, Peter; Goy, Andre; Auer, Rebecca; Kahl, Brad S.; Jurczak, Wojciech; Advani, Ranjana H.; Romaguera, Jorge E.; Williams, Michael E.; Barrientos, Jacqueline C.; Chmielowska, Ewa; Radford, John; Stilgenbauer, Stephan; Dreyling, Martin; Jedrzejczak, Wieslaw Wiktor; Johnson, Peter; Spurgeon, Stephen E.; Li, Lei; Zhang, Liang; Newberry, Kate; Ou, Zhishuo; Cheng, Nancy; Fang, Bingliang; McGreivy, Jesse; Clow, Fong; Buggy, Joseph J.; Chang, Betty Y.; Beaupre, Darrin M.; Kunkel, Lori A.; Blum, Kristie A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">507-516</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Bruton's tyrosine kinase (BTK) is a mediator of the B-cell-receptor signaling pathway implicated in the pathogenesis of B-cell cancers.  In a phase 1 study, ibrutinib, a BTK inhibitor, showed antitumor activity in several types of non-Hodgkin's lymphoma, including mantle-cell lymphoma.  METHODS: In this phase 2 study, we investigated oral ibrutinib, at a daily dose of 560 mg, in 111 patients with relapsed or refractory mantle-cell lymphoma.  Patients were enrolled into two groups: those who had previously received at least 2 cycles of bortezomib therapy and those who had received less than 2 complete cycles of bortezomib or had received no prior bortezomib therapy.  The primary end point was the overall response rate.  Secondary end points were duration of response, progression-free survival, overall survival, and safety.  RESULTS: The median age was 68 years, and 86% of patients had intermediate-risk or high-risk mantle-cell lymphoma according to clin. prognostic factors.  Patients had received a median of three prior therapies.  The most common treatment-related adverse events were mild or moderate diarrhea, fatigue, and nausea.  Grade 3 or higher hematol. events were infrequent and included neutropenia (in 16% of patients), thrombocytopenia (in 11%), and anemia (in 10%).  A response rate of 68% (75 patients) was obsd., with a complete response rate of 21% and a partial response rate of 47%; prior treatment with bortezomib had no effect on the response rate.  With an estd. median follow-up of 15.3 mo, the estd. median response duration was 17.5 mo (95% confidence interval [CI], 15.8 to not reached), the estd. median progression-free survival was 13.9 mo (95% CI, 7.0 to not reached), and the median overall survival was not reached.  The estd. rate of overall survival was 58% at 18 mo.  CONCLUSIONS: Ibrutinib shows durable single-agent efficacy in relapsed or refractory mantle-cell lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovUuOKvHS0NrVg90H21EOLACvtfcHk0ljfeEuMXPQaXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OgtL%252FF&md5=7a92bbd5acf86e614cea96f44503e12b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1306220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1306220%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%2BL.%26aulast%3DRule%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DGoy%26aufirst%3DA.%26aulast%3DAuer%26aufirst%3DR.%26aulast%3DKahl%26aufirst%3DB.%2BS.%26aulast%3DJurczak%26aufirst%3DW.%26aulast%3DAdvani%26aufirst%3DR.%2BH.%26aulast%3DRomaguera%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DM.%2BE.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DChmielowska%26aufirst%3DE.%26aulast%3DRadford%26aufirst%3DJ.%26aulast%3DStilgenbauer%26aufirst%3DS.%26aulast%3DDreyling%26aufirst%3DM.%26aulast%3DJedrzejczak%26aufirst%3DW.%2BW.%26aulast%3DJohnson%26aufirst%3DP.%26aulast%3DSpurgeon%26aufirst%3DS.%2BE.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DOu%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DN.%26aulast%3DFang%26aufirst%3DB.%26aulast%3DMcGreivy%26aufirst%3DJ.%26aulast%3DClow%26aufirst%3DF.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DChang%26aufirst%3DB.%2BY.%26aulast%3DBeaupre%26aufirst%3DD.%2BM.%26aulast%3DKunkel%26aufirst%3DL.%2BA.%26aulast%3DBlum%26aufirst%3DK.%2BA.%26atitle%3DTargeting%2520BTK%2520with%2520ibrutinib%2520in%2520relapsed%2520or%2520refractory%2520mantle-cell%2520lymphoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26issue%3D6%26spage%3D507%26epage%3D516%26doi%3D10.1056%2FNEJMoa1306220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Chang, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francesco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokolove, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magadala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span> </span><span class="NLM_article-title">The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">R115</span><span class="refDoi"> DOI: 10.1186/ar3400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1186%2Far3400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=21752263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFGltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=R115&issue=4&author=B.+Y.+Changauthor=M.+M.+Huangauthor=M.+Francescoauthor=J.+Chenauthor=J.+Sokoloveauthor=P.+Magadalaauthor=W.+H.+Robinsonauthor=J.+J.+Buggy&title=The+Bruton+tyrosine+kinase+inhibitor+PCI-32765+ameliorates+autoimmune+arthritis+by+inhibition+of+multiple+effector+cells&doi=10.1186%2Far3400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells</span></div><div class="casAuthors">Chang, Betty Y.; Huang, Min Mei; Francesco, Michelle; Chen, Jun; Sokolove, Jeremy; Magadala, Padmaja; Robinson, William H.; Buggy, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">R115</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction: The aim was to det. the effect of the Bruton tyrosine kinase (Btk)-selective inhibitor PCI-32765, currently in Phase I/II studies in lymphoma trials, in arthritis and immune-complex (IC) based animal models and describe the underlying cellular mechanisms.  Methods: PCI-32765 was administered in a series of murine IC disease models including collagen-induced arthritis (CIA), collagen antibody-induced arthritis (CAIA), reversed passive anaphylactic reaction (RPA), and passive cutaneous anaphylaxis (PCA).  Clin. and pathol. features characteristic of each model were examd. following treatment.  PCI-32765 was then examd. in assays using immune cells relevant to the pathogenesis of arthritis, and where Btk is thought to play a functional role.  These included proliferation and calcium mobilization in B cells, cytokine and chemokine prodn. in monocytes/macrophages, degranulation of mast cells and its subsequent cytokine/chemokine prodn.  Results: PCI-32765 dose-dependently and potently reversed arthritic inflammation in a therapeutic CIA model with an ED50 of 2.6 mg/kg/day.  PCI-32765 also prevented clin. arthritis in CAIA models.  In both models, infiltration of monocytes and macrophages into the synovium was completely inhibited and importantly, the bone and cartilage integrity of the joints were preserved.  PCI-32765 reduced inflammation in the Arthus and PCA assays.  In vitro, PCI-32765 inhibited BCR-activated primary B cell proliferation (IC50 = 8 nM).  Following FcγR stimulation, PCI-32765 inhibited TNFα, IL-1β and IL-6 prodn. in primary monocytes (IC50 = 2.6, 0.5, 3.9 nM, resp.).  Following Fc.vepsiln.RI stimulation of cultured human mast cells, PCI-32765 inhibited release of histamine, PGD2, TNF-α, IL-8 and MCP-1.  Conclusions: PCI-32765 is efficacious in CIA, and in IC models that do not depend upon autoantibody prodn. from B cells.  Thus PCI-32765 targets not only B lymphocytes but also monocytes, macrophages and mast cells, which are important Btk-expressing effector cells in arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQLy1_wdvr7rVg90H21EOLACvtfcHk0ljRLZaYMw0TMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFGltrs%253D&md5=ab0d3df5dc8816194c4087a131125744</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2Far3400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far3400%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DB.%2BY.%26aulast%3DHuang%26aufirst%3DM.%2BM.%26aulast%3DFrancesco%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSokolove%26aufirst%3DJ.%26aulast%3DMagadala%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DW.%2BH.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Bruton%2520tyrosine%2520kinase%2520inhibitor%2520PCI-32765%2520ameliorates%2520autoimmune%2520arthritis%2520by%2520inhibition%2520of%2520multiple%2520effector%2520cells%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2011%26volume%3D13%26issue%3D4%26spage%3DR115%26doi%3D10.1186%2Far3400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Evans, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tester, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labenski, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witowski, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lounsbury, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazdiyasni, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubrovskiy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, W. F.</span><span> </span><span class="NLM_article-title">Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span><span class="refDoi"> DOI: 10.1124/jpet.113.203489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1124%2Fjpet.113.203489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23709115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOjsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2013&pages=219-228&issue=2&author=E.+K.+Evansauthor=R.+Testerauthor=S.+Aslanianauthor=R.+Karpauthor=M.+Sheetsauthor=M.+T.+Labenskiauthor=S.+R.+Witowskiauthor=H.+Lounsburyauthor=P.+Chaturvediauthor=H.+Mazdiyasniauthor=Z.+Zhuauthor=M.+Nachtauthor=M.+I.+Freedauthor=R.+C.+Petterauthor=A.+Dubrovskiyauthor=J.+Singhauthor=W.+F.+Westlin&title=Inhibition+of+Btk+with+CC-292+provides+early+pharmacodynamic+assessment+of+activity+in+mice+and+humans&doi=10.1124%2Fjpet.113.203489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans</span></div><div class="casAuthors">Evans, Erica K.; Tester, Richland; Aslanian, Sharon; Karp, Russell; Sheets, Michael; Labenski, Matthew T.; Witowski, Steven R.; Lounsbury, Heather; Chaturvedi, Prasoon; Mazdiyasni, Hormoz; Zhu, Zhendong; Nacht, Mariana; Freed, Martin I.; Petter, Russell C.; Dubrovskiy, Alex; Singh, Juswinder; Westlin, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-228</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Targeted therapies that suppress B cell receptor (BCR) signaling have emerged as promising agents in autoimmune disease and B cell malignancies.  Bruton's tyrosine kinase (Btk) plays a crucial role in B cell development and activation through the BCR signaling pathway and represents a new target for diseases characterized by inappropriate B cell activity.  N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide (CC-292) is a highly selective, covalent Btk inhibitor and a sensitive and quant. assay that measures CC-292-Btk engagement has been developed.  This translational pharmacodynamic assay has accompanied CC-292 through each step of drug discovery and development.  These studies demonstrate the quantity of Btk bound by CC-292 correlates with the efficacy of CC-292 in vitro and in the collagen-induced arthritis model of autoimmune disease.  Recently, CC-292 has entered human clin. trials with a trial design that has provided rapid insight into safety, pharmacokinetics, and pharmacodynamics.  This first-in-human healthy volunteer trial has demonstrated that a single oral dose of 2 mg/kg CC-292 consistently engaged all circulating Btk protein and provides the basis for rational dose selection in future clin. trials.  This targeted covalent drug design approach has enabled the discovery and early clin. development of CC-292 and has provided support for Btk as a valuable drug target for B-cell mediated disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN2l8ZCVqCFLVg90H21EOLACvtfcHk0ljRLZaYMw0TMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOjsbbM&md5=95fac997a246e59d943dd554af358a65</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.203489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.203489%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DE.%2BK.%26aulast%3DTester%26aufirst%3DR.%26aulast%3DAslanian%26aufirst%3DS.%26aulast%3DKarp%26aufirst%3DR.%26aulast%3DSheets%26aufirst%3DM.%26aulast%3DLabenski%26aufirst%3DM.%2BT.%26aulast%3DWitowski%26aufirst%3DS.%2BR.%26aulast%3DLounsbury%26aufirst%3DH.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DMazdiyasni%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DNacht%26aufirst%3DM.%26aulast%3DFreed%26aufirst%3DM.%2BI.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DDubrovskiy%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DWestlin%26aufirst%3DW.%2BF.%26atitle%3DInhibition%2520of%2520Btk%2520with%2520CC-292%2520provides%2520early%2520pharmacodynamic%2520assessment%2520of%2520activity%2520in%2520mice%2520and%2520humans%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D346%26issue%3D2%26spage%3D219%26epage%3D228%26doi%3D10.1124%2Fjpet.113.203489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Walter, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rule, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quittet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtenay-Luck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morschhauser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fegan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, G.</span><span> </span><span class="NLM_article-title">A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1182/blood-2015-08-664086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1182%2Fblood-2015-08-664086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2016&pages=411-419&issue=4&author=H.+S.+Walterauthor=S.+A.+Ruleauthor=M.+J.+Dyerauthor=L.+Karlinauthor=C.+Jonesauthor=B.+Cazinauthor=P.+Quittetauthor=N.+Shahauthor=C.+V.+Hutchinsonauthor=H.+Hondaauthor=K.+Duffyauthor=J.+Birkettauthor=V.+Jamiesonauthor=N.+Courtenay-Luckauthor=T.+Yoshizawaauthor=J.+Sharpeauthor=T.+Ohnoauthor=S.+Abeauthor=A.+Nishimuraauthor=G.+Cartronauthor=F.+Morschhauserauthor=C.+Feganauthor=G.+Salles&title=A+phase+1+clinical+trial+of+the+selective+BTK+inhibitor+ONO%2FGS-4059+in+relapsed+and+refractory+mature+B-cell+malignancies&doi=10.1182%2Fblood-2015-08-664086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1182%2Fblood-2015-08-664086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2015-08-664086%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DH.%2BS.%26aulast%3DRule%26aufirst%3DS.%2BA.%26aulast%3DDyer%26aufirst%3DM.%2BJ.%26aulast%3DKarlin%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DCazin%26aufirst%3DB.%26aulast%3DQuittet%26aufirst%3DP.%26aulast%3DShah%26aufirst%3DN.%26aulast%3DHutchinson%26aufirst%3DC.%2BV.%26aulast%3DHonda%26aufirst%3DH.%26aulast%3DDuffy%26aufirst%3DK.%26aulast%3DBirkett%26aufirst%3DJ.%26aulast%3DJamieson%26aufirst%3DV.%26aulast%3DCourtenay-Luck%26aufirst%3DN.%26aulast%3DYoshizawa%26aufirst%3DT.%26aulast%3DSharpe%26aufirst%3DJ.%26aulast%3DOhno%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DA.%26aulast%3DCartron%26aufirst%3DG.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DFegan%26aufirst%3DC.%26aulast%3DSalles%26aufirst%3DG.%26atitle%3DA%2520phase%25201%2520clinical%2520trial%2520of%2520the%2520selective%2520BTK%2520inhibitor%2520ONO%252FGS-4059%2520in%2520relapsed%2520and%2520refractory%2520mature%2520B-cell%2520malignancies%26jtitle%3DBlood%26date%3D2016%26volume%3D127%26issue%3D4%26spage%3D411%26epage%3D419%26doi%3D10.1182%2Fblood-2015-08-664086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Tam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigg, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbertson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicorleto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimovski, B.</span><span> </span><span class="NLM_article-title">The BTK inhibitor, Bgb-3111, is safe, tolerable, and highly active in patients with relapsed/refractory B-cell malignancies: initial report of a phase 1 first-in-human trial</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">832</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=832&issue=23&author=C.+Tamauthor=A.+P.+Griggauthor=S.+Opatauthor=M.+Kuauthor=M.+Gilbertsonauthor=M.+A.+Andersonauthor=J.+F.+Seymourauthor=D.+S.+Ritchieauthor=C.+Dicorletoauthor=B.+Dimovski&title=The+BTK+inhibitor%2C+Bgb-3111%2C+is+safe%2C+tolerable%2C+and+highly+active+in+patients+with+relapsed%2Frefractory+B-cell+malignancies%3A+initial+report+of+a+phase+1+first-in-human+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DC.%26aulast%3DGrigg%26aufirst%3DA.%2BP.%26aulast%3DOpat%26aufirst%3DS.%26aulast%3DKu%26aufirst%3DM.%26aulast%3DGilbertson%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DM.%2BA.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DRitchie%26aufirst%3DD.%2BS.%26aulast%3DDicorleto%26aufirst%3DC.%26aulast%3DDimovski%26aufirst%3DB.%26atitle%3DThe%2520BTK%2520inhibitor%252C%2520Bgb-3111%252C%2520is%2520safe%252C%2520tolerable%252C%2520and%2520highly%2520active%2520in%2520patients%2520with%2520relapsed%252Frefractory%2520B-cell%2520malignancies%253A%2520initial%2520report%2520of%2520a%2520phase%25201%2520first-in-human%2520trial%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26issue%3D23%26spage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachlewitz, R. F.</span><span> </span><span class="NLM_article-title">Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.09.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.bmcl.2005.09.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=118-122&issue=1&author=A.+Burchatauthor=D.+W.+Borhaniauthor=D.+J.+Calderwoodauthor=G.+C.+Hirstauthor=B.+Liauthor=R.+F.+Stachlewitz&title=Discovery+of+A-770041%2C+a+src-family+selective+orally+active+lck+inhibitor+that+prevents+organ+allograft+rejection&doi=10.1016%2Fj.bmcl.2005.09.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.09.039%26sid%3Dliteratum%253Aachs%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DStachlewitz%26aufirst%3DR.%2BF.%26atitle%3DDiscovery%2520of%2520A-770041%252C%2520a%2520src-family%2520selective%2520orally%2520active%2520lck%2520inhibitor%2520that%2520prevents%2520organ%2520allograft%2520rejection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D1%26spage%3D118%26epage%3D122%26doi%3D10.1016%2Fj.bmcl.2005.09.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">Evaluation and application of MD-PB/SA in structure-based hierarchical virtual screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1996</span><span class="refDoi"> DOI: 10.1021/ci5003203</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci5003203" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKnsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=1987-1996&issue=7&author=R.+Caoauthor=N.+Huangauthor=Y.+Wang&title=Evaluation+and+application+of+MD-PB%2FSA+in+structure-based+hierarchical+virtual+screening&doi=10.1021%2Fci5003203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and Application of MD-PB/SA in Structure-Based Hierarchical Virtual Screening</span></div><div class="casAuthors">Cao, Ran; Huang, Niu; Wang, Yanli</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1987-1996</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. dynamics (MD) based mol. mechanics Poisson-Boltzmann and surface area (MM-PB/SA) calcn. (MD-PB/SA) has been widely used to est. binding free energies for receptor-ligand complexes.  While numerous reports have focused on assessing accuracy and efficiency, fewer studies have paid attention to performance in lead discovery.  In the present study, we report a crit. evaluation of MD-PB/SA in hierarchical virtual screening (HVS) both theor. and practically.  It is shown that based on native poses, MD-PB/SA could be well applied to predict the relative binding energy for both congeneric and diverse ligands for different protein targets.  However, there is a limitation for MD-PB/SA to distinguish the native pose of one ligand from the artificial pose of another when a huge difference exists between two mols.  By combining a physics-based scoring function with a knowledge-based structural filter, we improve the predictability and validate the practical use of MD-PB/SA in lead discovery by identifying novel inhibitors of p38 MAP kinase.  We also expand our study to other protein targets such as HIV-1 RT and NA to assess the general validity of MD-PB/SA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkOfWO0vnXUbVg90H21EOLACvtfcHk0li00adwQBnzVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKnsbzJ&md5=323706ee0576c4ba0e04b95ba5c353af</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fci5003203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci5003203%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DEvaluation%2520and%2520application%2520of%2520MD-PB%252FSA%2520in%2520structure-based%2520hierarchical%2520virtual%2520screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26issue%3D7%26spage%3D1987%26epage%3D1996%26doi%3D10.1021%2Fci5003203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">The maximal affinity of ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">9997</span><span class="NLM_x">–</span> <span class="NLM_lpage">10002</span><span class="refDoi"> DOI: 10.1073/pnas.96.18.9997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1073%2Fpnas.96.18.9997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10468550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=9997-10002&issue=18&author=I.+D.+Kuntzauthor=K.+Chenauthor=K.+A.+Sharpauthor=P.+A.+Kollman&title=The+maximal+affinity+of+ligands&doi=10.1073%2Fpnas.96.18.9997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The maximal affinity of ligands</span></div><div class="casAuthors">Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9997-10002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We explore the question of what are the best ligands for macromol. targets.  A survey of exptl. data on a large no. of the strongest-binding ligands indicates that the free energy of binding increases with the no. of nonhydrogen atoms with an initial slope of ≈-1.5 kcal/mol (1 cal = 4.18 J) per atom.  For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative mol. mass.  This nonlinearity is largely ascribed to nonthermodynamic factors.  An anal. of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands.  Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L6KZhR0TxbVg90H21EOLACvtfcHk0li7MlzZi29Ung"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D&md5=46fe894b016f3041831a2f0b71f812b1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.9997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.9997%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520maximal%2520affinity%2520of%2520ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26issue%3D18%26spage%3D9997%26epage%3D10002%26doi%3D10.1073%2Fpnas.96.18.9997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&issue=10&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eaqtZxizBDDJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26issue%3D10%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Karcher, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Successful structure-based design of recent p38 MAP kinase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.2174/156802609789007363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.2174%2F156802609789007363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=19689372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=655-676&issue=7&author=S.+C.+Karcherauthor=S.+A.+Laufer&title=Successful+structure-based+design+of+recent+p38+MAP+kinase+inhibitors&doi=10.2174%2F156802609789007363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Successful structure-based design of recent p38 MAP kinase inhibitors</span></div><div class="casAuthors">Karcher, Solveigh C.; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">655-676</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Inflammation is a complex immune response to cellular and tissue damage caused by phys., chem., immunol., or microbial stimuli.  Prior to the successful launch of the anti-cytokine biologist, therapeutic approaches for the treatment of chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease were assocd. with severe side effects.  Although biol. agents have revolutionized the treatment of inflammatory disorders, the high costs and inconvenient dosing regimens would greatly benefit from novel safe and effective orally active inhibitors of tumor necrosis factor (TNF) α and interleukin (IL) 1β.  The clin. benefit of anti-cytokine therapy and the central role of the p38 mitogen-activated protein (MAP) kinase in up-regulation of proinflammatory cytokines such as IL-1β and TNF-α suggest that p38 MAP kinase is a promising target for antiinflammatory therapy.  Since 1993 an immense no. of inhibitors of p38 MAP kinase have been characterized.  To date, aside from the well known pyridinylimidazoles, multiple novel scaffolds have been identified, but only a small no. have advanced into clin. phase II studies, probably due to high toxicity and poor selectivity.  To gain safe drug profiles, high potency, marginal CYP450 (cytochrome P 450) interaction and toxicity, as well as high levels of selectivity would be desirable.  This review will summarize current knowledge on p38 MAP kinase inhibitors and will critically discuss proceedings and strategies toward achieving selectivity and potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1YpMV6vHn37Vg90H21EOLACvtfcHk0li7MlzZi29Ung"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjK&md5=597b42a2f0a0cb61db7aa0146450796b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F156802609789007363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789007363%26sid%3Dliteratum%253Aachs%26aulast%3DKarcher%26aufirst%3DS.%2BC.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DSuccessful%2520structure-based%2520design%2520of%2520recent%2520p38%2520MAP%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26issue%3D7%26spage%3D655%26epage%3D676%26doi%3D10.2174%2F156802609789007363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellecchia, M.</span><span> </span><span class="NLM_article-title">A fragment-based approach for the discovery of isoform-specific p38alpha inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.1021/cb700025j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb700025j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=329-336&issue=5&author=J.+Chenauthor=Z.+Zhangauthor=J.+L.+Stebbinsauthor=X.+Zhangauthor=R.+Hoffmanauthor=A.+Mooreauthor=M.+Pellecchia&title=A+fragment-based+approach+for+the+discovery+of+isoform-specific+p38alpha+inhibitors&doi=10.1021%2Fcb700025j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcb700025j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb700025j%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DStebbins%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHoffman%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DA%2520fragment-based%2520approach%2520for%2520the%2520discovery%2520of%2520isoform-specific%2520p38alpha%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2007%26volume%3D2%26issue%3D5%26spage%3D329%26epage%3D336%26doi%3D10.1021%2Fcb700025j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ostrem, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x"> (</span><span class="NLM_issue">7477</span><span class="NLM_x">) </span> <span class="NLM_fpage">548</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span><span class="refDoi"> DOI: 10.1038/nature12796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnature12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=24256730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=548-551&issue=7477&author=J.+M.+Ostremauthor=U.+Petersauthor=M.+L.+Sosauthor=J.+A.+Wellsauthor=K.+M.+Shokat&title=K-Ras%28G12C%29+inhibitors+allosterically+control+GTP+affinity+and+effector+interactions&doi=10.1038%2Fnature12796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span></div><div class="casAuthors">Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Wells, James A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7477</span>),
    <span class="NLM_cas:pages">548-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally assocd. with poor response to std. therapies.  Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP and the absence of known allosteric regulatory sites.  Oncogenic mutations result in functional activation of Ras family proteins by impairing GTP hydrolysis.  With diminished regulation by GTPase activity, the nucleotide state of Ras becomes more dependent on relative nucleotide affinity and concn.  This gives GTP an advantage over GDP and increases the proportion of active GTP-bound Ras.  Here we report the development of small mols. that irreversibly bind to a common oncogenic mutant, K-Ras(G12C).  These compds. rely on the mutant cysteine for binding and therefore do not affect the wild-type protein.  Crystallog. studies reveal the formation of a new pocket that is not apparent in previous structures of Ras, beneath the effector binding switch-II region.  Binding of these inhibitors to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favor GDP over GTP and impairing binding to Raf.  Our data provide structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkgcVXuBn_rVg90H21EOLACvtfcHk0lird2c-wKXSjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO&md5=27c1e7d8ef6b7e4b2919e9f00a073923</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12796%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DK-Ras%2528G12C%2529%2520inhibitors%2520allosterically%2520control%2520GTP%2520affinity%2520and%2520effector%2520interactions%26jtitle%3DNature%26date%3D2013%26volume%3D503%26issue%3D7477%26spage%3D548%26epage%3D551%26doi%3D10.1038%2Fnature12796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Huang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyanaraman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span> </span><span class="NLM_article-title">Physics-based scoring of protein-ligand complexes: enrichment of known inhibitors in large-scale virtual screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1021/ci0502855</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci0502855" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2ku77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=243-253&issue=1&author=N.+Huangauthor=C.+Kalyanaramanauthor=J.+J.+Irwinauthor=M.+P.+Jacobson&title=Physics-based+scoring+of+protein-ligand+complexes%3A+enrichment+of+known+inhibitors+in+large-scale+virtual+screening&doi=10.1021%2Fci0502855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Physics-Based Scoring of Protein-Ligand Complexes: Enrichment of Known Inhibitors in Large-Scale Virtual Screening</span></div><div class="casAuthors">Huang, Niu; Kalyanaraman, Chakrapani; Irwin, John J.; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">243-253</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors demonstrate that using an all-atom mol. mechanics force field combined with an implicit solvent model for scoring protein-ligand complexes is a promising approach for improving inhibitor enrichment in the virtual screening of large compd. databases.  The rescoring method is evaluated by the extent to which known binders for nine diverse, therapeutically relevant enzymes are enriched against a background of ∼100 000 drug-like decoys.  The improvement in enrichment is most robust and dramatic within the top 1% of the ranked database, i.e., the first thousand compds.; below the first few percent of the ranked database, there is little overall improvement.  The improved early enrichment is likely due to the more realistic treatment of ligand and receptor desolvation in the rescoring procedure.  We also present anecdotal but encouraging results assessing the ability of the rescoring method to predict specificity of inhibitors for structurally related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUqkz9N6IErLVg90H21EOLACvtfcHk0lird2c-wKXSjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2ku77N&md5=cf636695aca21a87e050e0f39286ea1d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fci0502855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci0502855%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DPhysics-based%2520scoring%2520of%2520protein-ligand%2520complexes%253A%2520enrichment%2520of%2520known%2520inhibitors%2520in%2520large-scale%2520virtual%2520screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2006%26volume%3D46%26issue%3D1%26spage%3D243%26epage%3D253%26doi%3D10.1021%2Fci0502855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Huang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyanaraman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernacki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span> </span><span class="NLM_article-title">Molecular mechanics methods for predicting protein-ligand binding</span> <span class="citation_source-journal">Phys. Chem. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">44</span><span class="NLM_x">) </span> <span class="NLM_fpage">5166</span><span class="NLM_x">–</span> <span class="NLM_lpage">5177</span><span class="refDoi"> DOI: 10.1039/B608269F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1039%2FB608269F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=17203140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFyit7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=5166-5177&issue=44&author=N.+Huangauthor=C.+Kalyanaramanauthor=K.+Bernackiauthor=M.+P.+Jacobson&title=Molecular+mechanics+methods+for+predicting+protein-ligand+binding&doi=10.1039%2FB608269F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanics methods for predicting protein-ligand binding</span></div><div class="casAuthors">Huang, Niu; Kalyanaraman, Chakrapani; Bernacki, Katarzyna; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">5166-5177</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review with some new data.  Ligand binding affinity prediction is one of the most important applications of computational chem.  However, accurately ranking compds. with respect to their estd. binding affinities to a biomol. target remains highly challenging.  The authors provide an overview of recent work using mol. mechanics energy functions to address this challenge.  The authors briefly review methods that use mol. dynamics and Monte Carlo simulations to predict abs. and relative ligand binding free energies, as well as the authors' own work in which they have developed a physics-based scoring method that can be applied to hundreds of thousands of compds. by invoking a no. of simplifying approxns.  In the authors' previous studies, they have demonstrated that their scoring method is a promising approach for improving the discrimination between ligands that are known to bind and those that are presumed not to, in virtual screening of large compd. databases.  In new results presented here, the authors explore several improvements to their computational method including modifying the dielec. const. used for the protein and ligand interiors, and empirically scaling energy terms to compensate for deficiencies in the energy model.  Future directions for further improving the authors' physics-based scoring method are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrog6pXfJmCo7Vg90H21EOLACvtfcHk0ljFFu5ZN0yj0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFyit7nP&md5=427d48383280229c26a55a8c31c4cc5e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2FB608269F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB608269F%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DBernacki%26aufirst%3DK.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DMolecular%2520mechanics%2520methods%2520for%2520predicting%2520protein-ligand%2520binding%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2006%26volume%3D8%26issue%3D44%26spage%3D5166%26epage%3D5177%26doi%3D10.1039%2FB608269F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, N.</span><span> </span><span class="NLM_article-title">Discovery of 2-acylaminothiophene-3-carboxamides as multitarget inhibitors for BCR-ABL kinase and microtubules</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2435</span><span class="NLM_x">–</span> <span class="NLM_lpage">2442</span><span class="refDoi"> DOI: 10.1021/acs.jcim.5b00540</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00540" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslSrtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=2435-2442&issue=11&author=R.+Caoauthor=Y.+Wangauthor=N.+Huang&title=Discovery+of+2-acylaminothiophene-3-carboxamides+as+multitarget+inhibitors+for+BCR-ABL+kinase+and+microtubules&doi=10.1021%2Facs.jcim.5b00540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-Acylaminothiophene-3-Carboxamides as Multitarget Inhibitors for BCR-ABL Kinase and Microtubules</span></div><div class="casAuthors">Cao, Ran; Wang, Yanli; Huang, Niu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2435-2442</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of drug resistance of the BCR-ABL kinase inhibitor imatinib, esp. toward the T315I gatekeeper mutation, poses a great challenge to targeted therapy in treating chronic myeloid leukemia (CML) patients.  To discover novel inhibitors against drug-resistant CML bearing T315I mutation, we applied a physics-based hierarchical virtual screening approach to dock a large chem. library against ATP binding pockets of both wild-type (WT) and T315I mutant ABL kinases in a combinatorial fashion.  This strategy automatically resulted in 87 compds. satisfying structural and energetic criteria of both WT and T315I mutant kinases.  Among them, nine compds., which share a common thiophene-based scaffold and adopt similar binding poses, were chosen for exptl. testing and one of them was shown to have low micromolar inhibition activities against both WT and mutant ABL kinases.  Structure-activity relationship anal. with a series of structural modifications based on 2-acylaminothiophene-3-carboxamide scaffold supports our predicted binding mode.  Interestingly, the same chem. scaffold was also enriched in our previous virtual screening campaign against colchicine site of microtubules using the same computational protocol, which suggests our virtual screening strategy is capable of discovering small-mol. ligands targeting distinct protein binding sites without sharing any sequential and structural similarity.  Furthermore, the multitarget inhibition activity of this class of compds. was assessed in cellular expts.  We expect that the 2-acylaminothiophene-3-carboxamide scaffold may serve as a promising starting point for developing multitarget inhibitors in cancer treatment by targeting both kinases and microtubules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpld0oaDA-WjrVg90H21EOLACvtfcHk0ljFFu5ZN0yj0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslSrtb7M&md5=3678e2f00328d7a6c5b351f24dadc458</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00540%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25202-acylaminothiophene-3-carboxamides%2520as%2520multitarget%2520inhibitors%2520for%2520BCR-ABL%2520kinase%2520and%2520microtubules%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26issue%3D11%26spage%3D2435%26epage%3D2442%26doi%3D10.1021%2Facs.jcim.5b00540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, N.</span><span> </span><span class="NLM_article-title">Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2730</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/ci300302c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci300302c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKltrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2730-2740&issue=10&author=R.+Caoauthor=M.+Liuauthor=M.+Yinauthor=Q.+Liuauthor=Y.+Wangauthor=N.+Huang&title=Discovery+of+novel+tubulin+inhibitors+via+structure-based+hierarchical+virtual+screening&doi=10.1021%2Fci300302c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Tubulin Inhibitors via Structure-Based Hierarchical Virtual Screening</span></div><div class="casAuthors">Cao, Ran; Liu, Minyu; Yin, Min; Liu, Quanhai; Wang, Yanli; Huang, Niu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2730-2740</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To discover novel tubulin inhibitors, we performed structure-based virtual screening against the colchicine binding pocket.  In combination with a hierarchical docking and scoring procedure, the structural information of an addnl. subpocket in colchicine site was applied to filter out the undesired docking hits.  This strategy automatically resulted in 63 candidates meeting the structural and energetic criteria from a screening library contg. approx. 100 000 diverse druglike compds.  Among them, nine mols. were chosen for exptl. validation, which all share the similar binding pose and contain an enriched scaffold bearing thiophene core.  Encouragingly, five compds. are active in tubulin polymn. assay.  The most potent inhibitor, 2-(2-fluorobenzamido)-3-carboxamide-4,5-dimethylthiophene, is structurally distinct to any known colchicine site binders and has higher ligand efficiency than colchicine.  On the basis of its predicted binding pose, we systematically probed its binding characteristics by testing series of structural modifications.  The obtained structure-activity relationship results are consistent with our binding model, and the inhibition activities of two analogs are improved by 2-fold.  We expect that the novel structure discovered in the present study may serve as a starting point for developing tubulin inhibitors with improved efficacy and fewer side effects.  We also expect that our hierarchical strategy may be generally applicable in structure-based virtual screening campaigns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeoH-2Mo3J0LVg90H21EOLACvtfcHk0ljFFu5ZN0yj0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKltrzJ&md5=ddc129d0a8e5baa601f3e0076a184bbf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fci300302c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300302c%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520novel%2520tubulin%2520inhibitors%2520via%2520structure-based%2520hierarchical%2520virtual%2520screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26issue%3D10%26spage%3D2730%26epage%3D2740%26doi%3D10.1021%2Fci300302c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Aldrich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merz, K. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepartz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">The ecstasy and agony of assay interference compounds</span> <span class="citation_source-journal">ACS Cent. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span><span class="refDoi"> DOI: 10.1021/acscentsci.7b00069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.7b00069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=143-147&issue=3&author=C.+Aldrichauthor=C.+Bertozziauthor=G.+I.+Georgauthor=L.+Kiesslingauthor=C.+Lindsleyauthor=D.+Liottaauthor=K.+M.+Merzauthor=A.+Schepartzauthor=S.+Wang&title=The+ecstasy+and+agony+of+assay+interference+compounds&doi=10.1021%2Facscentsci.7b00069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The Ecstasy and Agony of Assay Interference Compounds</span></div><div class="casAuthors">Aldrich, Courtney; Bertozzi, Carolyn; Georg, Gunda I.; Kiessling, Laura; Lindsley, Craig; Liotta, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">143-147</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu6WoIK7zSJ7Vg90H21EOLACvtfcHk0linFSUh6XJVlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsL0%253D&md5=faf234b3422df9d9bd0d5ace6db46bfc</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.7b00069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.7b00069%26sid%3Dliteratum%253Aachs%26aulast%3DAldrich%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DC.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DKiessling%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DSchepartz%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DThe%2520ecstasy%2520and%2520agony%2520of%2520assay%2520interference%2520compounds%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2017%26volume%3D3%26issue%3D3%26spage%3D143%26epage%3D147%26doi%3D10.1021%2Facscentsci.7b00069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Martz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baur, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schattel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goettert, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer-Wrangowski, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Targeting the hinge glycine flip and the activation loop: novel approach to potent p38alpha inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">7862</span><span class="NLM_x">–</span> <span class="NLM_lpage">7874</span><span class="refDoi"> DOI: 10.1021/jm300951u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300951u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7862-7874&issue=17&author=K.+E.+Martzauthor=A.+Dornauthor=B.+Baurauthor=V.+Schattelauthor=M.+I.+Goettertauthor=S.+C.+Mayer-Wrangowskiauthor=D.+Rauhauthor=S.+A.+Laufer&title=Targeting+the+hinge+glycine+flip+and+the+activation+loop%3A+novel+approach+to+potent+p38alpha+inhibitors&doi=10.1021%2Fjm300951u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm300951u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300951u%26sid%3Dliteratum%253Aachs%26aulast%3DMartz%26aufirst%3DK.%2BE.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DBaur%26aufirst%3DB.%26aulast%3DSchattel%26aufirst%3DV.%26aulast%3DGoettert%26aufirst%3DM.%2BI.%26aulast%3DMayer-Wrangowski%26aufirst%3DS.%2BC.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DTargeting%2520the%2520hinge%2520glycine%2520flip%2520and%2520the%2520activation%2520loop%253A%2520novel%2520approach%2520to%2520potent%2520p38alpha%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D17%26spage%3D7862%26epage%3D7874%26doi%3D10.1021%2Fjm300951u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Huang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span> </span><span class="NLM_article-title">Physics-based methods for studying protein-ligand interactions</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=17554859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVWls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=325-331&issue=3&author=N.+Huangauthor=M.+P.+Jacobson&title=Physics-based+methods+for+studying+protein-ligand+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Physics-based methods for studying protein-ligand interactions</span></div><div class="casAuthors">Huang, Niu; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-331</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The accurate prediction of relative or abs. ligand-binding affinities is challenging in both theor. and practical aspects.  However, with the aid of advanced computing power and sophisticated methodol. development, physics-based free-energy calcns., which can be used to predict ligand-binding affinities, have become increasingly utilized in the field of structure-based drug design.  This review summarizes recent progress made in developing and applying physics-based methods to studying protein-ligand interactions, focusing on methods using mol. mechanics force fields.  Applications of these methods include predicting ligand binding poses, enriching binders in virtual screening, and calcg. relative and abs. binding free energies.  Future directions for further improving current physics-based methods are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH-FuHDbblC7Vg90H21EOLACvtfcHk0linFSUh6XJVlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVWls7o%253D&md5=3aaf948edd0254cc81a44645cbe05a6b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DPhysics-based%2520methods%2520for%2520studying%2520protein-ligand%2520interactions%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26issue%3D3%26spage%3D325%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Bukhtiyarova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northrop, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpusas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springman, E.</span><span> </span><span class="NLM_article-title">Improved expression, purification, and crystallization of p38alpha MAP kinase</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span><span class="refDoi"> DOI: 10.1016/j.pep.2004.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.pep.2004.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=15294293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Clsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2004&pages=154-161&issue=1&author=M.+Bukhtiyarovaauthor=K.+Northropauthor=X.+Chaiauthor=D.+Casperauthor=M.+Karpusasauthor=E.+Springman&title=Improved+expression%2C+purification%2C+and+crystallization+of+p38alpha+MAP+kinase&doi=10.1016%2Fj.pep.2004.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Improved expression, purification, and crystallization of p38α MAP kinase</span></div><div class="casAuthors">Bukhtiyarova, Marina; Northrop, Katrina; Chai, Xiaomei; Casper, David; Karpusas, Michael; Springman, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154-161</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">P38α mitogen-activated protein (MAP) kinase is widely expressed in many mammalian tissues and is activated as a part of signal transduction cascades that respond to inflammatory stimuli.  The activation of p38 is known to trigger various biol. effects, including cell death, differentiation, and proliferation.  The central role played by p38α in cellular signaling events, including those that control a wide range of inflammatory and autoimmune diseases, makes it an attractive drug target.  To develop optimized small mol. therapeutics targeting p38α, different techniques must be employed for the detailed biochem., biophys., and structural characterization of the interactions of p38α with lead compds.  These methods typically require large quantities of highly purified p38α protein.  We describe here an improved expression and purifn. method for recombinant p38α prodn. that reproducibly yields over 70 mg of highly purified protein per L of shake flask bacterial culture.  This yield is significantly higher than that previously reported for p38α prodn. in Escherichia coli.  We achieved a significant increase in sol. p38α protein expression by using the genetically modified E. coli strain BL21 DE3 Rosetta, which is optimized for expression of eukaryotic proteins with codons rarely used in E. coli.  The p38α protein was purified to near homogeneity using a simple two-step procedure including nickel-chelating Sepharose chromatog. followed by anion-exchange chromatog. using MonoQ resin.  Purified p38α was characterized using the std. com. available small mol. inhibitor SB-203580.  The binding assocn. and dissocn. rate consts. detd. by Biacore are in excellent agreement with previously reported values.  The purified p38α protein was efficiently activated by MKK6 kinase to yield phosphorylated p38α.  Purified p38α protein was also successfully crystd., producing crystals diffracting to 1.9 A, exceeding the highest resoln. for p38α reported in the Protein DataBank.  The simplicity and efficiency of this approach should prove useful for many labs. that are interested in prodn. of p38α for biochem. and biophys. studies and structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohVxPQ6n4uUrVg90H21EOLACvtfcHk0linFSUh6XJVlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Clsrs%253D&md5=c754c7e367e0502c024622989154879b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2004.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2004.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DBukhtiyarova%26aufirst%3DM.%26aulast%3DNorthrop%26aufirst%3DK.%26aulast%3DChai%26aufirst%3DX.%26aulast%3DCasper%26aufirst%3DD.%26aulast%3DKarpusas%26aufirst%3DM.%26aulast%3DSpringman%26aufirst%3DE.%26atitle%3DImproved%2520expression%252C%2520purification%252C%2520and%2520crystallization%2520of%2520p38alpha%2520MAP%2520kinase%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2004%26volume%3D37%26issue%3D1%26spage%3D154%26epage%3D161%26doi%3D10.1016%2Fj.pep.2004.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saluste, C. G.</span><span> </span><span class="NLM_article-title">Structure-based design of novel 2-amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1637</span><span class="NLM_x">–</span> <span class="NLM_lpage">1648</span><span class="refDoi"> DOI: 10.1021/jm701095m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701095m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1637-1648&issue=6&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=C.+Boucherauthor=L.+Chaiauthor=L.+F.+Epsteinauthor=T.+Faustauthor=S.+Floresauthor=P.+Gallantauthor=A.+Goreauthor=Y.+Guauthor=F.+Hsiehauthor=X.+Huangauthor=J.+L.+Kimauthor=S.+Middletonauthor=K.+Morgensternauthor=A.+Oliveira-dos-Santosauthor=V.+F.+Patelauthor=D.+Powersauthor=P.+Roseauthor=Y.+Tudorauthor=S.+M.+Turciauthor=A.+A.+Welcherauthor=D.+Zackauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhuauthor=C.+Ghironauthor=M.+Ermannauthor=D.+Johnstonauthor=C.+G.+Saluste&title=Structure-based+design+of+novel+2-amino-6-phenyl-pyrimido%5B5%E2%80%B2%2C4%E2%80%B2%3A5%2C6%5Dpyrimido%5B1%2C2-a%5Dbenzimidazol-5%286H%29-ones+as+potent+and+orally+active+inhibitors+of+lymphocyte+specific+kinase+%28Lck%29%3A+synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity&doi=10.1021%2Fjm701095m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm701095m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701095m%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DFlores%26aufirst%3DS.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DTudor%26aufirst%3DY.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DZack%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DJohnston%26aufirst%3DD.%26aulast%3DSaluste%26aufirst%3DC.%2BG.%26atitle%3DStructure-based%2520design%2520of%2520novel%25202-amino-6-phenyl-pyrimido%255B5%25E2%2580%25B2%252C4%25E2%2580%25B2%253A5%252C6%255Dpyrimido%255B1%252C2-a%255Dbenzimidazol-5%25286H%2529-ones%2520as%2520potent%2520and%2520orally%2520active%2520inhibitors%2520of%2520lymphocyte%2520specific%2520kinase%2520%2528Lck%2529%253A%2520synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D6%26spage%3D1637%26epage%3D1648%26doi%3D10.1021%2Fjm701095m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maderna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnute, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashiro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lussier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrocklage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soutter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunussi-Joannopoulos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douhan, J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">6258</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.bmcl.2011.09.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6258-6263&issue=21&author=K.+H.+Kimauthor=A.+Madernaauthor=M.+E.+Schnuteauthor=M.+Hegenauthor=S.+Mohanauthor=J.+Miyashiroauthor=L.+Linauthor=E.+Liauthor=S.+Keeganauthor=J.+Lussierauthor=C.+Wrocklageauthor=C.+L.+Nickerson-Nutterauthor=A.+J.+Wittwerauthor=H.+Soutterauthor=N.+Caspersauthor=S.+Hanauthor=R.+Kurumbailauthor=K.+Dunussi-Joannopoulosauthor=J.+Douhanauthor=A.+Wissner&title=Imidazo%5B1%2C5-a%5Dquinoxalines+as+irreversible+BTK+inhibitors+for+the+treatment+of+rheumatoid+arthritis&doi=10.1016%2Fj.bmcl.2011.09.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DMaderna%26aufirst%3DA.%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DMiyashiro%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DE.%26aulast%3DKeegan%26aufirst%3DS.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DWrocklage%26aufirst%3DC.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DSoutter%26aufirst%3DH.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DDunussi-Joannopoulos%26aufirst%3DK.%26aulast%3DDouhan%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DImidazo%255B1%252C5-a%255Dquinoxalines%2520as%2520irreversible%2520BTK%2520inhibitors%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D21%26spage%3D6258%26epage%3D6263%26doi%3D10.1016%2Fj.bmcl.2011.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhrlage, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Developing irreversible inhibitors of the protein kinase cysteinome</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2012.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2Fj.chembiol.2012.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=23438744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=146-159&issue=2&author=Q.+Liuauthor=Y.+Sabnisauthor=Z.+Zhaoauthor=T.+Zhangauthor=S.+J.+Buhrlageauthor=L.+H.+Jonesauthor=N.+S.+Gray&title=Developing+irreversible+inhibitors+of+the+protein+kinase+cysteinome&doi=10.1016%2Fj.chembiol.2012.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Irreversible Inhibitors of the Protein Kinase Cysteinome</span></div><div class="casAuthors">Liu, Qingsong; Sabnis, Yogesh; Zhao, Zheng; Zhang, Tinghu; Buhrlage, Sara J.; Jones, Lyn H.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-159</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a large family of approx. 530 highly conserved enzymes that transfer a γ-phosphate group from ATP to a variety of amino acid residues, such as tyrosine, serine, and threonine, that serves as a ubiquitous mechanism for cellular signal transduction.  The clin. success of a no. of kinase-directed drugs and the frequent observation of disease causing mutations in protein kinases suggest that a large no. of kinases may represent therapeutically relevant targets.  To date, the majority of clin. and preclin. kinase inhibitors are ATP competitive, noncovalent inhibitors that achieve selectivity through recognition of unique features of particular protein kinases.  Recently, there has been renewed interest in the development of irreversible inhibitors that form covalent bonds with cysteine or other nucleophilic residues in the ATP-binding pocket.  Irreversible kinase inhibitors have a no. of potential advantages including prolonged pharmacodynamics, suitability for rational design, high potency, and ability to validate pharmacol. specificity through mutation of the reactive cysteine residue.  Here, we review recent efforts to develop cysteine-targeted irreversible protein kinase inhibitors and discuss their modes of recognizing the ATP-binding pocket and their biol. activity profiles.  In addn., we provided an informatics assessment of the potential "kinase cysteinome" and discuss strategies for the efficient development of new covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVGD7TX3oIeLVg90H21EOLACvtfcHk0lizV70UpLQvDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D&md5=cef80823123bae88362e816a0a638133</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSabnis%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDeveloping%2520irreversible%2520inhibitors%2520of%2520the%2520protein%2520kinase%2520cysteinome%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26issue%3D2%26spage%3D146%26epage%3D159%26doi%3D10.1016%2Fj.chembiol.2012.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devereux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaves, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierda, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awan, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillmen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrientos, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaptein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannutti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGreivy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamdy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothbaum, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diacovo, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, R. R.</span><span> </span><span class="NLM_article-title">Acalabrutinib (ACP-196) in relapsed chronic lymphocytic Leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1056/NEJMoa1509981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1056%2FNEJMoa1509981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=26641137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOlur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2016&pages=323-332&issue=4&author=J.+C.+Byrdauthor=B.+Harringtonauthor=S.+O%E2%80%99Brienauthor=J.+A.+Jonesauthor=A.+Schuhauthor=S.+Devereuxauthor=J.+Chavesauthor=W.+G.+Wierdaauthor=F.+T.+Awanauthor=J.+R.+Brownauthor=P.+Hillmenauthor=D.+M.+Stephensauthor=P.+Ghiaauthor=J.+C.+Barrientosauthor=J.+M.+Pagelauthor=J.+Woyachauthor=D.+Johnsonauthor=J.+Huangauthor=X.+Wangauthor=A.+Kapteinauthor=B.+J.+Lannuttiauthor=T.+Coveyauthor=M.+Fardisauthor=J.+McGreivyauthor=A.+Hamdyauthor=W.+Rothbaumauthor=R.+Izumiauthor=T.+G.+Diacovoauthor=A.+J.+Johnsonauthor=R.+R.+Furman&title=Acalabrutinib+%28ACP-196%29+in+relapsed+chronic+lymphocytic+Leukemia&doi=10.1056%2FNEJMoa1509981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia</span></div><div class="casAuthors">Byrd, John C.; Harrington, Bonnie; O'Brien, Susan; Jones, Jeffrey A.; Schuh, Anna; Devereux, Steve; Chaves, Jorge; Wierda, William G.; Awan, Farrukh T.; Brown, Jennifer R.; Hillmen, Peter; Stephens, Deborah M.; Ghia, Paolo; Barrientos, Jacqueline C.; Pagel, John M.; Woyach, Jennifer; Johnson, Dave; Huang, Jane; Wang, Xiaolin; Kaptein, Allard; Lannutti, Brian J.; Covey, Todd; Fardis, Maria; McGreivy, Jesse; Hamdy, Ahmed; Rothbaum, Wayne; Izumi, Raquel; Diacovo, Thomas G.; Johnson, Amy J.; Furman, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-332</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Irreversible inhibition of Bruton's tyrosine kinase (BTK) by ibrutinib represents an important therapeutic advance for the treatment of chronic lymphocytic leukemia (CLL).  However, ibrutinib also irreversibly inhibits alternative kinase targets, which potentially compromises its therapeutic index.  Acalabrutinib (ACP-196) is a more selective, irreversible BTK inhibitor that is specifically designed to improve on the safety and efficacy of first-generation BTK inhibitors.  In this uncontrolled, phase 1-2, multicenter study, we administered oral acalabrutinib to 61 patients who had relapsed CLL to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of acalabrutinib.  Patients were treated with acalabrutinib at a dose of 100 to 400 mg once daily in the dose-escalation (phase 1) portion of the study and 100 mg twice daily in the expansion (phase 2) portion.  The median age of the patients was 62 years, and patients had received a median of three previous therapies for CLL; 31% had chromosome 17p13.1 deletion, and 75% had unmutated Ig heavy-chain variable genes.  No dose-limiting toxic effects occurred during the dose-escalation portion of the study.  The most common adverse events obsd. were headache (in 43% of the patients), diarrhea (in 39%), and in- creased wt. (in 26%).  Most adverse events were of grade 1 or 2.  At a median follow- up of 14.3 mo, the overall response rate was 95%, including 85% with a partial response and 10% with a partial response with lymphocytosis; the remaining 5% of patients had stable disease.  Among patients with chromosome 17p13.1 deletion, the overall response rate was 100%.  No cases of Richter's transformation (CLL that has evolved into large-cell lymphoma) and only one case of CLL progression have occurred.  In this study, the selective BTK inhibitor acalabrutinib had promising safety and efficacy profiles in patients with relapsed CLL, including those with chromosome 17p13.1 deletion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGHCPciF9hPrVg90H21EOLACvtfcHk0liIF760y1aUPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOlur%252FI&md5=d20e0158f9ea308b9d06fa668154516e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1509981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1509981%26sid%3Dliteratum%253Aachs%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DHarrington%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DJ.%2BA.%26aulast%3DSchuh%26aufirst%3DA.%26aulast%3DDevereux%26aufirst%3DS.%26aulast%3DChaves%26aufirst%3DJ.%26aulast%3DWierda%26aufirst%3DW.%2BG.%26aulast%3DAwan%26aufirst%3DF.%2BT.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DHillmen%26aufirst%3DP.%26aulast%3DStephens%26aufirst%3DD.%2BM.%26aulast%3DGhia%26aufirst%3DP.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DWoyach%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKaptein%26aufirst%3DA.%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26aulast%3DCovey%26aufirst%3DT.%26aulast%3DFardis%26aufirst%3DM.%26aulast%3DMcGreivy%26aufirst%3DJ.%26aulast%3DHamdy%26aufirst%3DA.%26aulast%3DRothbaum%26aufirst%3DW.%26aulast%3DIzumi%26aufirst%3DR.%26aulast%3DDiacovo%26aufirst%3DT.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DFurman%26aufirst%3DR.%2BR.%26atitle%3DAcalabrutinib%2520%2528ACP-196%2529%2520in%2520relapsed%2520chronic%2520lymphocytic%2520Leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2016%26volume%3D374%26issue%3D4%26spage%3D323%26epage%3D332%26doi%3D10.1056%2FNEJMoa1509981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Wilson, W. H.</span><span> </span><span class="NLM_article-title">Progress in chronic lymphocytic leukemia with targeted therapy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1056/NEJMe1515235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1056%2FNEJMe1515235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=26816016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A280%3ADC%252BC28nltVGqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2016&pages=386-388&issue=4&author=W.+H.+Wilson&title=Progress+in+chronic+lymphocytic+leukemia+with+targeted+therapy&doi=10.1056%2FNEJMe1515235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in Chronic Lymphocytic Leukemia with Targeted Therapy</span></div><div class="casAuthors">Wilson Wyndham H</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">386-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPkuFuFUBzrkkUaC_kzhvyfW6udTcc2eZMlq2xbl6yN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nltVGqsg%253D%253D&md5=acec7b19b9ac62546de92789e615d8b5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1515235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1515235%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DW.%2BH.%26atitle%3DProgress%2520in%2520chronic%2520lymphocytic%2520leukemia%2520with%2520targeted%2520therapy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2016%26volume%3D374%26issue%3D4%26spage%3D386%26epage%3D388%26doi%3D10.1056%2FNEJMe1515235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Levade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michallet, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ysebaert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payrastre, B.</span><span> </span><span class="NLM_article-title">Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">3991</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span><span class="refDoi"> DOI: 10.1182/blood-2014-06-583294</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1182%2Fblood-2014-06-583294" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3991-3995&issue=26&author=M.+Levadeauthor=E.+Davidauthor=C.+Garciaauthor=P.+A.+Laurentauthor=S.+Cadotauthor=A.+S.+Michalletauthor=J.+C.+Bordetauthor=C.+Tamauthor=P.+Sieauthor=L.+Ysebaertauthor=B.+Payrastre&title=Ibrutinib+treatment+affects+collagen+and+von+Willebrand+factor-dependent+platelet+functions&doi=10.1182%2Fblood-2014-06-583294"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-06-583294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-06-583294%26sid%3Dliteratum%253Aachs%26aulast%3DLevade%26aufirst%3DM.%26aulast%3DDavid%26aufirst%3DE.%26aulast%3DGarcia%26aufirst%3DC.%26aulast%3DLaurent%26aufirst%3DP.%2BA.%26aulast%3DCadot%26aufirst%3DS.%26aulast%3DMichallet%26aufirst%3DA.%2BS.%26aulast%3DBordet%26aufirst%3DJ.%2BC.%26aulast%3DTam%26aufirst%3DC.%26aulast%3DSie%26aufirst%3DP.%26aulast%3DYsebaert%26aufirst%3DL.%26aulast%3DPayrastre%26aufirst%3DB.%26atitle%3DIbrutinib%2520treatment%2520affects%2520collagen%2520and%2520von%2520Willebrand%2520factor-dependent%2520platelet%2520functions%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26issue%3D26%26spage%3D3991%26epage%3D3995%26doi%3D10.1182%2Fblood-2014-06-583294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, I. D.</span><span> </span><span class="NLM_article-title">Automated docking with grid-based energy evaluation</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span><span class="refDoi"> DOI: 10.1002/jcc.540130412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1002%2Fjcc.540130412" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=505-524&issue=4&author=E.+C.+Mengauthor=B.+K.+Shoichetauthor=I.+D.+Kuntz&title=Automated+docking+with+grid-based+energy+evaluation&doi=10.1002%2Fjcc.540130412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Fjcc.540130412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.540130412%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26atitle%3DAutomated%2520docking%2520with%2520grid-based%2520energy%2520evaluation%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1992%26volume%3D13%26issue%3D4%26spage%3D505%26epage%3D524%26doi%3D10.1002%2Fjcc.540130412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Lorber, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Hierarchical docking of databases of multiple ligand conformations</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.2174/1568026054637683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.2174%2F1568026054637683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=16101414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFGht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=739-749&issue=8&author=D.+M.+Lorberauthor=B.+K.+Shoichet&title=Hierarchical+docking+of+databases+of+multiple+ligand+conformations&doi=10.2174%2F1568026054637683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Hierarchical docking of databases of multiple ligand conformations</span></div><div class="casAuthors">Lorber, David M.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">739-749</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Ligand flexibility is an important problem in mol. docking and virtual screening.  To address this challenge, we investigate a hierarchical pre-organization of multiple conformations of small mols.  Such organization of pre-calcd. conformations removes the exploration of ligand conformational space from the docking calcn. and allows for concise representation of what can be thousands of conformations.  The hierarchy also recognizes and prunes incompatible conformations early in the calcn., eliminating redundant calcns. of fit.  We investigate the method by docking the MDL Drug Data Report (MDDR), an annotated database of 100,000 mols., into apo and holo forms of 7 unrelated targets.  This annotated database allows us to track the ranking of tens to hundreds of annotated ligands in each of the docking systems.  The binding sites and database are prepd. in an automated fashion in an attempt to remove some human bias from the calcns.  Many thousands of explicit and implicit ligand conformations may be docked in calcns. not much longer than required for single conformer docking.  As long as internal energies are not considered, recombination with the hierarchy is additive as the no. of degrees of freedom is increased.  Mols. with even millions of conformations can be docked in a few minutes on a single desktop computer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJZ_iMnNjm9LVg90H21EOLACvtfcHk0ljQAI3rGpUVWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFGht74%253D&md5=25c833b5608e5faedc1af3ad38fdfa06</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.2174%2F1568026054637683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054637683%26sid%3Dliteratum%253Aachs%26aulast%3DLorber%26aufirst%3DD.%2BM.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DHierarchical%2520docking%2520of%2520databases%2520of%2520multiple%2520ligand%2520conformations%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26issue%3D8%26spage%3D739%26epage%3D749%26doi%3D10.2174%2F1568026054637683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Wei, B. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baase, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">A model binding site for testing scoring functions in molecular docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1016/S0022-2836(02)00777-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2FS0022-2836%2802%2900777-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=12217695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1Wqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2002&pages=339-355&issue=2&author=B.+Q.+Weiauthor=W.+A.+Baaseauthor=L.+H.+Weaverauthor=B.+W.+Matthewsauthor=B.+K.+Shoichet&title=A+model+binding+site+for+testing+scoring+functions+in+molecular+docking&doi=10.1016%2FS0022-2836%2802%2900777-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A Model Binding Site for Testing Scoring Functions in Molecular Docking</span></div><div class="casAuthors">Wei, Binqing Q.; Baase, Walter A.; Weaver, Larry H.; Matthews, Brian W.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-355</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Prediction of interaction energies between ligands and their receptors remains a major challenge for structure-based inhibitor discovery.  Much effort has been devoted to developing scoring schemes that can successfully rank the affinities of a diverse set of possible ligands to a binding site for which the structure is known.  To test these scoring functions, well-characterized exptl. systems can be very useful.  Here, mutation-created binding sites in T4 lysozyme were used to investigate how the quality of at. charges and solvation energies affects mol. docking.  At. charges and solvation energies were calcd. for 172,118 mols. in the Available Chems.  Directory using a semi-empirical quantum mech. approach by the program AMSOL.  The database was first screened against the apolar cavity site created by the mutation Leu99Ala (L99A).  Compared to the electronegativity-based charges that are widely used, the new charges and desolvation energies improved ranking of known apolar ligands, and better distinguished them from more polar isosteres that are not obsd. to bind.  To investigate whether the new charges had predictive value, the non-polar residue Met102, which forms part of the binding site, was changed to the polar residue glutamine.  The structure of the resulting Leu99 Ala and Met102 Gln double mutant of T4 lysozyme (L99A/M102Q) was detd. and the docking calcn. was repeated for the new site.  Seven representative polar mols. that preferentially docked to the polar vs. the apolar binding site were tested exptl.  All seven bind to the polar cavity (L99A/M102Q) but do not detectably bind to the apolar cavity (L99A).  Five ligand-bound structures of L99A/M102Q were detd. by X-ray crystallog.  Docking predictions corresponded to the crystallog. results to within 0.4 A RMSD.  Improved treatment of partial at. charges and desolvation energies in database docking appears feasible and leads to better distinction of true ligands.  Simple model binding sites, such as L99A and its more polar variants, may find broad use in the development and testing of docking algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGral4WDhJW6jbVg90H21EOLACvtfcHk0ljQAI3rGpUVWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1Wqsrs%253D&md5=040e009b33f125ab4abbb322cf32d2c9</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2802%2900777-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252802%252900777-5%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DB.%2BQ.%26aulast%3DBaase%26aufirst%3DW.%2BA.%26aulast%3DWeaver%26aufirst%3DL.%2BH.%26aulast%3DMatthews%26aufirst%3DB.%2BW.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DA%2520model%2520binding%2520site%2520for%2520testing%2520scoring%2520functions%2520in%2520molecular%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D322%26issue%3D2%26spage%3D339%26epage%3D355%26doi%3D10.1016%2FS0022-2836%2802%2900777-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapp, C. S.</span><span> </span><span class="NLM_article-title">Force field validation using protein side chain prediction</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x"> (</span><span class="NLM_issue">44</span><span class="NLM_x">) </span> <span class="NLM_fpage">11673</span><span class="NLM_x">–</span> <span class="NLM_lpage">11680</span><span class="refDoi"> DOI: 10.1021/jp021564n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp021564n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2002&pages=11673-11680&issue=44&author=M.+P.+Jacobsonauthor=G.+A.+Kaminskiauthor=R.+A.+Friesnerauthor=C.+S.+Rapp&title=Force+field+validation+using+protein+side+chain+prediction&doi=10.1021%2Fjp021564n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjp021564n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp021564n%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26atitle%3DForce%2520field%2520validation%2520using%2520protein%2520side%2520chain%2520prediction%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2002%26volume%3D106%26issue%3D44%26spage%3D11673%26epage%3D11680%26doi%3D10.1021%2Fjp021564n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pincus, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapp, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">A hierarchical approach to all-atom protein loop prediction</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1002/prot.10613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1002%2Fprot.10613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=15048827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=351-367&issue=2&author=M.+P.+Jacobsonauthor=D.+L.+Pincusauthor=C.+S.+Rappauthor=T.+J.+Dayauthor=B.+Honigauthor=D.+E.+Shawauthor=R.+A.+Friesner&title=A+hierarchical+approach+to+all-atom+protein+loop+prediction&doi=10.1002%2Fprot.10613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A hierarchical approach to all-atom protein loop prediction</span></div><div class="casAuthors">Jacobson, Matthew P.; Pincus, David L.; Rapp, Chaya S.; Day, Tyler J. F.; Honig, Barry; Shaw, David E.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The application of all-atom force fields (and explicit or implicit solvent models) to protein homol.-modeling tasks such as side-chain and loop prediction remains challenging both because of the expense of the individual energy calcns. and because of the difficulty of sampling the rugged all-atom energy surface.  Here the authors address this challenge for the problem of loop prediction through the development of numerous new algorithms, with an emphasis on multiscale and hierarchical techniques.  As a first step in evaluating the performance of the authors' loop prediction algorithm, the authors have applied it to the problem of reconstructing loops in native structures; the authors also explicitly include crystal packing to provide a fair comparison with crystal structures.  In brief, large nos. of loops are generated by using a dihedral angle-based buildup procedure followed by iterative cycles of clustering, side-chain optimization, and complete energy minimization of selected loop structures.  The authors evaluate this method by the largest test set yet used for validation of a loop prediction method, with a total of 833 loops ranging from 4 to 12 residues in length.  Av./median backbone root-mean-square deviations (RMSDs) to the native structures (superimposing the body of the protein, not the loop itself) are 0.42/0.24 Å for 5 residue loops, 1.00/0.44 Å for 8 residue loops, and 2.47/1.83 Å for 11 residue loops.  Median RMSDs are substantially lower than the avs. because of a small no. of outliers; the causes of these failures are examd. in some detail, and many can be attributed to errors in assignment of protonation states of titratable residues, omission of ligands from the simulation, and, in a few cases, probable errors in the exptl. detd. structures.  When these obvious problems in the data sets are filtered out, av. RMSDs to the native structures improve to 0.43 Å for 5 residue loops, 0.84 Å for 8 residue loops, and 1.63 Å for 11 residue loops.  In the vast majority of cases, the method locates energy min. that are lower than or equal to that of the minimized native loop, thus indicating that sampling rarely limits prediction accuracy.  The overall results are, to the authors' knowledge, the best reported to date, and the authors attribute this success to the combination of an accurate all-atom energy function, efficient methods for loop buildup and side-chain optimization, and, esp. for the longer loops, the hierarchical refinement protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqYMnqaWXvLVg90H21EOLACvtfcHk0lhb44AFRw79cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKhsrc%253D&md5=e0eff655eeefb30ea00ae041ea9099c8</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fprot.10613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10613%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DPincus%26aufirst%3DD.%2BL.%26aulast%3DRapp%26aufirst%3DC.%2BS.%26aulast%3DDay%26aufirst%3DT.%2BJ.%26aulast%3DHonig%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DA%2520hierarchical%2520approach%2520to%2520all-atom%2520protein%2520loop%2520prediction%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2004%26volume%3D55%26issue%3D2%26spage%3D351%26epage%3D367%26doi%3D10.1002%2Fprot.10613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">High-resolution prediction of protein helix positions and orientations</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span><span class="refDoi"> DOI: 10.1002/prot.20014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1002%2Fprot.20014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=368-382&issue=2&author=X.+Liauthor=M.+P.+Jacobsonauthor=R.+A.+Friesner&title=High-resolution+prediction+of+protein+helix+positions+and+orientations&doi=10.1002%2Fprot.20014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fprot.20014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20014%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DHigh-resolution%2520prediction%2520of%2520protein%2520helix%2520positions%2520and%2520orientations%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2004%26volume%3D55%26issue%3D2%26spage%3D368%26epage%3D382%26doi%3D10.1002%2Fprot.20014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Case, D. A.; Darden, T. A.; Cheatham, I. T. E.; Simmerling, C. L.; Wang, J.; Duke, R. E.; Luo, R.; Crowley, M.; Walker, R. C.; Zhang, W.; Merz, K. M.; Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Kolossváry, I.; Wong, K. F.; Paesani, F.; Vanicek, J.; Wu, X.; Brozell, S. R.; Steinbrecher, T.; Gohlke, H.</span> <span class="citation_source-book">AMBER 10</span>; <span class="NLM_publisher-name">University of California</span>, <span class="NLM_publisher-loc">San Francisco</span>.<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+A.+Case&author=T.+A.+Darden&author=I.+T.+E.+Cheatham&author=C.+L.+Simmerling&author=J.+Wang&author=R.+E.+Duke&author=R.+Luo&author=M.+Crowley&author=R.+C.+Walker&author=W.+Zhang&author=K.+M.+Merz&author=B.+Wang&author=S.+Hayik&author=A.+Roitberg&author=G.+Seabra&author=I.+Kolossv%C3%A1ry&author=K.+F.+Wong&author=F.+Paesani&author=J.+Vanicek&author=X.+Wu&author=S.+R.+Brozell&author=T.+Steinbrecher&author=H.+Gohlke&title=AMBER+10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26btitle%3DAMBER%252010%26pub%3DUniversity%2520of%2520California%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieplak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span><span class="refDoi"> DOI: 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1049-1074&issue=12&author=J.+Wangauthor=P.+Cieplakauthor=P.+A.+Kollman&title=How+well+does+a+restrained+electrostatic+potential+%28RESP%29+model+perform+in+calculating+conformational+energies+of+organic+and+biological+molecules%3F&doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span></div><div class="casAuthors">Wang, Junmei; Cieplak, Piotr; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1049-1074</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors present conformational energies for a mol. mech. model (Parm99) developed for org. and biol. mols. using the restrained electrostatic potential (RESP) approach to derive the partial charges.  This approach uses the simple generic force field model (Parm94), and attempts to add a minimal no. of extra Fourier components to the torsional energies, but doing so only when there is a phys. justification.  The results are quite encouraging, not only for the 34-mol. set that was studied by both the highest level ab initio model (GVB/LMP2) and expt., but also for the 55-mol. set for which high-quality exptl. data are available.  Considering the 55 mols. studied by all the force field models for which there are exptl. data, the av. abs. errors (AAEs) are 0.28 (this model), 0.52 (MM3), 0.57 (CHARMm [MSI]), and 0.43 kcal/mol (MMFF).  For the 34-mol. set, the AAEs of this model vs. expt. and ab initio are 0.28 and 0.27 kcal/mol, resp.  This is a lower error than found with MM3 and CHARMm, and is comparable to that found with MMFF (0.31 and 0.22 kcal/mol).  The authors also present 2 examples of how well the torsional parameters are transferred from the training set to the test set.  The abs. errors of mols. in the test set are only slightly larger than in the training set (differences of <0.1 kcal/mol).  Therefore, a simple generic force field with a limited no. of specific torsional parameters can describe intra- and intermol. interactions, although all comparison mols. were selected from 82-compd. training set.  Also this effective 2-body model can be extended for use with a nonadditive force field (NAFF), both with and without lone pairs.  Without changing the torsional parameters, the use of more accurate charges and polarization increases av. abs. error compared with expt., but adjustment of the parameters restores the level of agreement found with the additive model.  After reoptimizing the Ψ, Φ torsional parameters in peptides using alanine dipeptide (6 conformational pairs) and alanine tetrapeptide (11 conformational pairs), the new model gives better energies than the Cornell et al. force field.  The av. abs. error of this model for high-level ab initio calcn. is 0.82 kcal/mol for alanine dipeptide and tetrapeptide as compared with 1.80 kcal/mol for the Cornell et al. model.  For nucleosides, the new model also gives improved energies compared with the Cornell et al. model.  To optimize force field parameters, the authors developed a program called parmscan, which can iteratively scan the torsional parameters in a systematic manner and finally obtain the vest torsional potentials.  Besides the org. mols. in test set, parmscan was also successful in optimizing the Ψ, Φ torsional parameters in peptides to significantly improve agreement between mol. mech. and high-level ab initio energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0dHME9_PfT7Vg90H21EOLACvtfcHk0lhb44AFRw79cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D&md5=c81631289cf58f63917e2a9fa9547ab6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-987X%2528200009%252921%253A12%253C1049%253A%253AAID-JCC3%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DHow%2520well%2520does%2520a%2520restrained%2520electrostatic%2520potential%2520%2528RESP%2529%2520model%2520perform%2520in%2520calculating%2520conformational%2520energies%2520of%2520organic%2520and%2520biological%2520molecules%253F%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2000%26volume%3D21%26issue%3D12%26spage%3D1049%26epage%3D1074%26doi%3D10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, D. A.</span><span> </span><span class="NLM_article-title">Development and testing of a general amber force field</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1174</span><span class="refDoi"> DOI: 10.1002/jcc.20035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1002%2Fjcc.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=15116359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1157-1174&issue=9&author=J.+Wangauthor=R.+M.+Wolfauthor=J.+W.+Caldwellauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Development+and+testing+of+a+general+amber+force+field&doi=10.1002%2Fjcc.20035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development and testing of a general Amber force field</span></div><div class="casAuthors">Wang, Junmei; Wolf, Romain M.; Caldwell, James W.; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1174</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe here a general Amber force field (GAFF) for org. mols.  GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most org. and pharmaceutical mols. that are composed of H, C, N, O, S, P, and halogens.  It uses a simple functional form and a limited no. of atom types, but incorporates both empirical and heuristic models to est. force consts. and partial at. charges.  The performance of GAFF in test cases is encouraging.  In test I, 74 crystallog. structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 Å, which is comparable to that of the Tripos 5.2 force field (0.25 Å) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 Å, resp.).  In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermol. energies were compared to MP2/6-31G* results.  The RMS of displacements and relative energies were 0.25 Å and 1.2 kcal/mol, resp.  These data are comparable to results from Parm99/RESP (0.16 Å and 1.18 kcal/mol, resp.), which were parameterized to these base pairs.  Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field.  The RMS error in relative energies (compared to expt.) is about 0.5 kcal/mol.  GAFF can be applied to wide range of mols. in an automatic fashion, making it suitable for rational drug design and database searching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW8Gsf8IiW7Vg90H21EOLACvtfcHk0lhb44AFRw79cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D&md5=2992017a8cf51f89290ae2562403b115</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520a%2520general%2520amber%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26issue%3D9%26spage%3D1157%26epage%3D1174%26doi%3D10.1002%2Fjcc.20035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Bradshaw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paavilainen, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisconte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughhead, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunn, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karr, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritsen, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunton, J.</span><span> </span><span class="NLM_article-title">Prolonged and tunable residence time using reversible covalent kinase inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span><span class="refDoi"> DOI: 10.1038/nchembio.1817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnchembio.1817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=26006010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=525-531&issue=7&author=J.+M.+Bradshawauthor=J.+M.+McFarlandauthor=V.+O.+Paavilainenauthor=A.+Bisconteauthor=D.+Tamauthor=V.+T.+Phanauthor=S.+Romanovauthor=D.+Finkleauthor=J.+Shuauthor=V.+Patelauthor=T.+Tonauthor=X.+Liauthor=D.+G.+Loughheadauthor=P.+A.+Nunnauthor=D.+E.+Karrauthor=M.+E.+Gerritsenauthor=J.+O.+Funkauthor=T.+D.+Owensauthor=E.+Vernerauthor=K.+A.+Brameldauthor=R.+J.+Hillauthor=D.+M.+Goldsteinauthor=J.+Taunton&title=Prolonged+and+tunable+residence+time+using+reversible+covalent+kinase+inhibitors&doi=10.1038%2Fnchembio.1817"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged and tunable residence time using reversible covalent kinase inhibitors</span></div><div class="casAuthors">Bradshaw, J. Michael; McFarland, Jesse M.; Paavilainen, Ville O.; Bisconte, Angelina; Tam, Danny; Phan, Vernon T.; Romanov, Sergei; Finkle, David; Shu, Jin; Patel, Vaishali; Ton, Tony; Li, Xiaoyan; Loughhead, David G.; Nunn, Philip A.; Karr, Dane E.; Gerritsen, Mary E.; Funk, Jens Oliver; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Hill, Ronald J.; Goldstein, David M.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">525-531</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drugs with prolonged on-target residence times often show superior efficacy, yet general strategies for optimizing drug-target residence time are lacking.  Here the authors made progress toward this elusive goal by targeting a noncatalytic cysteine in Bruton's tyrosine kinase (BTK) with reversible covalent inhibitors.  Using an inverted orientation of the cysteine-reactive cyanoacrylamide electrophile, the authors identified potent and selective BTK inhibitors that demonstrated biochem. residence times spanning from minutes to 7 d.  An inverted cyanoacrylamide with prolonged residence time in vivo remained bound to BTK for more than 18 h after clearance from the circulation.  The inverted cyanoacrylamide strategy was further used to discover fibroblast growth factor receptor (FGFR) kinase inhibitors with residence times of several days, demonstrating the generalizability of the approach.  Targeting of noncatalytic cysteines with inverted cyanoacrylamides may serve as a broadly applicable platform that facilitates 'residence time by design', the ability to modulate and improve the duration of target engagement in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXCpNprhn6kLVg90H21EOLACvtfcHk0lhRbL4mj_IH9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE&md5=85a73d9ecd62695d03166f7009c68dd8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1817%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DPaavilainen%26aufirst%3DV.%2BO.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DPhan%26aufirst%3DV.%2BT.%26aulast%3DRomanov%26aufirst%3DS.%26aulast%3DFinkle%26aufirst%3DD.%26aulast%3DShu%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DTon%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLoughhead%26aufirst%3DD.%2BG.%26aulast%3DNunn%26aufirst%3DP.%2BA.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DGerritsen%26aufirst%3DM.%2BE.%26aulast%3DFunk%26aufirst%3DJ.%2BO.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DProlonged%2520and%2520tunable%2520residence%2520time%2520using%2520reversible%2520covalent%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D7%26spage%3D525%26epage%3D531%26doi%3D10.1038%2Fnchembio.1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Jasinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwolak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borja-Cacho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, A. Z.</span><span> </span><span class="NLM_article-title">MT477 acts in tumor cells as an AURKA inhibitor and strongly induces NRF-2 signaling</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1181</span><span class="NLM_x">–</span> <span class="NLM_lpage">1187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=21508363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A280%3ADC%252BC3Mvlt1ahuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=1181-1187&issue=4&author=P.+Jasinskiauthor=P.+Zwolakauthor=K.+Teraiauthor=R.+I.+Vogelauthor=D.+Borja-Cachoauthor=A.+Z.+Dudek&title=MT477+acts+in+tumor+cells+as+an+AURKA+inhibitor+and+strongly+induces+NRF-2+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">MT477 acts in tumor cells as an AURKA inhibitor and strongly induces NRF-2 signaling</span></div><div class="casAuthors">Jasinski Piotr; Zwolak Pawel; Terai Kaoru; Vogel Rachel Isaksson; Borja-Cacho Daniel; Dudek Arkadiusz Z</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1181-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The novel compound thiopyrano [2,3-c]quinoline (MT477) has been shown to exhibit antitumor activity in both in vitro and in vivo studies.  The present study examined the expression levels of 10,000 genes and how they changed after MT477 treatment in three cancer cell lines: H226, MDA231 and MiaPaCa-2.  Materials and Methods/  RESULTS:  Molecular function analysis revealed changes in genes involved in cell death, cell-cycle progression and cellular growth and proliferation in all three cancer cell lines.  Canonical pathway analysis showed the involvement of the NRF2-mediated oxidative stress response, glucocorticoid, p53, RXR-VDR, G(1)/S checkpoint regulation, ERK, SAPK/JNK and JAS/Stat signaling.  Analysis of 234 kinases and phosphatases using a kinase inhibition assay demonstrated a strong inhibitory effect for MAPK14 (104 ± 2%), AMPK A2/B1/G1 (89%) and FGR (83 ± 2%).  AURKA was inhibited at 77 ± 1%.  MiaPaCa-2 tumor xenograft studies showed a 49.5 ±1 4.8% inhibitory effect in mice treated with 100 μg/kg MT477 compared to untreated mice (p=0.0021).  CONCLUSION:  MT477 induces molecular mechanisms related to cell death, survival, and inhibition of cellular growth in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSocJNnCvcebFWTCLT8lX9SfW6udTcc2ebIfyoSHxXomrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mvlt1ahuw%253D%253D&md5=910c126d01738133ad34eebe6bd5b727</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJasinski%26aufirst%3DP.%26aulast%3DZwolak%26aufirst%3DP.%26aulast%3DTerai%26aufirst%3DK.%26aulast%3DVogel%26aufirst%3DR.%2BI.%26aulast%3DBorja-Cacho%26aufirst%3DD.%26aulast%3DDudek%26aufirst%3DA.%2BZ.%26atitle%3DMT477%2520acts%2520in%2520tumor%2520cells%2520as%2520an%2520AURKA%2520inhibitor%2520and%2520strongly%2520induces%2520NRF-2%2520signaling%26jtitle%3DAnticancer%2520Res.%26date%3D2011%26volume%3D31%26issue%3D4%26spage%3D1181%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">McGovern, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helfand, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">A specific mechanism of nonspecific inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">4265</span><span class="NLM_x">–</span> <span class="NLM_lpage">4272</span><span class="refDoi"> DOI: 10.1021/jm030266r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030266r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFamsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4265-4272&issue=20&author=S.+L.+McGovernauthor=B.+T.+Helfandauthor=B.+Fengauthor=B.+K.+Shoichet&title=A+specific+mechanism+of+nonspecific+inhibition&doi=10.1021%2Fjm030266r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A Specific Mechanism of Nonspecific Inhibition</span></div><div class="casAuthors">McGovern, Susan L.; Helfand, Brian T.; Feng, Brian; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4265-4272</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Promiscuous small mols. plague screening libraries and hit lists.  Previous work has found that several nonspecific compds. form submicrometer aggregates, and it has been suggested that this aggregate species is responsible for the inhibition of many different enzymes.  It is not understood how aggregates inhibit their targets.  To address this question, biophys., kinetic, and microscopy methods were used to study the interaction of promiscuous, aggregate-forming inhibitors with model proteins.  By use of centrifugation and gel electrophoresis, aggregates and protein were found to directly interact.  This is consistent with a subsequent observation from confocal fluorescence microscopy that aggregates conc. green fluorescent protein.  β-Lactamase mutants with increased or decreased thermodn. stability relative to wild-type enzyme were equally inhibited by an aggregate-forming compd., suggesting that denaturation by unfolding was not the primary mechanism of interaction.  Instead, visualization by electron microscopy revealed that enzyme assocs. with the surface of inhibitor aggregates.  This assocn. could be reversed or prevented by the addn. of Triton X-100.  These observations suggest that the aggregates formed by promiscuous compds. reversibly sequester enzyme, resulting in apparent inhibition.  They also suggest a simple method to identify or reverse the action of aggregate-based inhibitors, which appear to be widespread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppdLVG_GeLZbVg90H21EOLACvtfcHk0lg-q7tC0ze-0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFamsbs%253D&md5=cd0fd6bf0a64ceb7d7219dae2406dd21</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm030266r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030266r%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DHelfand%26aufirst%3DB.%2BT.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DA%2520specific%2520mechanism%2520of%2520nonspecific%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D20%26spage%3D4265%26epage%3D4272%26doi%3D10.1021%2Fjm030266r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Feng, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">A detergent-based assay for the detection of promiscuous inhibitors</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">550</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1038/nprot.2006.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnprot.2006.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=17191086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOitLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=550-553&issue=2&author=B.+Y.+Fengauthor=B.+K.+Shoichet&title=A+detergent-based+assay+for+the+detection+of+promiscuous+inhibitors&doi=10.1038%2Fnprot.2006.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">A detergent-based assay for the detection of promiscuous inhibitors</span></div><div class="casAuthors">Feng, Brian Y.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">550-553</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">At micromolar concns., many small mols. self-assoc. into colloidal aggregates that non-specifically inhibit enzymes and other proteins.  Here the authors describe a protocol for identifying aggregate-based inhibitors and distinguishing them from small mols. that inhibit via specific mechanisms.  As a convenient proxy for promiscuous, aggregate-based inhibition, the authors monitor inhibition of β-lactamase in the absence and presence of detergent.  Inhibition that is attenuated in the presence of detergent is characteristic of an aggregate-based mechanism.  In the 96-well-format assay described here, about 200 mols. can be tested, in duplicate, per h for detergent-dependent sensitivity.  Furthermore, the authors also describe simple expts. that can offer addnl. confirmation of aggregate-based inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplGQSBvMgM-7Vg90H21EOLACvtfcHk0lg-q7tC0ze-0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOitLjO&md5=8aa7562b5f69c896af7e133ecc35e6de</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.77%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%2BY.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DA%2520detergent-based%2520assay%2520for%2520the%2520detection%2520of%2520promiscuous%2520inhibitors%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26issue%3D2%26spage%3D550%26epage%3D553%26doi%3D10.1038%2Fnprot.2006.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Anastassiadis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devarajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. R.</span><span> </span><span class="NLM_article-title">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1045</span><span class="refDoi"> DOI: 10.1038/nbt.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1038%2Fnbt.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=22037377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1039-1045&issue=11&author=T.+Anastassiadisauthor=S.+W.+Deaconauthor=K.+Devarajanauthor=H.+Maauthor=J.+R.+Peterson&title=Comprehensive+assay+of+kinase+catalytic+activity+reveals+features+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span></div><div class="casAuthors">Anastassiadis, Theonie; Deacon, Sean W.; Devarajan, Karthik; Ma, Haiching; Peterson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1045</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. protein kinase inhibitors are widely used to elucidate cellular signaling pathways and are promising therapeutic agents.  Owing to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases.  Interpretation of expts. that use these compds. is confounded by a lack of data on the comprehensive kinase selectivity of most inhibitors.  Here we used functional assays to profile the activity of 178 com. available kinase inhibitors against a panel of 300 recombinant protein kinases.  Quant. anal. revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity.  Many off-target interactions occur with seemingly unrelated kinases, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases.  The results have implications for drug development and provide a resource for selecting compds. to elucidate kinase function and for interpreting the results of expts. involving kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUljWIhZGPkrVg90H21EOLACvtfcHk0lg-q7tC0ze-0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E&md5=b2f705509b0e09afa46b01d4669f0515</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2017%26sid%3Dliteratum%253Aachs%26aulast%3DAnastassiadis%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%2BW.%26aulast%3DDevarajan%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DJ.%2BR.%26atitle%3DComprehensive%2520assay%2520of%2520kinase%2520catalytic%2520activity%2520reveals%2520features%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26issue%3D11%26spage%3D1039%26epage%3D1045%26doi%3D10.1038%2Fnbt.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Wang, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earnest, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J. H.</span><span> </span><span class="NLM_article-title">The macromolecular crystallography beamline of SSRF</span> <span class="citation_source-journal">Nucl. Sci. Tech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.13538/j.1001-8042/nst.26.010102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.13538%2Fj.1001-8042%2Fnst.26.010102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=12-17&issue=1&author=Q.+S.+Wangauthor=F.+Yuauthor=S.+Huangauthor=B.+Sunauthor=K.+H.+Zhangauthor=K.+Liuauthor=Z.+J.+Wangauthor=C.+Y.+Xuauthor=S.+S.+Wangauthor=L.+F.+Yangauthor=Q.+Y.+Panauthor=L.+Liauthor=H.+Zhouauthor=Y.+Cuiauthor=Q.+Xuauthor=T.+Earnestauthor=J.+H.+He&title=The+macromolecular+crystallography+beamline+of+SSRF&doi=10.13538%2Fj.1001-8042%2Fnst.26.010102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.13538%2Fj.1001-8042%2Fnst.26.010102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.13538%252Fj.1001-8042%252Fnst.26.010102%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%2BS.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DK.%2BH.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%2BJ.%26aulast%3DXu%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DS.%2BS.%26aulast%3DYang%26aufirst%3DL.%2BF.%26aulast%3DPan%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DEarnest%26aufirst%3DT.%26aulast%3DHe%26aufirst%3DJ.%2BH.%26atitle%3DThe%2520macromolecular%2520crystallography%2520beamline%2520of%2520SSRF%26jtitle%3DNucl.%2520Sci.%2520Tech.%26date%3D2015%26volume%3D26%26issue%3D1%26spage%3D12%26epage%3D17%26doi%3D10.13538%2Fj.1001-8042%2Fnst.26.010102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span><span class="refDoi"> DOI: 10.1016/S0076-6879(97)76066-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode&doi=10.1016%2FS0076-6879%2897%2976066-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0ljDaZtzIcuP7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326%26doi%3D10.1016%2FS0076-6879%2897%2976066-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljDaZtzIcuP7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D4%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skubak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&issue=4&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0ljIfPsG9DbgMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26issue%3D4%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OUY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OUY','PDB','1OUY'); return false;">PDB: 1OUY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYX','PDB','5XYX'); return false;">PDB: 5XYX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BYM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3BYM','PDB','3BYM'); return false;">PDB: 3BYM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T9T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T9T','PDB','3T9T'); return false;">PDB: 3T9T</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYY','PDB','5XYY'); return false;">PDB: 5XYY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYZ','PDB','5XYZ'); return false;">PDB: 5XYZ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i18"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01075">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62701"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01075">10.1021/acs.jmedchem.7b01075</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Structure and activity of tested compounds, representative binding modes of known kinase inhibitors, structural comparison between the predicted binding mode and crystal structure, statistics of crystal structures, chemical similarity analysis, and <sup>1</sup>H NMR, HPLC, and HRMS results of representative compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Compound characterization checklist (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_002.xls">XLS</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_001.pdf">jm7b01075_si_001.pdf (4.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_002.xls">jm7b01075_si_002.xls (91.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01075/suppl_file/jm7b01075_si_003.csv">jm7b01075_si_003.csv (0.77 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes for p38α MAPK bound with <b>1</b> and <b>3</b> are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYX">5XYX</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYY">5XYY</a>. PDB code for BTK bound with <b>8</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XYZ">5XYZ</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01075&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01075%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-20%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01075" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799586d698e3db8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
